Interpretation of the evidence for the efficacy and safety of statin therapy

This Review is intended to help clinicians, patients, and the public make informed decisions about statin therapy for the prevention of heart attacks and strokes. It explains how the evidence that is available from randomised controlled trials yields reliable information about both the efficacy and...

Full description

Saved in:

Bibliographic Details
Published in:	The Lancet (British edition) Vol. 388; no. 10059; pp. 2532 - 2561
Main Authors:	Collins, Rory, Reith, Christina, Emberson, Jonathan, Armitage, Jane, Baigent, Colin, Blackwell, Lisa, Blumenthal, Roger, Danesh, John, Smith, George Davey, DeMets, David, Evans, Stephen, Law, Malcolm, MacMahon, Stephen, Martin, Seth, Neal, Bruce, Poulter, Neil, Preiss, David, Ridker, Paul, Roberts, Ian, Rodgers, Anthony, Sandercock, Peter, Schulz, Kenneth, Sever, Peter, Simes, John, Smeeth, Liam, Wald, Nicholas, Yusuf, Salim, Peto, Richard
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 19.11.2016 Elsevier Limited
Subjects:	Anticholesteremic Agents - therapeutic use Cardiovascular disease Cholesterol Cholesterol, LDL - blood Clinical outcomes Clinical Trials as Topic Coronary Disease - drug therapy Coronary Disease - prevention & control Drug therapy Drug-Related Side Effects and Adverse Reactions Health risks Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Internal Medicine Myocardial Infarction - drug therapy Myocardial Infarction - prevention & control Pain Patient safety Patients Prevention Risk Assessment Safety Side effects Simvastatin - therapeutic use Statins Stroke - drug therapy Stroke - prevention & control Studies Vascular diseases
ISSN:	0140-6736, 1474-547X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	This Review is intended to help clinicians, patients, and the public make informed decisions about statin therapy for the prevention of heart attacks and strokes. It explains how the evidence that is available from randomised controlled trials yields reliable information about both the efficacy and safety of statin therapy. In addition, it discusses how claims that statins commonly cause adverse effects reflect a failure to recognise the limitations of other sources of evidence about the effects of treatment. Large-scale evidence from randomised trials shows that statin therapy reduces the risk of major vascular events (ie, coronary deaths or myocardial infarctions, strokes, and coronary revascularisation procedures) by about one-quarter for each mmol/L reduction in LDL cholesterol during each year (after the first) that it continues to be taken. The absolute benefits of statin therapy depend on an individual's absolute risk of occlusive vascular events and the absolute reduction in LDL cholesterol that is achieved. For example, lowering LDL cholesterol by 2 mmol/L (77 mg/dL) with an effective low-cost statin regimen (eg, atorvastatin 40 mg daily, costing about £2 per month) for 5 years in 10 000 patients would typically prevent major vascular events from occurring in about 1000 patients (ie, 10% absolute benefit) with pre-existing occlusive vascular disease (secondary prevention) and in 500 patients (ie, 5% absolute benefit) who are at increased risk but have not yet had a vascular event (primary prevention). Statin therapy has been shown to reduce vascular disease risk during each year it continues to be taken, so larger absolute benefits would accrue with more prolonged therapy, and these benefits persist long term. The only serious adverse events that have been shown to be caused by long-term statin therapy—ie, adverse effects of the statin—are myopathy (defined as muscle pain or weakness combined with large increases in blood concentrations of creatine kinase), new-onset diabetes mellitus, and, probably, haemorrhagic stroke. Typically, treatment of 10 000 patients for 5 years with an effective regimen (eg, atorvastatin 40 mg daily) would cause about 5 cases of myopathy (one of which might progress, if the statin therapy is not stopped, to the more severe condition of rhabdomyolysis), 50–100 new cases of diabetes, and 5–10 haemorrhagic strokes. However, any adverse impact of these side-effects on major vascular events has already been taken into account in the estimates of the absolute benefits. Statin therapy may cause symptomatic adverse events (eg, muscle pain or weakness) in up to about 50–100 patients (ie, 0·5–1·0% absolute harm) per 10 000 treated for 5 years. However, placebo-controlled randomised trials have shown definitively that almost all of the symptomatic adverse events that are attributed to statin therapy in routine practice are not actually caused by it (ie, they represent misattribution). The large-scale evidence available from randomised trials also indicates that it is unlikely that large absolute excesses in other serious adverse events still await discovery. Consequently, any further findings that emerge about the effects of statin therapy would not be expected to alter materially the balance of benefits and harms. It is, therefore, of concern that exaggerated claims about side-effect rates with statin therapy may be responsible for its under-use among individuals at increased risk of cardiovascular events. For, whereas the rare cases of myopathy and any muscle-related symptoms that are attributed to statin therapy generally resolve rapidly when treatment is stopped, the heart attacks or strokes that may occur if statin therapy is stopped unnecessarily can be devastating.
AbstractList	This Review is intended to help clinicians, patients, and the public make informed decisions about statin therapy for the prevention of heart attacks and strokes. It explains how the evidence that is available from randomised controlled trials yields reliable information about both the efficacy and safety of statin therapy. In addition, it discusses how claims that statins commonly cause adverse effects reflect a failure to recognise the limitations of other sources of evidence about the effects of treatment. Large-scale evidence from randomised trials shows that statin therapy reduces the risk of major vascular events (ie, coronary deaths or myocardial infarctions, strokes, and coronary revascularisation procedures) by about one-quarter foreachmmol/L reduction in LDL cholesterol duringeachyear (after the first) that it continues to be taken. The absolute benefits of statin therapy depend on an individual's absolute risk of occlusive vascular events and the absolute reduction in LDL cholesterol that is achieved. For example, lowering LDL cholesterol by 2 mmol/L (77 mg/dL) with an effective low-cost statin regimen (eg, atorvastatin 40 mg daily, costing about £2 per month) for 5 years in 10 000 patients would typically prevent major vascular events from occurring in about 1000 patients (ie, 10% absolute benefit) with pre-existing occlusive vascular disease (secondary prevention) and in 500 patients (ie, 5% absolute benefit) who are at increased risk but have not yet had a vascular event (primary prevention). Statin therapy has been shown to reduce vascular disease risk during each year it continues to be taken, so larger absolute benefits would accrue with more prolonged therapy, and these benefits persist long term. The only serious adverse events that have been shown to be caused by long-term statin therapy--ie, adverseeffectsof the statin--are myopathy (defined as muscle pain or weakness combined with large increases in blood concentrations of creatine kinase), new-onset diabetes mellitus, and, probably, haemorrhagic stroke. Typically, treatment of 10 000 patients for 5 years with an effective regimen (eg, atorvastatin 40 mg daily) would cause about 5 cases of myopathy (one of which might progress, if the statin therapy is not stopped, to the more severe condition of rhabdomyolysis), 50-100 new cases of diabetes, and 5-10 haemorrhagic strokes. However, any adverse impact of these side-effects on major vascular events has already been taken into account in the estimates of the absolute benefits. Statin therapy may cause symptomatic adverse events (eg, muscle pain or weakness) in up to about 50-100 patients (ie, 0·5-1·0% absolute harm) per 10 000 treated for 5 years. However, placebo-controlled randomised trials have shown definitively that almost all of the symptomatic adverse events that are attributed to statin therapy in routine practice are not actually caused by it (ie, they represent misattribution). The large-scale evidence available from randomised trials also indicates that it is unlikely that large absolute excesses in other serious adverse events still await discovery. Consequently, any further findings that emerge about the effects of statin therapy would not be expected to alter materially the balance of benefits and harms. It is, therefore, of concern that exaggerated claims about side-effect rates with statin therapy may be responsible for its under-use among individuals at increased risk of cardiovascular events. For, whereas the rare cases of myopathy and any muscle-related symptoms that are attributed to statin therapy generally resolve rapidly when treatment is stopped, the heart attacks or strokes that may occur if statin therapy is stopped unnecessarily can be devastating. This Review is intended to help clinicians, patients, and the public make informed decisions about statin therapy for the prevention of heart attacks and strokes. It explains how the evidence that is available from randomised controlled trials yields reliable information about both the efficacy and safety of statin therapy. In addition, it discusses how claims that statins commonly cause adverse effects reflect a failure to recognise the limitations of other sources of evidence about the effects of treatment. Large-scale evidence from randomised trials shows that statin therapy reduces the risk of major vascular events (ie, coronary deaths or myocardial infarctions, strokes, and coronary revascularisation procedures) by about one-quarter for each mmol/L reduction in LDL cholesterol during each year (after the first) that it continues to be taken. The absolute benefits of statin therapy depend on an individual's absolute risk of occlusive vascular events and the absolute reduction in LDL cholesterol that is achieved. For example, lowering LDL cholesterol by 2 mmol/L (77 mg/dL) with an effective low-cost statin regimen (eg, atorvastatin 40 mg daily, costing about £2 per month) for 5 years in 10 000 patients would typically prevent major vascular events from occurring in about 1000 patients (ie, 10% absolute benefit) with pre-existing occlusive vascular disease (secondary prevention) and in 500 patients (ie, 5% absolute benefit) who are at increased risk but have not yet had a vascular event (primary prevention). Statin therapy has been shown to reduce vascular disease risk during each year it continues to be taken, so larger absolute benefits would accrue with more prolonged therapy, and these benefits persist long term. The only serious adverse events that have been shown to be caused by long-term statin therapy—ie, adverse effects of the statin—are myopathy (defined as muscle pain or weakness combined with large increases in blood concentrations of creatine kinase), new-onset diabetes mellitus, and, probably, haemorrhagic stroke. Typically, treatment of 10 000 patients for 5 years with an effective regimen (eg, atorvastatin 40 mg daily) would cause about 5 cases of myopathy (one of which might progress, if the statin therapy is not stopped, to the more severe condition of rhabdomyolysis), 50–100 new cases of diabetes, and 5–10 haemorrhagic strokes. However, any adverse impact of these side-effects on major vascular events has already been taken into account in the estimates of the absolute benefits. Statin therapy may cause symptomatic adverse events (eg, muscle pain or weakness) in up to about 50–100 patients (ie, 0·5–1·0% absolute harm) per 10 000 treated for 5 years. However, placebo-controlled randomised trials have shown definitively that almost all of the symptomatic adverse events that are attributed to statin therapy in routine practice are not actually caused by it (ie, they represent misattribution). The large-scale evidence available from randomised trials also indicates that it is unlikely that large absolute excesses in other serious adverse events still await discovery. Consequently, any further findings that emerge about the effects of statin therapy would not be expected to alter materially the balance of benefits and harms. It is, therefore, of concern that exaggerated claims about side-effect rates with statin therapy may be responsible for its under-use among individuals at increased risk of cardiovascular events. For, whereas the rare cases of myopathy and any muscle-related symptoms that are attributed to statin therapy generally resolve rapidly when treatment is stopped, the heart attacks or strokes that may occur if statin therapy is stopped unnecessarily can be devastating. Summary This Review is intended to help clinicians, patients, and the public make informed decisions about statin therapy for the prevention of heart attacks and strokes. It explains how the evidence that is available from randomised controlled trials yields reliable information about both the efficacy and safety of statin therapy. In addition, it discusses how claims that statins commonly cause adverse effects reflect a failure to recognise the limitations of other sources of evidence about the effects of treatment. Large-scale evidence from randomised trials shows that statin therapy reduces the risk of major vascular events (ie, coronary deaths or myocardial infarctions, strokes, and coronary revascularisation procedures) by about one-quarter for each mmol/L reduction in LDL cholesterol during each year (after the first) that it continues to be taken. The absolute benefits of statin therapy depend on an individual's absolute risk of occlusive vascular events and the absolute reduction in LDL cholesterol that is achieved. For example, lowering LDL cholesterol by 2 mmol/L (77 mg/dL) with an effective low-cost statin regimen (eg, atorvastatin 40 mg daily, costing about £2 per month) for 5 years in 10 000 patients would typically prevent major vascular events from occurring in about 1000 patients (ie, 10% absolute benefit) with pre-existing occlusive vascular disease (secondary prevention) and in 500 patients (ie, 5% absolute benefit) who are at increased risk but have not yet had a vascular event (primary prevention). Statin therapy has been shown to reduce vascular disease risk during each year it continues to be taken, so larger absolute benefits would accrue with more prolonged therapy, and these benefits persist long term. The only serious adverse events that have been shown to be caused by long-term statin therapy—ie, adverse effects of the statin—are myopathy (defined as muscle pain or weakness combined with large increases in blood concentrations of creatine kinase), new-onset diabetes mellitus, and, probably, haemorrhagic stroke. Typically, treatment of 10 000 patients for 5 years with an effective regimen (eg, atorvastatin 40 mg daily) would cause about 5 cases of myopathy (one of which might progress, if the statin therapy is not stopped, to the more severe condition of rhabdomyolysis), 50–100 new cases of diabetes, and 5–10 haemorrhagic strokes. However, any adverse impact of these side-effects on major vascular events has already been taken into account in the estimates of the absolute benefits. Statin therapy may cause symptomatic adverse events (eg, muscle pain or weakness) in up to about 50–100 patients (ie, 0·5–1·0% absolute harm) per 10 000 treated for 5 years. However, placebo-controlled randomised trials have shown definitively that almost all of the symptomatic adverse events that are attributed to statin therapy in routine practice are not actually caused by it (ie, they represent misattribution). The large-scale evidence available from randomised trials also indicates that it is unlikely that large absolute excesses in other serious adverse events still await discovery. Consequently, any further findings that emerge about the effects of statin therapy would not be expected to alter materially the balance of benefits and harms. It is, therefore, of concern that exaggerated claims about side-effect rates with statin therapy may be responsible for its under-use among individuals at increased risk of cardiovascular events. For, whereas the rare cases of myopathy and any muscle-related symptoms that are attributed to statin therapy generally resolve rapidly when treatment is stopped, the heart attacks or strokes that may occur if statin therapy is stopped unnecessarily can be devastating.
Author	Armitage, Jane Sandercock, Peter Blumenthal, Roger Wald, Nicholas Schulz, Kenneth Emberson, Jonathan Poulter, Neil Sever, Peter MacMahon, Stephen Rodgers, Anthony Yusuf, Salim Danesh, John Blackwell, Lisa Evans, Stephen Preiss, David Martin, Seth DeMets, David Simes, John Neal, Bruce Peto, Richard Reith, Christina Smith, George Davey Baigent, Colin Roberts, Ian Smeeth, Liam Law, Malcolm Collins, Rory Ridker, Paul
Author_xml	– sequence: 1 givenname: Rory surname: Collins fullname: Collins, Rory email: rory.collins@ndph.ox.ac.uk organization: Clinical Trial Service Unit & Epidemiological Studies Unit and MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK – sequence: 2 givenname: Christina surname: Reith fullname: Reith, Christina organization: Clinical Trial Service Unit & Epidemiological Studies Unit and MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK – sequence: 3 givenname: Jonathan surname: Emberson fullname: Emberson, Jonathan organization: Clinical Trial Service Unit & Epidemiological Studies Unit and MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK – sequence: 4 givenname: Jane surname: Armitage fullname: Armitage, Jane organization: Clinical Trial Service Unit & Epidemiological Studies Unit and MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK – sequence: 5 givenname: Colin surname: Baigent fullname: Baigent, Colin organization: Clinical Trial Service Unit & Epidemiological Studies Unit and MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK – sequence: 6 givenname: Lisa surname: Blackwell fullname: Blackwell, Lisa organization: Clinical Trial Service Unit & Epidemiological Studies Unit and MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK – sequence: 7 givenname: Roger surname: Blumenthal fullname: Blumenthal, Roger organization: Ciccarone Center for the Prevention of Heart Disease, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA – sequence: 8 givenname: John surname: Danesh fullname: Danesh, John organization: MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK – sequence: 9 givenname: George Davey surname: Smith fullname: Smith, George Davey organization: MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK – sequence: 10 givenname: David surname: DeMets fullname: DeMets, David organization: Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI, USA – sequence: 11 givenname: Stephen surname: Evans fullname: Evans, Stephen organization: Department of Medical Statistics, London School of Hygiene & Tropical Medicine, University of London, London, UK – sequence: 12 givenname: Malcolm surname: Law fullname: Law, Malcolm organization: Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK – sequence: 13 givenname: Stephen surname: MacMahon fullname: MacMahon, Stephen organization: The George Institute for Global Health, University of Sydney, Sydney, Australia – sequence: 14 givenname: Seth surname: Martin fullname: Martin, Seth organization: Ciccarone Center for the Prevention of Heart Disease, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA – sequence: 15 givenname: Bruce surname: Neal fullname: Neal, Bruce organization: The George Institute for Global Health, University of Sydney, Sydney, Australia – sequence: 16 givenname: Neil surname: Poulter fullname: Poulter, Neil organization: International Centre for Circulatory Health & Imperial Clinical Trials Unit, Imperial College London, London, UK – sequence: 17 givenname: David surname: Preiss fullname: Preiss, David organization: Clinical Trial Service Unit & Epidemiological Studies Unit and MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK – sequence: 18 givenname: Paul surname: Ridker fullname: Ridker, Paul organization: Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA – sequence: 19 givenname: Ian surname: Roberts fullname: Roberts, Ian organization: Clinical Trials Unit, London School of Hygiene & Tropical Medicine, University of London, London, UK – sequence: 20 givenname: Anthony surname: Rodgers fullname: Rodgers, Anthony organization: The George Institute for Global Health, University of Sydney, Sydney, Australia – sequence: 21 givenname: Peter surname: Sandercock fullname: Sandercock, Peter organization: Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK – sequence: 22 givenname: Kenneth surname: Schulz fullname: Schulz, Kenneth organization: FHI 360, University of North Carolina School of Medicine, University of North Carolina, Chapel Hill, NC, USA – sequence: 23 givenname: Peter surname: Sever fullname: Sever, Peter organization: International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, UK – sequence: 24 givenname: John surname: Simes fullname: Simes, John organization: National Health and Medical Research Council Clinical Trial Centre, University of Sydney, Sydney, Australia – sequence: 25 givenname: Liam surname: Smeeth fullname: Smeeth, Liam organization: Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, University of London, London, UK – sequence: 26 givenname: Nicholas surname: Wald fullname: Wald, Nicholas organization: Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK – sequence: 27 givenname: Salim surname: Yusuf fullname: Yusuf, Salim organization: Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, ON, Canada – sequence: 28 givenname: Richard surname: Peto fullname: Peto, Richard organization: Clinical Trial Service Unit & Epidemiological Studies Unit and MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/27616593$$D View this record in MEDLINE/PubMed
BookMark	eNqNkV1rFDEYhYNU7Lb6E5QBb9qL0WTyMTOISil-FBa8UMG7kEneYOpssk2yhfn3TnZahQWpV0OG5zwJ55ygIx88IPSc4FcEE_H6KyYM16Kl4oyIc0oob2v-CK0Ia1nNWfvjCK3-IMfoJKVrjDETmD9Bx00riOA9XaH1lc8QtxGyyi74Ktgq_4QKbp0Br6GyIS4_rHVa6alS3lRJWchTYVOJ-UJEtZ2eosdWjQme3X1P0fePH75dfq7XXz5dXV6say0Iz7VmGBjuB64pECAD7jTF1PQEN23PeqOgb-hATCu0Grpet9QKoRllVhgtMNBTdLZ4tzHc7CBluXFJwzgqD2GXJOlYw_uOMDqjLw_Q67CLfn5doURHG0LZTL24o3bDBozcRrdRcZL3Pc3AmwXQMaQUwUrtlsZyVG6UBMuyityvIkvlcj7tV5F8TvOD9P0FD-XeLzmYy7x1EGXSrsxiXASdpQnuQcO7A4MenZ-XHH_BBOlvFzI1Ei-S4iBibyiCt_8W_McDfgMLlMpk
CODEN	LANCAO
CitedBy_id	crossref_primary_10_1161_CIRCULATIONAHA_120_048340 crossref_primary_10_1007_s11897_017_0347_7 crossref_primary_10_1007_s00394_018_1608_2 crossref_primary_10_1155_2021_6264414 crossref_primary_10_1007_s11886_019_1246_1 crossref_primary_10_1093_eurheartj_ehx661 crossref_primary_10_1097_HCO_0000000000001208 crossref_primary_10_1016_j_jacl_2018_04_006 crossref_primary_10_1515_cclm_2022_1301 crossref_primary_10_1038_s41394_020_00378_y crossref_primary_10_2337_dc21_1607 crossref_primary_10_1016_j_atherosclerosis_2021_01_009 crossref_primary_10_3233_JAD_170858 crossref_primary_10_1038_s41598_017_11070_x crossref_primary_10_1093_ndt_gfx329 crossref_primary_10_1093_brain_awz413 crossref_primary_10_3390_molecules28073176 crossref_primary_10_1177_09691413241235488 crossref_primary_10_1007_s40268_017_0213_9 crossref_primary_10_1016_j_jacl_2020_09_001 crossref_primary_10_1002_cpt_3213 crossref_primary_10_1080_14737175_2021_1866988 crossref_primary_10_1007_s11883_019_0793_7 crossref_primary_10_1007_s00392_025_02608_5 crossref_primary_10_1016_j_jad_2021_04_002 crossref_primary_10_1136_heartjnl_2017_311244 crossref_primary_10_1007_s10557_017_6723_4 crossref_primary_10_1177_1363459320946067 crossref_primary_10_1016_j_atherosclerosis_2018_02_035 crossref_primary_10_3390_diagnostics13030503 crossref_primary_10_1038_nrcardio_2017_92 crossref_primary_10_1016_j_ijcard_2018_04_068 crossref_primary_10_1016_S0140_6736_18_31878_6 crossref_primary_10_1080_14779072_2017_1357468 crossref_primary_10_1002_anie_202511725 crossref_primary_10_1016_j_ejim_2017_12_011 crossref_primary_10_1016_j_jff_2024_106357 crossref_primary_10_1016_j_phymed_2022_154625 crossref_primary_10_1007_s11886_021_01514_2 crossref_primary_10_1016_j_atherosclerosis_2018_10_009 crossref_primary_10_1007_s40273_022_01152_8 crossref_primary_10_1097_FPC_0000000000000412 crossref_primary_10_1177_23969873251340815 crossref_primary_10_3390_jcm13040943 crossref_primary_10_1016_j_therap_2017_12_004 crossref_primary_10_1038_s41598_023_38275_7 crossref_primary_10_1016_j_athx_2019_100002 crossref_primary_10_1016_j_athplu_2022_08_002 crossref_primary_10_1111_acel_13497 crossref_primary_10_1111_bph_13700 crossref_primary_10_1016_j_jdiacomp_2024_108923 crossref_primary_10_1016_j_jacl_2017_09_006 crossref_primary_10_1016_j_jdiacomp_2020_107713 crossref_primary_10_1016_j_ajem_2020_11_033 crossref_primary_10_1016_j_atherosclerosis_2020_07_019 crossref_primary_10_3390_life13061325 crossref_primary_10_1093_ehjqcco_qcx003 crossref_primary_10_1007_s11883_021_00932_5 crossref_primary_10_1161_CIRCULATIONAHA_123_065770 crossref_primary_10_1016_j_clinbiochem_2018_10_011 crossref_primary_10_1159_000456618 crossref_primary_10_36290_vnl_2023_109 crossref_primary_10_1007_s11886_018_1003_x crossref_primary_10_1371_journal_pbio_3000572 crossref_primary_10_1016_S0140_6736_19_33002_8 crossref_primary_10_1016_j_cjca_2018_01_091 crossref_primary_10_1186_s12916_019_1298_5 crossref_primary_10_1016_j_mmm_2021_02_011 crossref_primary_10_7554_eLife_57191 crossref_primary_10_1016_j_jjcc_2017_10_009 crossref_primary_10_1016_j_atherosclerosis_2021_02_011 crossref_primary_10_2337_dc20_0913 crossref_primary_10_1016_j_ijcard_2021_03_007 crossref_primary_10_1007_s15006_018_0090_3 crossref_primary_10_1001_jama_2019_16598 crossref_primary_10_1111_imj_14190 crossref_primary_10_1186_s12902_021_00690_0 crossref_primary_10_1155_2019_6724903 crossref_primary_10_1161_CIR_0000000000000624 crossref_primary_10_1161_CIR_0000000000000625 crossref_primary_10_1111_joim_12614 crossref_primary_10_1007_s11883_023_01167_2 crossref_primary_10_1002_psb_2110 crossref_primary_10_1016_j_atherosclerosis_2020_06_023 crossref_primary_10_1016_j_ymthe_2018_06_004 crossref_primary_10_1007_s10557_018_6794_x crossref_primary_10_1080_00498254_2022_2090301 crossref_primary_10_1111_jgs_15763 crossref_primary_10_1161_ATVBAHA_121_316159 crossref_primary_10_1016_j_therap_2019_07_004 crossref_primary_10_1210_clinem_dgaf031 crossref_primary_10_1007_s11560_024_00789_0 crossref_primary_10_1016_j_mattod_2017_07_008 crossref_primary_10_1016_j_jacc_2017_09_001 crossref_primary_10_1056_NEJMoa1706444 crossref_primary_10_1136_dtb_2018_000060 crossref_primary_10_3390_jcm13113179 crossref_primary_10_5551_jat_65624 crossref_primary_10_1093_ehjqcco_qcx027 crossref_primary_10_1007_s12013_022_01123_y crossref_primary_10_1302_2046_3758_1010_BJR_2021_0162_R3 crossref_primary_10_1002_ejlt_202300105 crossref_primary_10_3390_microorganisms12020242 crossref_primary_10_2196_71675 crossref_primary_10_1016_j_amjmed_2016_12_046 crossref_primary_10_1016_j_jacc_2018_04_054 crossref_primary_10_3389_fphar_2024_1363501 crossref_primary_10_1111_jpc_13567 crossref_primary_10_1136_thoraxjnl_2019_213790 crossref_primary_10_3390_ijms222011067 crossref_primary_10_3389_fphys_2021_666449 crossref_primary_10_1038_s41467_021_25703_3 crossref_primary_10_1152_ajpendo_00056_2025 crossref_primary_10_1007_s00108_020_00799_9 crossref_primary_10_1007_s12170_018_0565_x crossref_primary_10_1007_s00228_020_02967_0 crossref_primary_10_1093_eurheartj_ehy533 crossref_primary_10_1161_STROKEAHA_122_039728 crossref_primary_10_1093_eurheartj_ehz629 crossref_primary_10_1017_S0950268823000286 crossref_primary_10_1016_j_jacc_2018_04_061 crossref_primary_10_1161_HCQ_0000000000000121 crossref_primary_10_1038_s41572_019_0106_z crossref_primary_10_1007_s11906_019_0927_x crossref_primary_10_1007_s40263_019_00633_3 crossref_primary_10_36290_neu_2020_067 crossref_primary_10_1016_j_amjmed_2019_01_042 crossref_primary_10_1002_adhm_202500196 crossref_primary_10_1186_s12933_023_01752_4 crossref_primary_10_1007_s00592_017_0990_1 crossref_primary_10_1016_j_jstrokecerebrovasdis_2020_104793 crossref_primary_10_1016_j_vph_2019_106566 crossref_primary_10_1177_1535370217750088 crossref_primary_10_1002_ctm2_1587 crossref_primary_10_1016_j_atherosclerosis_2021_03_017 crossref_primary_10_1007_s15006_018_1120_x crossref_primary_10_1016_j_clineuro_2023_107900 crossref_primary_10_1097_HCO_0000000000000518 crossref_primary_10_3390_cancers14030825 crossref_primary_10_1016_j_ccl_2017_12_007 crossref_primary_10_3390_biom9090496 crossref_primary_10_1016_j_amjmed_2019_01_031 crossref_primary_10_1016_j_atherosclerosis_2019_09_005 crossref_primary_10_1080_17425255_2018_1482276 crossref_primary_10_1016_j_eprac_2024_08_013 crossref_primary_10_1007_s00392_024_02420_7 crossref_primary_10_1016_j_jacadv_2024_101231 crossref_primary_10_1038_d41586_020_01281_0 crossref_primary_10_1093_eurjpc_zwab209 crossref_primary_10_1056_NEJMoa1910355 crossref_primary_10_1194_jlr_S074039 crossref_primary_10_1016_j_jcmg_2021_03_028 crossref_primary_10_1038_s41467_024_48568_8 crossref_primary_10_1056_NEJMsb1901642 crossref_primary_10_1016_S0140_6736_17_30717_1 crossref_primary_10_1038_nrcardio_2016_164 crossref_primary_10_1007_s10557_020_07106_6 crossref_primary_10_1007_s40656_021_00367_w crossref_primary_10_1016_j_amjcard_2018_02_011 crossref_primary_10_1080_14740338_2024_2424411 crossref_primary_10_3390_ijms19061680 crossref_primary_10_1371_journal_pone_0257760 crossref_primary_10_1038_s41586_018_0457_8 crossref_primary_10_1134_S1990750823600474 crossref_primary_10_1007_s40261_020_00989_1 crossref_primary_10_1177_1740774518764449 crossref_primary_10_1186_s12959_022_00445_4 crossref_primary_10_15829_1560_4071_2024_6117 crossref_primary_10_15829_1728_8800_2025_4385 crossref_primary_10_1093_rheumatology_kez613 crossref_primary_10_2217_pgs_2018_0007 crossref_primary_10_1093_eurheartj_ehz455 crossref_primary_10_1007_s40265_024_02113_5 crossref_primary_10_1016_j_acvd_2017_07_007 crossref_primary_10_1007_s11886_019_1108_x crossref_primary_10_1038_s41598_023_31643_3 crossref_primary_10_3390_jpm11111123 crossref_primary_10_1007_s10557_017_6727_0 crossref_primary_10_1097_HCO_0000000000001038 crossref_primary_10_1111_cts_12740 crossref_primary_10_1038_s41581_019_0212_x crossref_primary_10_1093_ehjqcco_qcaa023 crossref_primary_10_1002_pds_4389 crossref_primary_10_1111_acps_12722 crossref_primary_10_1007_s11307_025_02050_z crossref_primary_10_3390_cancers13225869 crossref_primary_10_1093_aje_kwx329 crossref_primary_10_1016_j_rccar_2017_10_002 crossref_primary_10_1186_s12877_018_0789_0 crossref_primary_10_1111_ane_12886 crossref_primary_10_1016_j_jacl_2018_02_013 crossref_primary_10_1016_S0140_6736_19_31893_8 crossref_primary_10_1016_j_jacl_2018_02_012 crossref_primary_10_1007_s00392_017_1193_z crossref_primary_10_1056_NEJMc2001195 crossref_primary_10_1007_s40256_018_0270_7 crossref_primary_10_1038_nrcardio_2017_189 crossref_primary_10_1016_j_ahj_2019_02_011 crossref_primary_10_1002_pds_5023 crossref_primary_10_1177_20501684231156958 crossref_primary_10_1016_j_pcad_2022_11_010 crossref_primary_10_1056_NEJMe1812000 crossref_primary_10_1097_CRD_0000000000001028 crossref_primary_10_1093_rheumatology_keaf238 crossref_primary_10_1371_journal_pone_0327500 crossref_primary_10_1007_s41999_018_0085_8 crossref_primary_10_1016_j_chemphyslip_2024_105377 crossref_primary_10_1016_j_mtchem_2022_101062 crossref_primary_10_1007_s11883_021_00936_1 crossref_primary_10_1136_heartjnl_2016_310959 crossref_primary_10_1093_eurheartj_ehy347 crossref_primary_10_1016_j_phymed_2025_157301 crossref_primary_10_3390_jcm11226619 crossref_primary_10_1093_eurjpc_zwaa126 crossref_primary_10_1016_j_lpm_2018_01_025 crossref_primary_10_1016_j_pcad_2022_11_008 crossref_primary_10_3389_fcvm_2025_1569904 crossref_primary_10_1007_s40520_024_02851_2 crossref_primary_10_1016_j_nrleng_2020_07_021 crossref_primary_10_1016_j_avsg_2021_03_055 crossref_primary_10_1136_openhrt_2017_000722 crossref_primary_10_1016_j_amjmed_2016_12_022 crossref_primary_10_1016_j_rce_2022_03_013 crossref_primary_10_1016_S0140_6736_19_33159_9 crossref_primary_10_7759_cureus_28783 crossref_primary_10_1186_s12944_017_0416_7 crossref_primary_10_1007_s11886_022_01760_y crossref_primary_10_1016_j_atherosclerosis_2019_08_014 crossref_primary_10_1097_HCO_0000000000001003 crossref_primary_10_1038_s41569_018_0098_5 crossref_primary_10_3390_biomedicines13081817 crossref_primary_10_1007_s00059_023_05219_w crossref_primary_10_1093_ehjqcco_qcaa072 crossref_primary_10_1093_eurjpc_zwaa164 crossref_primary_10_1186_s12935_023_03138_8 crossref_primary_10_1038_s41569_020_00493_1 crossref_primary_10_1016_j_jacc_2017_07_001 crossref_primary_10_1016_j_envres_2020_109678 crossref_primary_10_1007_s11883_020_00837_9 crossref_primary_10_1371_journal_pone_0209486 crossref_primary_10_3390_nu13093156 crossref_primary_10_7759_cureus_69492 crossref_primary_10_1093_ndt_gfae203 crossref_primary_10_1161_ATVBAHA_120_315628 crossref_primary_10_1111_ijcp_12936 crossref_primary_10_3390_medicina57060585 crossref_primary_10_1177_0300060517751452 crossref_primary_10_1186_s40246_025_00753_6 crossref_primary_10_5694_mja2_50142 crossref_primary_10_1161_STROKEAHA_116_015504 crossref_primary_10_5306_wjco_v11_i10_809 crossref_primary_10_1038_s41598_025_97428_y crossref_primary_10_1080_00325481_2017_1292107 crossref_primary_10_1007_s11883_019_0784_8 crossref_primary_10_3389_fcvm_2021_770746 crossref_primary_10_1016_j_amjmed_2021_11_009 crossref_primary_10_1371_journal_pcbi_1008491 crossref_primary_10_3390_ijms21217927 crossref_primary_10_7759_cureus_68150 crossref_primary_10_2196_14809 crossref_primary_10_1016_j_banm_2019_10_023 crossref_primary_10_1016_j_ahj_2022_05_021 crossref_primary_10_1016_j_jclinepi_2017_11_021 crossref_primary_10_1097_HCO_0000000000001222 crossref_primary_10_1016_j_phrs_2022_106370 crossref_primary_10_1016_S2215_0366_23_00366_8 crossref_primary_10_1097_MOP_0000000000000943 crossref_primary_10_1161_CIRCULATIONAHA_118_036846 crossref_primary_10_1093_aje_kwy233 crossref_primary_10_1177_0141076820914242 crossref_primary_10_1093_ehjcvp_pvaa076 crossref_primary_10_1080_14740338_2024_2389989 crossref_primary_10_1080_17460441_2022_2104247 crossref_primary_10_1111_bcpt_13343 crossref_primary_10_1016_j_jacc_2016_12_003 crossref_primary_10_1016_j_atherosclerosis_2018_11_001 crossref_primary_10_3390_toxins10060237 crossref_primary_10_36290_far_2017_036 crossref_primary_10_15829_1728_8800_2022_3235 crossref_primary_10_3390_jcm9010022 crossref_primary_10_1186_s12944_017_0493_7 crossref_primary_10_1007_s13300_021_01070_6 crossref_primary_10_3171_2021_12_JNS212797 crossref_primary_10_3390_jcdd12090355 crossref_primary_10_1161_STROKEAHA_117_019141 crossref_primary_10_1007_s11883_019_0807_5 crossref_primary_10_1016_j_tcm_2017_12_011 crossref_primary_10_1161_JAHA_121_025236 crossref_primary_10_1124_jpet_123_001963 crossref_primary_10_1016_j_biopha_2021_112519 crossref_primary_10_1016_j_endinu_2017_04_005 crossref_primary_10_1016_j_rhum_2018_09_002 crossref_primary_10_1097_HJH_0000000000002317 crossref_primary_10_3389_fcvm_2022_982815 crossref_primary_10_1016_j_jacc_2021_08_029 crossref_primary_10_1016_j_ejvs_2018_11_001 crossref_primary_10_1080_14779072_2023_2215982 crossref_primary_10_1016_j_repce_2019_11_008 crossref_primary_10_1016_j_semcancer_2019_10_018 crossref_primary_10_1097_YCO_0000000000000305 crossref_primary_10_1016_j_medcle_2018_03_001 crossref_primary_10_1053_j_gastro_2017_01_065 crossref_primary_10_1016_j_jacl_2022_09_001 crossref_primary_10_2337_dc19_1212 crossref_primary_10_1016_S2213_8587_18_30030_5 crossref_primary_10_1001_jama_2019_0015 crossref_primary_10_1016_j_ebiom_2018_01_015 crossref_primary_10_1097_MOL_0000000000000454 crossref_primary_10_1177_02698811211060307 crossref_primary_10_3390_jcm11195626 crossref_primary_10_1097_MOL_0000000000000453 crossref_primary_10_1080_17425255_2020_1822324 crossref_primary_10_1093_eurheartj_ehab647 crossref_primary_10_1097_MOL_0000000000000694 crossref_primary_10_1186_s12885_022_09385_8 crossref_primary_10_1038_s41467_025_55879_x crossref_primary_10_1016_j_yebeh_2022_108991 crossref_primary_10_1097_MOL_0000000000000459 crossref_primary_10_1161_CIRCULATIONAHA_117_028271 crossref_primary_10_1016_j_ajpc_2021_100294 crossref_primary_10_1016_S0140_6736_17_30712_2 crossref_primary_10_1111_bph_15893 crossref_primary_10_1093_eurjpc_zwab042 crossref_primary_10_1161_JAHA_119_012609 crossref_primary_10_1038_s41568_024_00743_1 crossref_primary_10_3390_jcm9123796 crossref_primary_10_1080_14737159_2021_1952075 crossref_primary_10_1016_j_amjmed_2020_09_058 crossref_primary_10_1016_j_jval_2023_05_002 crossref_primary_10_1002_ccd_27985 crossref_primary_10_1016_j_maturitas_2017_08_006 crossref_primary_10_1007_s41669_021_00300_8 crossref_primary_10_1161_CIRCRESAHA_117_311015 crossref_primary_10_1056_NEJMoa1701488 crossref_primary_10_1007_s10557_018_6775_0 crossref_primary_10_1080_00325481_2018_1436843 crossref_primary_10_1016_j_aimed_2024_08_006 crossref_primary_10_1093_ije_dyx207 crossref_primary_10_1016_j_ajpc_2025_101019 crossref_primary_10_1016_j_ejmech_2018_11_011 crossref_primary_10_1001_jamanetworkopen_2023_48213 crossref_primary_10_1016_j_mayocp_2024_08_025 crossref_primary_10_1080_14740338_2019_1615053 crossref_primary_10_1007_s00228_019_02645_w crossref_primary_10_3389_fendo_2023_1254221 crossref_primary_10_1053_j_gastro_2020_07_010 crossref_primary_10_1093_eurheartj_ehy182 crossref_primary_10_1161_CIRCOUTCOMES_122_009348 crossref_primary_10_1113_JP276747 crossref_primary_10_3390_metabo11080531 crossref_primary_10_14797_mdcvj_1617 crossref_primary_10_1097_MOL_0000000000000433 crossref_primary_10_1016_j_atherosclerosis_2017_11_020 crossref_primary_10_18087_cardio_2020_2_n943 crossref_primary_10_33393_grhta_2021_2255 crossref_primary_10_1016_j_molmet_2020_101003 crossref_primary_10_1093_eurheartj_ehaa574 crossref_primary_10_1136_dtb_2019_000066 crossref_primary_10_1016_j_bbagen_2018_06_005 crossref_primary_10_1016_j_amjcard_2019_02_043 crossref_primary_10_3390_foods14111880 crossref_primary_10_3390_jcm12175685 crossref_primary_10_1186_s12872_019_1034_2 crossref_primary_10_1007_s10557_020_07077_8 crossref_primary_10_1053_j_gastro_2017_01_054 crossref_primary_10_1080_07315724_2016_1277171 crossref_primary_10_1093_eurheartj_ehz282 crossref_primary_10_1177_2047487317706586 crossref_primary_10_1016_j_jacc_2019_11_072 crossref_primary_10_1080_14779072_2017_1364627 crossref_primary_10_1161_CIRCULATIONAHA_116_026859 crossref_primary_10_1016_j_pcad_2023_03_001 crossref_primary_10_1016_j_atherosclerosis_2022_06_1019 crossref_primary_10_1161_CIR_0000000000001038 crossref_primary_10_3390_molecules22040589 crossref_primary_10_1001_jamainternmed_2022_0134 crossref_primary_10_1007_s00228_024_03724_3 crossref_primary_10_1186_s12872_019_1187_z crossref_primary_10_1111_imj_13691 crossref_primary_10_1016_j_jacc_2018_02_032 crossref_primary_10_1002_adtp_202300107 crossref_primary_10_1016_j_jacc_2021_08_065 crossref_primary_10_1002_mus_26637 crossref_primary_10_1111_bph_14136 crossref_primary_10_1161_JAHA_120_017948 crossref_primary_10_1016_j_mehy_2023_111111 crossref_primary_10_1371_journal_pmed_1003841 crossref_primary_10_1016_j_dsx_2019_04_006 crossref_primary_10_1097_CRD_0000000000000994 crossref_primary_10_23736_S0021_9509_18_10463_0 crossref_primary_10_1186_s12916_020_01792_7 crossref_primary_10_1016_j_jep_2022_116110 crossref_primary_10_1093_eurheartj_ehab841 crossref_primary_10_1093_eurheartj_ehab604 crossref_primary_10_1111_jgs_16060 crossref_primary_10_1007_s10354_017_0594_y crossref_primary_10_1093_ije_dyw305 crossref_primary_10_1136_bmjopen_2018_026002 crossref_primary_10_1016_j_repce_2021_07_005 crossref_primary_10_1080_14740338_2021_1954158 crossref_primary_10_1007_s10557_024_07587_9 crossref_primary_10_1016_S0140_6736_23_01925_6 crossref_primary_10_1177_17557380251364739 crossref_primary_10_1016_j_tcm_2018_01_008 crossref_primary_10_1016_S0140_6736_17_31075_9 crossref_primary_10_1177_2047487317721980 crossref_primary_10_7717_peerj_7856 crossref_primary_10_1016_j_jacl_2018_03_088 crossref_primary_10_1186_s12883_025_04257_7 crossref_primary_10_1093_ehjcvp_pvaf007 crossref_primary_10_1007_s00125_023_05977_6 crossref_primary_10_1007_s11886_021_01584_2 crossref_primary_10_1016_S0140_6736_17_30721_3 crossref_primary_10_1161_STROKEAHA_120_030790 crossref_primary_10_3390_biom15040468 crossref_primary_10_1007_s12471_021_01600_8 crossref_primary_10_36660_abc_20230242 crossref_primary_10_3390_jcm10153427 crossref_primary_10_1080_14656566_2017_1285905 crossref_primary_10_3390_ijms22042070 crossref_primary_10_1681_ASN_0000000000000112 crossref_primary_10_5334_gh_1097 crossref_primary_10_1161_ATVBAHA_121_315882 crossref_primary_10_1161_STROKEAHA_123_042621 crossref_primary_10_1161_CIRCOUTCOMES_117_004171 crossref_primary_10_1016_j_ijcard_2018_06_104 crossref_primary_10_1016_j_jconrel_2021_03_034 crossref_primary_10_1093_eurheartj_ehab863 crossref_primary_10_1016_j_phrs_2024_107551 crossref_primary_10_1080_00325481_2018_1402658 crossref_primary_10_1371_journal_pone_0196030 crossref_primary_10_3389_fcvm_2022_1061346 crossref_primary_10_3389_fphar_2022_815882 crossref_primary_10_1093_cvr_cvac020 crossref_primary_10_1111_joim_13176 crossref_primary_10_2217_pgs_2021_0075 crossref_primary_10_1136_bmjebm_2019_111300 crossref_primary_10_1016_j_vph_2025_107516 crossref_primary_10_1371_journal_pgen_1009105 crossref_primary_10_1016_j_jacc_2019_12_072 crossref_primary_10_1093_eurjpc_zwaf219 crossref_primary_10_1016_j_jacl_2016_12_007 crossref_primary_10_1161_CIRCRESAHA_117_308903 crossref_primary_10_1080_14656566_2018_1544243 crossref_primary_10_1016_j_jfma_2023_09_018 crossref_primary_10_1161_CIRCULATIONAHA_119_043826 crossref_primary_10_1016_j_jtha_2024_01_017 crossref_primary_10_1186_s12933_025_02798_2 crossref_primary_10_3390_pharmaceutics16020214 crossref_primary_10_1016_j_amjmed_2019_06_003 crossref_primary_10_1093_ehjopen_oead029 crossref_primary_10_1038_s41598_019_55682_x crossref_primary_10_7759_cureus_46605 crossref_primary_10_1177_17557380241229980 crossref_primary_10_1016_j_jacl_2024_12_014 crossref_primary_10_1016_j_numecd_2018_03_012 crossref_primary_10_1161_STROKEAHA_120_029345 crossref_primary_10_3389_fnut_2023_1155817 crossref_primary_10_1007_s10557_021_07256_1 crossref_primary_10_1016_j_phrs_2017_06_011 crossref_primary_10_1016_j_repc_2019_02_009 crossref_primary_10_1038_s44161_022_00085_x crossref_primary_10_1017_S0029665119000685 crossref_primary_10_18311_jnr_2020_24795 crossref_primary_10_1002_clc_22868 crossref_primary_10_1080_07391102_2023_2222173 crossref_primary_10_1016_j_bbrc_2020_08_013 crossref_primary_10_1093_eurheartj_ehaf606 crossref_primary_10_1038_s41581_018_0072_9 crossref_primary_10_1177_1077558717707313 crossref_primary_10_1111_dme_14531 crossref_primary_10_1007_s12325_020_01608_3 crossref_primary_10_1007_s40266_019_00736_y crossref_primary_10_1016_j_ejim_2017_09_023 crossref_primary_10_3390_ijms24021366 crossref_primary_10_1007_s12265_021_10144_6 crossref_primary_10_3390_ijms25147694 crossref_primary_10_1093_eurheartj_ehab484 crossref_primary_10_1016_j_biopha_2023_115736 crossref_primary_10_1016_j_insmatheco_2020_11_001 crossref_primary_10_1016_j_jacl_2022_12_002 crossref_primary_10_1093_bja_aex248 crossref_primary_10_1097_HJH_0000000000003480 crossref_primary_10_1080_02648725_2023_2186559 crossref_primary_10_1016_j_tcm_2021_09_006 crossref_primary_10_1186_s12944_020_01265_z crossref_primary_10_1038_nrcardio_2017_11 crossref_primary_10_3390_medicina61050918 crossref_primary_10_1080_17425255_2024_2402493 crossref_primary_10_2147_DMSO_S234382 crossref_primary_10_1007_s10557_023_07459_8 crossref_primary_10_1016_S0140_6736_16_32075_X crossref_primary_10_1371_journal_pone_0187347 crossref_primary_10_1016_j_phrs_2017_09_013 crossref_primary_10_1161_STROKEAHA_119_026992 crossref_primary_10_1016_j_cpcardiol_2017_03_001 crossref_primary_10_1016_j_clinthera_2023_06_008 crossref_primary_10_1186_s12902_021_00813_7 crossref_primary_10_1016_j_atherosclerosis_2022_08_015 crossref_primary_10_3390_ijerph181910148 crossref_primary_10_1016_j_jacc_2023_11_029 crossref_primary_10_1080_10408398_2020_1778631 crossref_primary_10_1016_j_phrs_2021_105524 crossref_primary_10_5334_gh_1056 crossref_primary_10_1016_S1567_5688_17_30024_7 crossref_primary_10_1161_JAHA_117_006400 crossref_primary_10_7759_cureus_66483 crossref_primary_10_1097_MOL_0000000000000830 crossref_primary_10_1002_jcp_27121 crossref_primary_10_1080_17425255_2020_1749261 crossref_primary_10_1111_fcp_12756 crossref_primary_10_3390_cells10082007 crossref_primary_10_1016_j_beem_2023_101749 crossref_primary_10_3390_jcm10163642 crossref_primary_10_1016_j_acvd_2022_10_004 crossref_primary_10_1161_JAHA_119_014840 crossref_primary_10_1080_03007995_2018_1439829 crossref_primary_10_1097_MOL_0000000000000834 crossref_primary_10_1007_s00125_024_06100_z crossref_primary_10_1038_s41598_020_75901_0 crossref_primary_10_17116_jnevro202512506199 crossref_primary_10_1016_j_jacc_2017_10_080 crossref_primary_10_1016_j_clinbiochem_2021_06_004 crossref_primary_10_1161_CIRCULATIONAHA_117_027597 crossref_primary_10_3390_jcm12010363 crossref_primary_10_1136_bmjopen_2017_021309 crossref_primary_10_1016_j_jacc_2020_01_064 crossref_primary_10_1111_jgh_14794 crossref_primary_10_3389_fcell_2020_578790 crossref_primary_10_1016_j_artere_2017_12_001 crossref_primary_10_1016_j_jacc_2018_06_046 crossref_primary_10_1016_j_jacc_2022_02_048 crossref_primary_10_1016_j_ijcard_2021_04_025 crossref_primary_10_1111_eci_13594 crossref_primary_10_1002_hsr2_70165 crossref_primary_10_1016_j_nano_2018_06_010 crossref_primary_10_1001_jamanetworkopen_2021_39748 crossref_primary_10_1002_med_21590 crossref_primary_10_7326_L19_0260 crossref_primary_10_1371_journal_pone_0198263 crossref_primary_10_1016_j_phanu_2023_100374 crossref_primary_10_1136_bmjopen_2017_019041 crossref_primary_10_7326_M18_0808 crossref_primary_10_7326_L19_0262 crossref_primary_10_1016_j_ajhg_2021_08_014 crossref_primary_10_1016_j_bja_2020_01_010 crossref_primary_10_1016_j_cld_2025_06_003 crossref_primary_10_1159_000488311 crossref_primary_10_1007_s15027_017_1186_x crossref_primary_10_1016_j_ijcard_2018_02_085 crossref_primary_10_1016_j_diabres_2020_108197 crossref_primary_10_1016_j_jacc_2022_02_037 crossref_primary_10_1038_s41574_018_0110_5 crossref_primary_10_1097_MOL_0000000000000896 crossref_primary_10_1016_j_jacc_2017_11_068 crossref_primary_10_1038_s41398_023_02533_z crossref_primary_10_3389_fmed_2022_939800 crossref_primary_10_1161_JAHA_124_036357 crossref_primary_10_1155_2020_1954398 crossref_primary_10_1002_jat_3825 crossref_primary_10_1007_s10753_018_0812_9 crossref_primary_10_1016_j_mayocp_2018_08_011 crossref_primary_10_1097_MOL_0000000000000644 crossref_primary_10_1007_s43440_025_00716_7 crossref_primary_10_1016_j_dsx_2019_07_005 crossref_primary_10_3892_etm_2017_5584 crossref_primary_10_1038_s41569_024_01103_0 crossref_primary_10_1093_eurheartj_ehw637 crossref_primary_10_1111_nep_14411 crossref_primary_10_1136_bmjopen_2019_029420 crossref_primary_10_1111_dom_15146 crossref_primary_10_1016_j_numecd_2021_08_040 crossref_primary_10_1007_s11883_020_00853_9 crossref_primary_10_5694_mja2_51821 crossref_primary_10_1002_pds_4895 crossref_primary_10_1016_S0140_6736_16_30962_X crossref_primary_10_1016_j_atherosclerosis_2022_07_004 crossref_primary_10_15829_1560_4071_2023_5471 crossref_primary_10_1016_j_atherosclerosis_2022_07_003 crossref_primary_10_1371_journal_pmed_1004556 crossref_primary_10_1016_S0140_6736_18_31942_1 crossref_primary_10_1093_eurheartj_suaa116 crossref_primary_10_1007_s11886_023_01861_2 crossref_primary_10_1001_jamanetworkopen_2019_0223 crossref_primary_10_1093_bmb_ldad009 crossref_primary_10_1016_j_ijcard_2017_08_055 crossref_primary_10_1007_s10557_017_6743_0 crossref_primary_10_1016_j_amjms_2021_12_011 crossref_primary_10_1093_eurheartj_ehab220 crossref_primary_10_1371_journal_pgen_1009501 crossref_primary_10_1016_j_acvd_2021_01_001 crossref_primary_10_1016_j_jbspin_2017_09_014 crossref_primary_10_33678_cor_2022_043 crossref_primary_10_3390_nu13092957 crossref_primary_10_2196_jmir_8325 crossref_primary_10_1186_s12906_020_03012_4 crossref_primary_10_1007_s11883_019_0800_z crossref_primary_10_1093_eurpub_ckaa032 crossref_primary_10_3390_immuno2020021 crossref_primary_10_37489_2782_3784_myrwd_067 crossref_primary_10_1002_clc_22678 crossref_primary_10_1210_jc_2019_00195 crossref_primary_10_1016_j_jacc_2021_09_006 crossref_primary_10_1016_j_jacadv_2024_100886 crossref_primary_10_1038_nrcardio_2017_78 crossref_primary_10_1007_s00392_024_02556_6 crossref_primary_10_1093_eurheartj_ehy872 crossref_primary_10_3892_mmr_2025_13590 crossref_primary_10_3389_fcvm_2022_892335 crossref_primary_10_1016_j_jacl_2020_10_007 crossref_primary_10_1093_eurheartj_ehx549 crossref_primary_10_1136_bmj_l5674 crossref_primary_10_1016_j_jacc_2020_03_040 crossref_primary_10_1186_s13020_022_00666_9 crossref_primary_10_1016_j_eprac_2023_07_029 crossref_primary_10_1007_s11894_017_0584_7 crossref_primary_10_1016_j_pcl_2020_06_006 crossref_primary_10_1097_FJC_0000000000001402 crossref_primary_10_1186_s12944_024_02014_2 crossref_primary_10_1002_clc_23437 crossref_primary_10_1016_j_cjca_2018_07_013 crossref_primary_10_1016_j_clinthera_2022_03_013 crossref_primary_10_1161_CIRCOUTCOMES_121_008552 crossref_primary_10_1159_000515829 crossref_primary_10_1038_s41392_022_01125_5 crossref_primary_10_1111_ggi_13647 crossref_primary_10_1371_journal_pone_0315693 crossref_primary_10_3748_wjg_v27_i28_4639 crossref_primary_10_3389_fphar_2025_1626681 crossref_primary_10_3390_jcm8122127 crossref_primary_10_1016_j_yebeh_2017_10_021 crossref_primary_10_1093_rheumatology_keab851 crossref_primary_10_1016_S0140_6736_17_32471_6 crossref_primary_10_1016_j_ijcard_2023_131138 crossref_primary_10_1038_s41598_021_86090_9 crossref_primary_10_1007_s00018_023_04786_9 crossref_primary_10_1111_bcp_14217 crossref_primary_10_1161_CIRCOUTCOMES_120_007183 crossref_primary_10_1016_j_ijcard_2018_03_114 crossref_primary_10_2217_fca_2022_0020 crossref_primary_10_1038_s41598_021_94803_3 crossref_primary_10_3390_jcm14176241 crossref_primary_10_3389_fphar_2024_1398934 crossref_primary_10_1007_s40261_017_0589_x crossref_primary_10_1136_bmj_n135 crossref_primary_10_1136_practneurol_2017_001738 crossref_primary_10_1016_j_toxrep_2025_102049 crossref_primary_10_1093_ije_dyz068 crossref_primary_10_3389_fpubh_2023_1139496 crossref_primary_10_1007_s10557_023_07476_7 crossref_primary_10_1007_s40278_016_21194_7 crossref_primary_10_1371_journal_pmed_1003498 crossref_primary_10_1371_journal_pone_0247419 crossref_primary_10_1016_j_jad_2018_12_110 crossref_primary_10_1210_clinem_dgac708 crossref_primary_10_1093_ajhp_zxaa352 crossref_primary_10_3390_metabo12080753 crossref_primary_10_1016_j_artres_2017_04_001 crossref_primary_10_2217_pmt_2022_0017 crossref_primary_10_1016_j_ajpc_2025_100959 crossref_primary_10_1124_jpet_123_001878 crossref_primary_10_1016_j_repce_2019_07_004 crossref_primary_10_1111_bjhp_12298 crossref_primary_10_1007_s00125_019_05049_8 crossref_primary_10_20935_AcadNutr7875 crossref_primary_10_4103_jpbs_JPBS_30_17 crossref_primary_10_1016_j_cjca_2018_07_477 crossref_primary_10_1016_j_jacc_2017_12_068 crossref_primary_10_1371_journal_pone_0249409 crossref_primary_10_1111_bph_13818 crossref_primary_10_1016_j_kint_2019_01_028 crossref_primary_10_1016_j_ijcard_2019_07_094 crossref_primary_10_1016_j_atherosclerosis_2018_06_871 crossref_primary_10_1016_j_jep_2021_114058 crossref_primary_10_1016_j_tcm_2021_04_007 crossref_primary_10_1016_j_atherosclerosis_2019_12_006 crossref_primary_10_1371_journal_pbio_3001547 crossref_primary_10_1080_14656566_2022_2112945 crossref_primary_10_33590_emj_10312148 crossref_primary_10_1002_14651858_CD014565 crossref_primary_10_1016_j_jacadv_2023_100825 crossref_primary_10_1177_2047487317691874 crossref_primary_10_1016_j_therap_2016_10_004 crossref_primary_10_1080_14740338_2019_1681395 crossref_primary_10_1016_j_mjafi_2021_05_023 crossref_primary_10_1177_2047487320929779 crossref_primary_10_3390_md21120624 crossref_primary_10_1371_journal_pone_0292240 crossref_primary_10_1016_j_atherosclerosis_2021_09_020 crossref_primary_10_7717_peerj_3952 crossref_primary_10_1056_NEJMoa1615664 crossref_primary_10_1007_s00772_021_00840_7 crossref_primary_10_1007_s11606_021_07107_7 crossref_primary_10_1016_j_cjca_2024_04_017 crossref_primary_10_1093_eurheartj_ehx586 crossref_primary_10_1016_j_jpba_2018_08_033 crossref_primary_10_1097_HCO_0000000000000678 crossref_primary_10_2147_PPA_S334668 crossref_primary_10_12688_f1000research_23199_1 crossref_primary_10_1016_S2213_8587_17_30357_1 crossref_primary_10_2217_fon_2018_0160 crossref_primary_10_1097_CCM_0000000000002559 crossref_primary_10_1161_CIRCULATIONAHA_117_029960 crossref_primary_10_1161_STROKEAHA_119_028718 crossref_primary_10_1515_revneuro_2023_0005 crossref_primary_10_4330_wjc_v13_i9_472 crossref_primary_10_1111_apt_14451 crossref_primary_10_1001_jamanetworkopen_2021_0661 crossref_primary_10_1016_j_bpj_2022_08_039 crossref_primary_10_1016_j_clinthera_2022_04_010 crossref_primary_10_1016_j_jacc_2017_07_764 crossref_primary_10_1016_j_jpeds_2019_07_064 crossref_primary_10_1161_JAHA_122_028310 crossref_primary_10_1002_ange_202511725 crossref_primary_10_1016_j_atherosclerosissup_2018_04_001 crossref_primary_10_1161_CIRCOUTCOMES_118_005460 crossref_primary_10_1016_j_jacl_2019_07_005 crossref_primary_10_1186_s43044_020_00058_0 crossref_primary_10_1111_bcpt_12998 crossref_primary_10_1371_journal_pmed_1003062 crossref_primary_10_1136_bcr_2016_218942 crossref_primary_10_1016_j_tcm_2023_08_001 crossref_primary_10_1093_eurheartj_ehz778 crossref_primary_10_3390_cimb47050354 crossref_primary_10_1016_j_ebiom_2021_103318 crossref_primary_10_1093_eurheartj_ehad103 crossref_primary_10_1055_a_1488_6912 crossref_primary_10_1016_j_jcmg_2016_12_018 crossref_primary_10_1016_j_jclinepi_2021_10_003 crossref_primary_10_3389_fendo_2023_1239335 crossref_primary_10_1016_j_jacc_2024_08_007 crossref_primary_10_1038_s41467_024_48441_8 crossref_primary_10_2174_1381612828666220919085019 crossref_primary_10_1002_jcsm_12960 crossref_primary_10_1016_S2468_2667_19_30023_4 crossref_primary_10_1080_14737175_2021_2003705 crossref_primary_10_1136_bmj_p1723 crossref_primary_10_1001_jamanetworkopen_2023_29066 crossref_primary_10_1093_eurheartj_ehy653 crossref_primary_10_1007_s15006_019_0742_y crossref_primary_10_1016_j_amjcard_2025_05_029 crossref_primary_10_1016_S0140_6736_17_30718_3 crossref_primary_10_1007_s11739_021_02809_6 crossref_primary_10_1007_s15027_016_1031_7 crossref_primary_10_1097_MED_0000000000000595 crossref_primary_10_5334_gh_1412 crossref_primary_10_1002_ptr_8046 crossref_primary_10_1161_CIRCGENETICS_117_002014 crossref_primary_10_1016_j_atherosclerosis_2022_11_022 crossref_primary_10_1016_j_phrs_2017_12_028 crossref_primary_10_1002_acr_24866 crossref_primary_10_3390_livers4040046 crossref_primary_10_1016_j_clinthera_2021_07_019 crossref_primary_10_1002_cpt_1176 crossref_primary_10_1038_s41391_022_00554_1 crossref_primary_10_3390_metabo11120857 crossref_primary_10_1007_s12181_022_00575_z crossref_primary_10_1093_ehjcvp_pvx031 crossref_primary_10_1093_ehjopen_oeab039 crossref_primary_10_3390_jcm8030381 crossref_primary_10_3390_jpm11111226 crossref_primary_10_1093_eurheartj_ehz514 crossref_primary_10_1016_j_tcm_2020_08_008 crossref_primary_10_3390_molecules26102838 crossref_primary_10_1038_s41598_018_21819_7 crossref_primary_10_3389_fneur_2022_856239 crossref_primary_10_1016_j_cjca_2024_11_002 crossref_primary_10_1016_j_clinthera_2019_10_010 crossref_primary_10_3390_jcm13216562 crossref_primary_10_1016_j_jacc_2017_07_752 crossref_primary_10_1016_j_phrs_2023_106962 crossref_primary_10_1016_j_jjcc_2024_03_006 crossref_primary_10_3389_fimmu_2025_1550400 crossref_primary_10_1093_eurheartj_ehx144 crossref_primary_10_1007_s00108_023_01536_8 crossref_primary_10_1136_heartjnl_2016_310605 crossref_primary_10_1097_HPC_0000000000000390 crossref_primary_10_1007_s13273_019_0002_3 crossref_primary_10_1016_j_ahj_2018_12_007 crossref_primary_10_3390_molecules28104048 crossref_primary_10_1080_17512433_2018_1519391 crossref_primary_10_1016_j_ejro_2023_100527 crossref_primary_10_36290_vnl_2018_058 crossref_primary_10_1186_s13063_024_08273_9 crossref_primary_10_1016_j_jacc_2017_12_001 crossref_primary_10_4140_TCP_n_2025_347 crossref_primary_10_1136_bmj_n1537 crossref_primary_10_1002_cpt_1557 crossref_primary_10_1080_1744666X_2018_1440206 crossref_primary_10_1016_j_jacc_2025_02_016 crossref_primary_10_1016_j_atherosclerosis_2018_08_040 crossref_primary_10_1016_S0140_6736_25_00721_4 crossref_primary_10_1139_apnm_2018_0488 crossref_primary_10_1016_j_cjca_2016_10_019 crossref_primary_10_1016_j_japh_2018_12_003 crossref_primary_10_1007_s12181_024_00669_w crossref_primary_10_1016_j_jacl_2019_04_011 crossref_primary_10_1093_ckj_sfaf151 crossref_primary_10_1002_cpt_887 crossref_primary_10_7759_cureus_81034 crossref_primary_10_1016_S0140_6736_19_32966_6 crossref_primary_10_1016_j_cpcardiol_2022_101416 crossref_primary_10_1093_eurheartj_ehz785 crossref_primary_10_1097_MLR_0000000000000682 crossref_primary_10_3389_fphar_2019_00889 crossref_primary_10_7554_eLife_58567 crossref_primary_10_1111_1468_0009_12328 crossref_primary_10_1002_advs_202403451 crossref_primary_10_1161_JAHA_123_032678 crossref_primary_10_3389_fnagi_2022_968039 crossref_primary_10_1016_j_ijcard_2019_07_001 crossref_primary_10_1016_S0001_4079_19_30249_3 crossref_primary_10_1038_s41467_020_16969_0 crossref_primary_10_1161_JAHA_120_018338 crossref_primary_10_1016_j_ajpc_2024_100649 crossref_primary_10_1016_j_lpm_2018_09_002 crossref_primary_10_1055_a_1099_9556 crossref_primary_10_1161_JAHA_120_020893 crossref_primary_10_2215_CJN_0000000000000124 crossref_primary_10_4306_jknpa_2022_61_2_45 crossref_primary_10_3389_fimmu_2022_1103533 crossref_primary_10_1016_j_ijcard_2024_131857 crossref_primary_10_12998_wjcc_v13_i27_105415 crossref_primary_10_1080_09540261_2022_2113369 crossref_primary_10_1016_S0140_6736_17_30716_X crossref_primary_10_1186_s12939_025_02391_9 crossref_primary_10_1016_j_ijcard_2017_05_059 crossref_primary_10_1016_j_jad_2019_05_002 crossref_primary_10_38109_2075_082X_2024_4_5_109 crossref_primary_10_1016_j_jep_2021_114207 crossref_primary_10_1007_s10729_020_09537_x crossref_primary_10_1016_j_ahj_2023_12_010 crossref_primary_10_1002_jcsm_12344 crossref_primary_10_1007_s10049_021_00959_w crossref_primary_10_1136_bmjopen_2019_030290 crossref_primary_10_1016_S0140_6736_22_01545_8 crossref_primary_10_1016_j_atherosclerosis_2018_07_034 crossref_primary_10_1016_j_rec_2017_06_008 crossref_primary_10_1161_JAHA_124_038080 crossref_primary_10_3389_fcvm_2022_916031 crossref_primary_10_1007_s11883_021_00968_7 crossref_primary_10_1007_s11892_017_0837_8 crossref_primary_10_3389_fpsyt_2021_702617 crossref_primary_10_18087_cardio_2522 crossref_primary_10_1007_s12170_016_0523_4 crossref_primary_10_1038_d41586_021_01455_4 crossref_primary_10_1136_postgradmedj_2020_138746 crossref_primary_10_1016_S2213_8587_17_30150_X crossref_primary_10_1002_brb3_1751 crossref_primary_10_3945_ajcn_115_127357 crossref_primary_10_1097_PPO_0000000000000550 crossref_primary_10_1097_PRS_0000000000008526 crossref_primary_10_1161_CIRCULATIONAHA_116_026336 crossref_primary_10_7759_cureus_81260 crossref_primary_10_1016_j_acvd_2024_02_004 crossref_primary_10_1080_14656566_2019_1636033 crossref_primary_10_1002_cpt_1110 crossref_primary_10_1016_j_jbi_2022_104029 crossref_primary_10_4158_EP_2019_0078 crossref_primary_10_1093_ehjcvp_pvz079 crossref_primary_10_1016_j_ejvs_2025_07_014 crossref_primary_10_1161_CIRCRESAHA_118_313245 crossref_primary_10_1016_j_repc_2019_05_005 crossref_primary_10_1093_ehjcvp_pvab018 crossref_primary_10_1161_CIRCGEN_121_003503 crossref_primary_10_1007_s11926_020_00942_3 crossref_primary_10_1097_MD_0000000000023445 crossref_primary_10_1016_j_jacc_2025_03_499 crossref_primary_10_1016_j_jacl_2021_09_052 crossref_primary_10_1016_j_jacl_2020_11_008 crossref_primary_10_3390_jcm12030934 crossref_primary_10_1016_j_jcmg_2022_04_019 crossref_primary_10_1007_s10096_018_3399_z crossref_primary_10_3390_life11121365 crossref_primary_10_1080_13698575_2019_1667964 crossref_primary_10_1016_S0140_6736_21_01920_6 crossref_primary_10_1016_j_amjcard_2022_08_040 crossref_primary_10_1016_j_japh_2025_102898 crossref_primary_10_1080_17425255_2020_1828343 crossref_primary_10_15829_1728_8800_2022_3369 crossref_primary_10_1161_CIRCULATIONAHA_122_061620 crossref_primary_10_1161_CIRCULATIONAHA_118_034309 crossref_primary_10_1093_eurjpc_zwab154 crossref_primary_10_1016_j_jacc_2020_03_029 crossref_primary_10_1186_s12937_019_0438_2 crossref_primary_10_1016_j_gheart_2017_03_002 crossref_primary_10_3390_jcm11102924 crossref_primary_10_1007_s11892_018_1087_0 crossref_primary_10_1016_j_tem_2018_11_005 crossref_primary_10_1007_s11883_020_00891_3 crossref_primary_10_1097_JCMA_0000000000001227 crossref_primary_10_1016_j_tcm_2018_07_005 crossref_primary_10_1016_j_jacc_2020_11_079 crossref_primary_10_1016_S0140_6736_18_32263_3 crossref_primary_10_1038_s41467_019_09381_w crossref_primary_10_1016_j_sleep_2020_02_023 crossref_primary_10_7326_M20_6125 crossref_primary_10_1001_jama_2021_1527 crossref_primary_10_1016_j_pharmthera_2023_108507 crossref_primary_10_1146_annurev_med_042716_091351 crossref_primary_10_1016_j_ejvs_2023_05_041 crossref_primary_10_1016_j_therap_2019_01_004 crossref_primary_10_1017_eso_2020_15 crossref_primary_10_1038_s41569_018_0107_8 crossref_primary_10_1007_s15006_018_0243_4 crossref_primary_10_1155_2023_3801908 crossref_primary_10_1080_14656566_2021_1912734 crossref_primary_10_1177_09622802231192958 crossref_primary_10_7759_cureus_60877 crossref_primary_10_1002_prp2_601 crossref_primary_10_1097_CEJ_0000000000000419 crossref_primary_10_1016_j_beem_2022_101714 crossref_primary_10_1016_j_endien_2017_08_005 crossref_primary_10_1080_17512433_2025_2565619 crossref_primary_10_1093_eurheartj_ehac620 crossref_primary_10_1016_j_pharmthera_2018_02_005 crossref_primary_10_1016_S0140_6736_17_30713_4 crossref_primary_10_1093_eurjpc_zwaa088 crossref_primary_10_1016_j_revmed_2018_01_003 crossref_primary_10_1016_j_cpha_2024_11_003 crossref_primary_10_1016_S1155_1941_24_46693_6 crossref_primary_10_1002_pds_4557 crossref_primary_10_1161_ATVBAHA_120_315421 crossref_primary_10_3390_molecules27020434 crossref_primary_10_1016_j_xcrm_2025_102288 crossref_primary_10_1038_s41598_021_91928_3 crossref_primary_10_1002_prp2_856 crossref_primary_10_1055_a_1231_1278 crossref_primary_10_1161_STROKEAHA_120_031707 crossref_primary_10_1007_s15027_018_1480_2 crossref_primary_10_1038_s41538_025_00546_0 crossref_primary_10_1161_JAHA_118_010241 crossref_primary_10_5662_wjm_v13_i4_179 crossref_primary_10_1016_j_biopha_2023_115228 crossref_primary_10_1136_bcr_2018_225395 crossref_primary_10_7759_cureus_24778 crossref_primary_10_3390_ijms252312651 crossref_primary_10_1210_clinem_dgab147 crossref_primary_10_1080_14779072_2021_2022475 crossref_primary_10_1016_j_ajcnut_2023_03_019 crossref_primary_10_1007_s11883_022_01059_x crossref_primary_10_1093_eurheartj_ehy299 crossref_primary_10_1161_JAHA_123_030414 crossref_primary_10_1161_JAHA_118_011320 crossref_primary_10_1136_bmjopen_2018_023085 crossref_primary_10_1155_2019_1582183 crossref_primary_10_1093_eurheartj_ehab310 crossref_primary_10_1161_CIRCRESAHA_118_312782 crossref_primary_10_1016_j_ihj_2020_03_015 crossref_primary_10_1093_ehjcvp_pvac056 crossref_primary_10_1016_j_jacadv_2022_100197 crossref_primary_10_1186_s40360_024_00760_8 crossref_primary_10_1161_CIRCULATIONAHA_120_045851 crossref_primary_10_1371_journal_pone_0268709 crossref_primary_10_1093_eurheartj_ehz393 crossref_primary_10_1007_s11883_017_0683_9 crossref_primary_10_1016_j_numecd_2019_06_022 crossref_primary_10_1186_s12882_017_0545_2 crossref_primary_10_1007_s40256_022_00534_9 crossref_primary_10_1007_s00256_023_04473_7 crossref_primary_10_1007_s00404_021_06065_z crossref_primary_10_1016_j_neurot_2024_e00517 crossref_primary_10_1016_j_jdiacomp_2018_09_017 crossref_primary_10_1016_j_biomaterials_2019_02_027 crossref_primary_10_3389_fcvm_2021_749113 crossref_primary_10_1161_CIRCOUTCOMES_117_004249 crossref_primary_10_1016_j_ajpc_2022_100450 crossref_primary_10_1016_j_rceng_2022_03_006 crossref_primary_10_1002_prp2_404 crossref_primary_10_1136_bmjopen_2017_020309 crossref_primary_10_1007_s12170_019_0607_z crossref_primary_10_1371_journal_pone_0240166 crossref_primary_10_2147_DDDT_S487476 crossref_primary_10_1007_s11912_021_01023_z crossref_primary_10_1016_j_jacc_2023_03_409 crossref_primary_10_1007_s00108_017_0239_7 crossref_primary_10_1111_imj_14429 crossref_primary_10_12688_wellcomeopenres_17036_1 crossref_primary_10_1016_j_artere_2019_10_003 crossref_primary_10_1016_j_ijcard_2022_08_034 crossref_primary_10_1016_j_ahj_2023_11_007 crossref_primary_10_1152_ajpcell_00665_2024 crossref_primary_10_1007_s00125_016_4178_y crossref_primary_10_1016_j_ijcard_2020_06_021 crossref_primary_10_1097_MOL_0000000000000379 crossref_primary_10_1016_j_cpcardiol_2024_102419 crossref_primary_10_1111_jgs_18362 crossref_primary_10_1002_cpt_2844 crossref_primary_10_3390_cancers13143537 crossref_primary_10_1016_j_ejim_2021_10_017 crossref_primary_10_1016_j_repc_2021_01_002 crossref_primary_10_1038_s41586_021_03392_8 crossref_primary_10_1111_jgs_19452 crossref_primary_10_3390_nu15122682 crossref_primary_10_1093_cvr_cvab272 crossref_primary_10_1111_1753_0407_12769 crossref_primary_10_1161_JAHA_118_010049 crossref_primary_10_1055_a_1516_2471 crossref_primary_10_1007_s11883_020_00845_9 crossref_primary_10_1007_s40801_025_00491_0 crossref_primary_10_1055_a_2210_3395 crossref_primary_10_7759_cureus_68316 crossref_primary_10_1016_j_phrs_2021_105499 crossref_primary_10_1111_jdi_70070 crossref_primary_10_1016_j_clinthera_2021_12_005 crossref_primary_10_3390_jcm8081109 crossref_primary_10_3390_life14060679 crossref_primary_10_1016_j_jnma_2024_10_009 crossref_primary_10_3390_genes15081059 crossref_primary_10_1016_j_jcmg_2024_12_008 crossref_primary_10_7759_cureus_82846 crossref_primary_10_1016_j_amjcard_2016_11_040 crossref_primary_10_1161_CIRCULATIONAHA_118_034942 crossref_primary_10_2217_pme_2020_0110 crossref_primary_10_1161_CIRCULATIONAHA_117_032235 crossref_primary_10_1080_21691401_2019_1645149 crossref_primary_10_1111_jep_12903 crossref_primary_10_1186_s12934_022_01751_2 crossref_primary_10_1016_S2352_3018_21_00156_9 crossref_primary_10_3390_jcm13102987 crossref_primary_10_1007_s42765_025_00509_w crossref_primary_10_1097_CM9_0000000000001205 crossref_primary_10_1097_MCA_0000000000000605 crossref_primary_10_1177_2040622320924569 crossref_primary_10_1016_j_diabres_2024_111125 crossref_primary_10_1002_tcr_202400087 crossref_primary_10_1111_cge_13178 crossref_primary_10_1007_s40256_018_00317_1 crossref_primary_10_1016_j_ejvs_2023_08_067 crossref_primary_10_1093_eurjpc_zwae009 crossref_primary_10_1016_j_numecd_2017_03_001 crossref_primary_10_1093_ehjcvp_pvae025 crossref_primary_10_1161_JAHA_122_025813 crossref_primary_10_1213_ANE_0000000000002911 crossref_primary_10_1093_ehjqcco_qcaa004 crossref_primary_10_1080_14656566_2020_1801638 crossref_primary_10_1177_2047487320905721 crossref_primary_10_1136_bmjopen_2017_020584 crossref_primary_10_1016_S0140_6736_19_32519_X crossref_primary_10_1186_s13293_024_00642_y crossref_primary_10_1007_s11883_020_00861_9 crossref_primary_10_1007_s00398_024_00650_5 crossref_primary_10_1007_s00228_021_03149_2 crossref_primary_10_1371_journal_pone_0321728 crossref_primary_10_1016_S2213_8587_24_00040_8 crossref_primary_10_1016_j_hipert_2016_10_001 crossref_primary_10_1007_s42452_023_05320_z crossref_primary_10_1016_j_jacc_2017_01_019 crossref_primary_10_1016_j_biopha_2019_109338 crossref_primary_10_1038_s41569_024_01039_5 crossref_primary_10_1155_jdr_3661739 crossref_primary_10_1016_j_jep_2024_117768 crossref_primary_10_1001_jamanetworkopen_2020_25675 crossref_primary_10_1038_s41591_019_0366_x crossref_primary_10_1093_eurjpc_zwaf361 crossref_primary_10_1016_j_canlet_2018_04_001 crossref_primary_10_1097_01_CCN_0000549635_52054_5b crossref_primary_10_1159_000538551 crossref_primary_10_1111_acps_13016 crossref_primary_10_1161_STROKEAHA_121_035846 crossref_primary_10_1016_j_jacc_2019_09_040 crossref_primary_10_1093_ehjopen_oeac077 crossref_primary_10_1136_bjsports_2017_098497 crossref_primary_10_1001_jamanetworkopen_2024_22558 crossref_primary_10_1080_13543784_2017_1312339 crossref_primary_10_1161_CIRCULATIONAHA_117_028307 crossref_primary_10_1111_dom_13070 crossref_primary_10_1016_j_jocn_2019_08_074 crossref_primary_10_1016_j_cjca_2019_03_002 crossref_primary_10_15829_1728_8800_2019_6_75_79 crossref_primary_10_1016_j_pcad_2019_11_003 crossref_primary_10_1177_2047487318763825 crossref_primary_10_1152_ajpcell_00714_2024 crossref_primary_10_1016_j_apsb_2022_06_011 crossref_primary_10_1161_ATV_0000000000000073 crossref_primary_10_4103_ACCJ_ACCJ_28_24 crossref_primary_10_1016_j_ahj_2024_05_009 crossref_primary_10_1007_s11883_020_00898_w crossref_primary_10_1016_j_pharmthera_2020_107625 crossref_primary_10_1001_jama_2020_8390 crossref_primary_10_1007_s40264_021_01105_8 crossref_primary_10_1080_14740338_2020_1796966 crossref_primary_10_1007_s10557_021_07255_2 crossref_primary_10_3390_antiox10081293 crossref_primary_10_1016_j_zefq_2017_04_001 crossref_primary_10_1155_2017_2582745 crossref_primary_10_1177_2396987319838100 crossref_primary_10_1016_S0140_6736_16_32074_8 crossref_primary_10_1111_bcp_15245 crossref_primary_10_4103_ijmr_IJMR_2668_19 crossref_primary_10_3390_jcm9072292 crossref_primary_10_1124_pharmrev_120_000206 crossref_primary_10_3390_diagnostics13213349 crossref_primary_10_1016_j_jacc_2019_09_072 crossref_primary_10_3389_fcvm_2022_956482 crossref_primary_10_1007_s11883_020_00887_z crossref_primary_10_1007_s40263_017_0422_3 crossref_primary_10_1016_j_jacc_2018_10_021 crossref_primary_10_1161_ATVBAHA_117_310244 crossref_primary_10_1093_eurheartj_suy001 crossref_primary_10_1038_s41598_020_58668_2 crossref_primary_10_1016_S2215_0366_20_30311_4 crossref_primary_10_1007_s00059_022_05114_w crossref_primary_10_1007_s11883_024_01203_9 crossref_primary_10_1097_MOL_0000000000000783 crossref_primary_10_1016_j_ceb_2017_06_002 crossref_primary_10_36660_abc_20210180 crossref_primary_10_2217_pgs_2019_0109 crossref_primary_10_1080_14779072_2018_1497975 crossref_primary_10_1177_10742484211023715 crossref_primary_10_1007_s10096_018_3227_5 crossref_primary_10_1016_j_metabol_2021_154752 crossref_primary_10_1177_2047487318817082 crossref_primary_10_1080_14740338_2025_2536343 crossref_primary_10_1007_s10557_020_07049_y crossref_primary_10_1080_14740338_2025_2468855 crossref_primary_10_1093_eurheartj_ehad748 crossref_primary_10_1080_00325481_2022_2144030 crossref_primary_10_1111_bcp_14133 crossref_primary_10_1097_MOL_0000000000000531 crossref_primary_10_1016_j_jacl_2017_11_005 crossref_primary_10_1080_14712598_2020_1677604 crossref_primary_10_1007_s11883_022_00994_z crossref_primary_10_1016_j_jacc_2018_11_002 crossref_primary_10_1016_j_jacc_2018_11_003 crossref_primary_10_1097_MD_0000000000010930 crossref_primary_10_1111_ap_12392 crossref_primary_10_1016_j_pop_2019_05_007 crossref_primary_10_1016_S2213_8587_18_30199_2 crossref_primary_10_1016_j_ijcard_2025_133631 crossref_primary_10_1177_2048004016687211 crossref_primary_10_1093_eurheartj_ehaa1080 crossref_primary_10_3390_ijms23169326 crossref_primary_10_1016_j_ebiom_2018_10_001 crossref_primary_10_1016_j_cger_2020_04_006 crossref_primary_10_1093_bja_aex321 crossref_primary_10_1080_14656566_2020_1832991 crossref_primary_10_1136_bmj_l4897 crossref_primary_10_1093_eurheartj_ehab358 crossref_primary_10_1016_j_fbio_2021_101451 crossref_primary_10_1016_j_numecd_2024_10_017 crossref_primary_10_1007_s11606_022_07440_5 crossref_primary_10_1055_a_1956_9851 crossref_primary_10_1016_j_cpcardiol_2021_100880 crossref_primary_10_1161_JAHA_119_014758 crossref_primary_10_1016_j_ebiom_2019_06_003 crossref_primary_10_1097_MOL_0000000000000526 crossref_primary_10_1016_j_pcad_2019_10_005 crossref_primary_10_1080_20502877_2017_1314884 crossref_primary_10_1002_clc_23895 crossref_primary_10_2147_CEOR_S410711 crossref_primary_10_1016_j_kint_2023_10_018 crossref_primary_10_1093_fampra_cmad034 crossref_primary_10_3390_jcm12155082 crossref_primary_10_1155_2022_4604601 crossref_primary_10_1007_s11010_022_04621_y crossref_primary_10_1111_joim_12806 crossref_primary_10_1001_jamanetworkopen_2018_0818 crossref_primary_10_1016_j_ijcard_2022_07_048 crossref_primary_10_1038_s41533_021_00267_3 crossref_primary_10_1093_abm_kax064 crossref_primary_10_1016_S0140_6736_20_32332_1 crossref_primary_10_1016_j_pop_2018_10_004 crossref_primary_10_1080_14712598_2017_1365134 crossref_primary_10_1016_j_amjmed_2017_10_019 crossref_primary_10_1016_j_nutres_2024_03_013 crossref_primary_10_1111_bcp_14359 crossref_primary_10_3390_jcm13195970 crossref_primary_10_1253_circj_CJ_25_0089 crossref_primary_10_1007_s10557_020_07091_w crossref_primary_10_1016_j_ejvs_2021_06_031 crossref_primary_10_1136_bmj_2022_071727 crossref_primary_10_1210_clinem_dgaa674 crossref_primary_10_1080_17425255_2020_1802426 crossref_primary_10_1016_j_jacl_2018_07_007
Cites_doi	10.1001/jama.2009.1619 10.1016/j.amjmed.2011.08.007 10.1186/1741-7015-10-154 10.5694/mja15.01004 10.3310/hta7270 10.1016/j.jacc.2012.09.017 10.1001/archinternmed.2011.625 10.1001/jama.288.1.49 10.1016/S0140-6736(07)60716-8 10.1136/bmj.38855.610324.80 10.1136/bmj.f6782 10.1093/ije/dys223 10.1136/bmj.312.7040.1215 10.1002/pds.1603 10.5551/jat.33563 10.1093/aje/kwm214 10.1093/eurheartj/ehs344 10.1053/j.ajkd.2016.01.016 10.1136/bmj.f6123 10.1016/S0140-6736(05)61026-4 10.1111/j.1532-5415.1997.tb00971.x 10.1016/S0140-6736(07)60084-1 10.1212/WNL.0b013e3181d6476a 10.1016/S0140-6736(09)61965-6 10.1056/NEJMoa043792 10.1016/S0002-9149(99)80744-9 10.1016/j.jacl.2014.03.002 10.3949/ccjm.78a.10073 10.1016/S0140-6736(01)05553-2 10.1016/S0140-6736(04)16261-2 10.1016/j.amjcard.2006.02.030 10.1056/NEJMoa0900241 10.1371/journal.pone.0052929 10.1002/psb.1293 10.1046/j.1471-0528.2002.02214.x 10.1001/jamaoncol.2015.0494 10.1056/NEJMoa1403086 10.1161/CIRCULATIONAHA.112.136101 10.1016/j.ijcard.2013.05.068 10.1212/WNL.0b013e318228bf11 10.1136/bmj.304.6824.431 10.7326/0003-4819-159-10-201311190-00007 10.1016/S1070-3241(16)30460-6 10.1186/1472-6904-9-6 10.1007/s00125-015-3802-6 10.1093/rheumatology/ket171 10.1161/CIRCULATIONAHA.107.703579 10.1371/journal.pone.0072642 10.1161/CIRCOUTCOMES.111.000071 10.1016/j.ijcard.2016.02.028 10.1038/nrd1112 10.1056/NEJMc1311039 10.1016/S0140-6736(09)60708-X 10.1111/j.1600-6143.2005.01105.x 10.7326/M13-1921 10.1093/hmg/ddu328 10.1111/j.1742-1241.2008.01731.x 10.1136/bmj.303.6797.276 10.1001/jama.269.24.3107 10.1016/j.amjcard.2005.12.010 10.1038/clpt.2014.125 10.1186/1471-2490-14-24 10.1056/NEJM199610033351401 10.1016/S0140-6736(12)60367-5 10.1136/bmj.d7020 10.1093/eurheartj/ehu274 10.1056/NEJMoa1300955 10.1136/bmj.f6745 10.1016/j.mayocp.2013.07.013 10.1016/S0140-6736(14)61765-7 10.1016/S0140-6736(14)61183-1 10.1093/ije/dyt088 10.1016/0091-7435(91)90006-P 10.1001/jama.287.5.622 10.1007/s002280000248 10.1681/ASN.2013090965 10.1136/bmj.f880 10.1136/bmj.i3283 10.1200/JCO.2004.02.027 10.1136/bmj.g3743 10.5694/j.1326-5377.2002.tb04883.x 10.1001/archinte.1996.00440170097011 10.1001/jama.2012.13260 10.2165/1158822-S0-000000000-00000 10.1016/S0140-6736(04)15690-0 10.1001/jamainternmed.2013.6184 10.1016/j.jclinepi.2004.10.012 10.1007/s00415-009-5271-7 10.1001/jama.281.9.841 10.1016/S0140-6736(14)61368-4 10.1016/S0140-6736(02)07451-2 10.1521/suli.32.3.333.22177 10.1136/bmj.c2197 10.1007/s10557-005-5686-z 10.1093/ije/dyv031 10.1001/jama.2015.1335 10.1371/journal.pone.0083759 10.1016/j.ahj.2016.01.016 10.1378/chest.09-0194 10.1016/S0140-6736(00)02039-0 10.1136/bmj.39070.527986.68 10.1056/NEJMoa1201735 10.1212/WNL.58.9.1333 10.1186/s40560-014-0056-1 10.1016/0895-4356(91)90155-3 10.1177/2047487315602861 10.1056/NEJMp1112023 10.1002/sim.4780060308 10.1016/j.jclinepi.2009.03.001 10.1213/ANE.0b013e3181d8a078 10.1136/jnnp.73.4.385 10.1002/sim.4780101010 10.1136/bmjopen-2015-010401 10.7326/0003-4819-117-12-1016 10.1136/bmj.302.6788.1317 10.1016/j.contraception.2010.06.010 10.1136/bmj.316.7125.140 10.1016/S0140-6736(07)61778-4 10.1016/j.cjca.2014.12.018 10.1161/01.cir.0000437738.63853.7a 10.1093/ageing/afq129 10.1371/journal.pone.0041297 10.1161/ATVBAHA.107.142570 10.1016/j.jacc.2010.09.082 10.1370/afm.1641 10.1093/eurheartj/ehv641 10.1136/postgradmedj-2012-131730 10.1186/1465-9921-10-45 10.1016/j.cct.2003.08.014 10.1136/bmj.308.6925.373 10.1093/eurheartj/ehr333 10.1016/j.jacl.2015.08.006 10.1186/1741-7015-12-51 10.1016/j.jclinepi.2008.08.005 10.1001/jama.288.3.321 10.1200/JCO.2016.68.8879 10.1001/jamacardio.2016.1884 10.1016/j.cjca.2010.12.024 10.1093/aje/kwp115 10.1016/0140-6736(91)92526-8 10.1212/WNL.0b013e31829bfde3 10.1016/S0140-6736(08)61930-3 10.1056/NEJMoa0801936 10.1016/S0140-6736(02)07816-9 10.1056/NEJM200006223422511 10.1056/NEJMoa0807646 10.1136/thx.2006.062885 10.1136/bmj.f6340 10.1016/S0002-9343(97)00244-1 10.1002/cncr.23452 10.1001/jama.280.7.605 10.1016/S0140-6736(08)60104-X 10.2215/CJN.01430307 10.1016/0002-9149(91)90002-3 10.1016/S0140-6736(10)60310-8 10.1136/bmj.301.6747.309 10.1136/bmj.e1553 10.1016/S0140-6736(03)13637-9 10.1016/S0140-6736(00)03651-5 10.1517/14740338.2013.779667 10.1001/jama.294.14.1773 10.1136/bmj.326.7404.1423 10.1371/journal.pone.0034785 10.1002/sim.4780100417 10.1093/ije/dyl134 10.1161/CIRCULATIONAHA.115.018580 10.1136/bmj.g1523 10.1136/bmj.318.7192.1209 10.5694/mja15.00103 10.1016/S0140-6736(04)17670-8 10.1136/bmj.321.7259.504 10.1016/S0140-6736(04)16449-0 10.1177/2047487314525531 10.1016/j.jacl.2016.05.002 10.1093/eurheartj/eht055 10.1016/S0140-6736(14)62067-5 10.1016/S0140-6736(05)67394-1 10.1016/S0140-6736(02)09327-3 10.1093/eurheartj/ehv043 10.1161/01.CIR.102.2.157 10.1016/S0140-6736(04)16260-0 10.1586/17512433.2015.1011125 10.7326/0003-4819-158-7-201304020-00004 10.1371/journal.pmed.1001310 10.1001/jama.291.14.1701 10.1097/EDE.0b013e3181875e61 10.1016/S0140-6736(10)61350-5 10.1001/jama.2013.278040 10.1136/bmj.39241.630741.BE1 10.1001/jama.2016.3608 10.1056/NEJMoa1507750 10.1001/archinte.166.2.155 10.1097/HJR.0b013e3282f11f95 10.1212/WNL.54.5.1022 10.1093/aje/kwj079 10.1016/j.jacl.2014.03.004 10.1016/S0140-6736(02)11600-X 10.1001/archinternmed.2010.348 10.1016/S0140-6736(04)16936-5 10.1111/jch.12139 10.1056/NEJMoa1403285 10.1016/S0140-6736(03)12948-0 10.1016/j.jhep.2011.07.023 10.1136/bmj.305.6844.15 10.1093/aje/kwp113 10.1136/bmj.39554.624086.AD 10.1016/j.amjcard.2005.12.017 10.1200/JCO.2013.49.4757 10.1136/bmj.315.7119.1371 10.1002/14651858.CD009217.pub2 10.1016/j.amjcard.2010.05.030 10.1371/journal.pone.0029849 10.1093/aje/kwm165 10.1586/17512433.2015.1012494 10.1016/j.amjcard.2005.12.014 10.1097/CCM.0b013e3182120992 10.1001/archinternmed.2012.2145 10.1038/ncpcardio1086 10.1161/01.CIR.0000090686.57897.F5 10.1016/S0140-6736(11)61125-2 10.1093/ije/dyg106 10.1016/S0140-6736(09)60503-1 10.3132/dvdr.2008.029 10.1161/CIRCULATIONAHA.106.624890 10.1016/j.amjmed.2008.06.030 10.1161/CIRCULATIONAHA.114.013189 10.1136/bmj.318.7197.1548 10.1093/qjmed/hch035 10.1371/journal.pmed.0050067 10.1016/S0140-6736(00)04017-4 10.1001/jama.1991.03470010097038 10.1097/AOG.0b013e31826af61a 10.1136/heartjnl-2014-305693 10.1016/j.atherosclerosis.2014.12.016 10.1001/jama.1995.03530130055028 10.1136/bmj.g3306 10.1093/aje/kwi223 10.1097/MLR.0b013e3181dbebe3 10.1001/jama.291.18.2243 10.1016/j.athoracsur.2010.10.061 10.1093/eurheartj/eht273 10.1001/jama.2015.1206 10.1056/NEJM198904063201405 10.1016/j.jacc.2010.10.047 10.1016/j.ahj.2014.03.019 10.1093/oxfordjournals.bmb.a072548 10.1016/S0140-6736(11)61215-4 10.1016/S0140-6736(10)60484-9 10.1001/jama.2016.0548 10.1056/NEJMoa1401520 10.1146/annurev-statistics-022513-115645 10.1161/CIRCULATIONAHA.115.019014 10.1177/1740774509105223 10.1001/jama.2012.423 10.1001/jama.2011.860 10.1016/S0140-6736(12)61190-8 10.1056/NEJMoa061894 10.1016/S0140-6736(03)14065-2 10.1136/bjo.79.11.996 10.1056/NEJMoa1600176 10.1001/jama.2012.8439 10.1253/circj.CJ-10-0110 10.1136/bmj.h2463 10.1016/j.ijcard.2008.08.001 10.1136/bmj.308.6925.367 10.1371/journal.pone.0124451 10.1016/j.amjcard.2012.11.047 10.1185/030079906X167516 10.1002/(SICI)1097-0258(19970515)16:9<1017::AID-SIM508>3.0.CO;2-V
ContentType	Journal Article
Copyright	2016 Elsevier Ltd Elsevier Ltd Copyright © 2016 Elsevier Ltd. All rights reserved. Copyright Elsevier Limited Nov 19, 2016
Copyright_xml	– notice: 2016 Elsevier Ltd – notice: Elsevier Ltd – notice: Copyright © 2016 Elsevier Ltd. All rights reserved. – notice: Copyright Elsevier Limited Nov 19, 2016
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7RV 7TK 7U7 7U9 7X7 7XB 88A 88C 88E 88G 88I 8AF 8AO 8C1 8C2 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AN0 ASE AZQEC BBNVY BEC BENPR BHPHI C1K CCPQU DWQXO FPQ FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K6X K9- K9. KB0 KB~ LK8 M0R M0S M0T M1P M2M M2O M2P M7N M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U S0X 7U8 7X8 JXQ
DOI	10.1016/S0140-6736(16)31357-5
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts ProQuest Nursing & Allied Health Database Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) Psychology Database (Alumni) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Public Health Database Lancet Titles ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni Edition) ProQuest One Sustainability ProQuest Central UK/Ireland British Nursing Database British Nursing Index ProQuest Central Essentials Biological Science Collection eLibrary ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea British Nursing Index (BNI) (1985 to Present) Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection British Nursing Index Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Newsstand Professional ProQuest Biological Science Collection Consumer Health Database Health & Medical Collection (Alumni Edition) Healthcare Administration Database Medical Database Psychology Database ProQuest Research Library Science Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic SIRS Editorial TOXLINE MEDLINE - Academic Toxline
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology Research Library Prep ProQuest Central Student ProQuest Central Essentials Lancet Titles elibrary ProQuest AP Science SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Newsstand Professional Virology and AIDS Abstracts ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest One Academic Middle East (New) SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Public Health ProQuest Central Basic Toxicology Abstracts ProQuest Science Journals British Nursing Index with Full Text ProQuest Health Management British Nursing Index ProQuest Nursing & Allied Health Source ProQuest Psychology Journals (Alumni) ProQuest SciTech Collection ProQuest Medical Library ProQuest Psychology Journals ProQuest Central (Alumni) TOXLINE MEDLINE - Academic
DatabaseTitleList	ProQuest One Psychology MEDLINE TOXLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1474-547X
EndPage	2561
ExternalDocumentID	4272446421 27616593 10_1016_S0140_6736_16_31357_5 S0140673616313575 1_s2_0_S0140673616313575
Genre	Journal Article Review
GrantInformation_xml	– fundername: Medical Research Council grantid: MC_U137686853 – fundername: Medical Research Council grantid: MC_UU_12026/6 – fundername: Cancer Research UK grantid: 16896 – fundername: British Heart Foundation grantid: RG/13/13/30194 – fundername: Department of Health grantid: HTA/14/49/159 – fundername: Medical Research Council grantid: MC_U137686849 – fundername: Medical Research Council grantid: MR/L003120/1 – fundername: Medical Research Council grantid: MR/K006584/1 – fundername: British Heart Foundation grantid: SP/14/3/31114 – fundername: British Heart Foundation grantid: SP/08/010/25939
GroupedDBID	--- --K --M .1- .55 .CO .FO 0R~ 123 1B1 1P~ 1RT 1~5 29L 4.4 457 4G. 53G 5VS 7-5 71M 7RV 7X7 88E 88I 8AF 8AO 8C1 8C2 8FE 8FH 8FI 8FJ 8G5 9JM AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAMRU AAQFI AAQQT AATTM AAXKI AAXUO AAYWO ABBQC ABCQX ABFNM ABIVO ABJNI ABLJU ABMAC ABMZM ABOCM ABUFD ABUWG ACGFS ACGOD ACIEU ACIUM ACLOT ACPRK ACRLP ACVFH ADBBV ADCNI AEIPS AEKER AENEX AEUPX AEUYN AEVXI AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGAPS AGHFR AHHHB AHMBA AIIUN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AN0 ANZVX APXCP AQUVI AXJTR AZQEC BBNVY BCU BEC BENPR BHPHI BKEYQ BKNYI BKOJK BKOMP BNPGV BNQBC BPHCQ BVXVI CCPQU CS3 DU5 DWQXO EAU EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EWM EX3 F5P FD8 FDB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HCIFZ HMCUK IHE J1W K-O K9- KOM L7B LK8 LZ2 M0R M0T M1P M2M M2O M2P M7P MJL MO0 N9A NAPCQ O-L O9- OD. OO~ OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PRG PROAC PSQYO PSYQQ R2- ROL RPZ S0X SAD SDG SEL SES SJFOW SJN SPCBC SSH SSZ T5K TLN TWZ UAP UBE UKHRP UQL UV1 WOW X7M XAX XDU YYM Z5R ZMT ~HD .GJ 04C 3EH 3O- 3V. 41~ 88A 8WZ A6W AACTN AAEJM AAKAS AAQXK AAYOK ABDBF ABTAH ABWVN ACRPL ACRZS ACUHS ADMUD ADNMO ADZCM AFCTW AFFNX AFKWA AHQJS AJJEV AJOXV AKVCP ALIPV AMFUW ARTTT ASPBG AVWKF AZFZN D0S EAP EAS EAZ EBC EBD EBU EGS EHN EIHBH EMB EMK EMOBN ENC EPL EPS EPT ESX EVS FEDTE FGOYB HVGLF HZ~ J5H M0L M41 MVM OVD PKN Q~Q RIG SDF SV3 TEORI TH9 UHU WOQ WUQ XPP YYQ ZGI ZXP ZY4 ~G0 ABLVK ABYKQ AHPSJ AJBFU XFK ZA5 9DU AAYXX ADXHL AFFHD AGQPQ AIGII CITATION AGCQF AGRNS CGR CUY CVF ECM EIF NPM 7QL 7QP 7TK 7U7 7U9 7XB 8FK ASE C1K FPQ H94 K6X K9. KB~ M7N MBDVC PKEHL PQEST PQUKI PRINS Q9U 7U8 7X8 JXQ PUEGO
ID	FETCH-LOGICAL-c615t-c40e409b5c3e1e1b08c303d91027949dae923b1d76cab89c73f66c434f6dc60e3
IEDL.DBID	M7P
ISICitedReferencesCount	1125
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000388166300031&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0140-6736
IngestDate	Sat Sep 27 20:05:24 EDT 2025 Sat Nov 29 14:52:14 EST 2025 Mon Jul 21 06:01:34 EDT 2025 Sat Nov 29 05:12:42 EST 2025 Tue Nov 18 22:30:25 EST 2025 Fri Feb 23 02:34:52 EST 2024 Tue Feb 25 20:08:42 EST 2025 Tue Oct 14 19:31:09 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	10059
Language	English
License	Copyright © 2016 Elsevier Ltd. All rights reserved.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c615t-c40e409b5c3e1e1b08c303d91027949dae923b1d76cab89c73f66c434f6dc60e3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-3 content type line 23 ObjectType-Review-1
OpenAccessLink	http://www.thelancet.com/article/S0140673616313575/pdf
PMID	27616593
PQID	1846832134
PQPubID	40246
PageCount	30
ParticipantIDs	proquest_miscellaneous_1842598143 proquest_journals_1846832134 pubmed_primary_27616593 crossref_citationtrail_10_1016_S0140_6736_16_31357_5 crossref_primary_10_1016_S0140_6736_16_31357_5 elsevier_sciencedirect_doi_10_1016_S0140_6736_16_31357_5 elsevier_clinicalkeyesjournals_1_s2_0_S0140673616313575 elsevier_clinicalkey_doi_10_1016_S0140_6736_16_31357_5
PublicationCentury	2000
PublicationDate	2016-11-19
PublicationDateYYYYMMDD	2016-11-19
PublicationDate_xml	– month: 11 year: 2016 text: 2016-11-19 day: 19
PublicationDecade	2010
PublicationPlace	England
PublicationPlace_xml	– name: England – name: London
PublicationTitle	The Lancet (British edition)
PublicationTitleAlternate	Lancet
PublicationYear	2016
Publisher	Elsevier Ltd Elsevier Limited
Publisher_xml	– name: Elsevier Ltd – name: Elsevier Limited
References	(bib300) 2015 Schaffer, Buckley, Dobbins, Banks, Pearson (bib309) 2015; 202 (bib187) 2016; 176 Hopewell, Parish, Offer (bib183) 2013; 34 Rahimi, Bhala, Kamphuisen (bib203) 2012; 9 Ioannidis, Lau (bib45) 1999; 25 Faasse, Petrie (bib141) 2013; 89 Margolis, Davis, Baimbridge (bib103) 2013; 15 Nissen, Stroes, Dent-Acosta (bib253) 2016; 315 Dale, Coleman, Shah, Patel, Kluger, White (bib194) 2007; 23 Postmus, Deelen, Sedaghat (bib167) 2015; 44 Chlebowski, Rohan, Manson (bib126) 2015; 1 Yu, Eberg, Benayoun (bib140) 2014; 32 Strandberg, Pyörälä, Cook (bib101) 2004; 364 Boots Web (bib147) Moriarty, Thompson, Cannon (bib154) Nallamothu, Hayward, Bates (bib63) 2008; 118 (bib30) 2008; 371 Harris, Bron, Brown (bib60) 1995; 79 (bib42) 2014; 371 (bib83) 2010; 376 Preiss, Seshasai, Welsh (bib226) 2011; 305 Waters, Ho, DeMicco (bib227) 2011; 57 Roberts, Prieto-Merino (bib37) 2014; 2 Law, Wald, Rudnicka (bib160) 2003; 326 Pedersen (bib200) 2010; 10 Armitage, Baigent, Collins (bib19) 2014; 384 Hague, Simes, Kirby (bib100) 2016; 133 Pogue, Walter, Yusuf (bib25) 2009; 6 (bib157) 2007; 370 bib223 Spence (bib271) 2015; 31 Carroll, Kit, Lacher, Shero, Mussolino (bib179) 2012; 308 O'Neil, Sanna, Redlich (bib269) 2012; 10 Knatterud, Rosenberg, Campeau (bib106) 2000; 102 Richardson, Schoen, French (bib258) 2013; 159 Shen, Shah, Reyes (bib230) 2013; 347 Desai, Martin, Blumenthal (bib53) 2014; 349 Guyton, Bays, Grundy, Jacobson (bib64) 2014; 8 Johansen, Green, Sen, Kircher, Richardson (bib306) 2014; 12 Grimes, Schulz (bib143) 2011; 83 Cohen, Cziraky, Cai (bib180) 2010; 106 Armitage (bib145) 2007; 370 Yusuf, Wittes, Probstfield, Tyroler (bib70) 1991; 266 Law, Thompson, Wald (bib168) 1994; 308 Golomb, Criqui, White, Dimsdale (bib57) 2004; 25 Ravnskov (bib177) 1992; 305 Finch, Doyle, Lowe (bib182) 1998 Manson, Chlebowski, Stefanick (bib125) 2013; 310 Glasziou, Eckermann, Mulray (bib263) 2002; 177 Ueshima, Itoh, Kanazawa (bib272) 2016; 23 (bib81) 2009; 9 bib257 bib256 Lester (bib283) 2002; 32 Tobert, Newman (bib65) 2016; 23 (bib243) 2013 (bib224) 2013; 34 (bib280) 2014; 25 Cuchel, Bruckert, Ginsberg (bib171) 2014; 35 Culver, Ockene, Balasubramanian (bib229) 2012; 172 Roberts, Ker, Edwards, Beecher, Manno, Sydenham (bib215) 2015; 350 Okuyama, Langsjoen, Hamazaki (bib299) 2015; 8 Garcia-Rodriguez, Masso-Gonzalez, Wallander, Johansson (bib90) 2008; 17 Laties, Shear, Lippa (bib59) 1991; 67 Vivekananthan, Penn, Sapp, Hsu, Topol (bib132) 2003; 361 Mansi, Frei, Pugh, Makris, Mortensen (bib91) 2013; 173 Parker, Capizzi, Grimaldi (bib248) 2013; 127 Collins, MacMahon (bib3) 2001; 357 Prentice, Langer, Stefanick (bib129) 2006; 163 Ravnskov, Diamond, Hama (bib166) 2016; 6 Preiss, Tikkanen, Welsh (bib287) 2012; 308 Anderson, Boden, Desvigne-Nickens (bib43) 2014; 371 Wilkes, Meade (bib116) 1991; 302 Tobert (bib178) 2003; 2 Chalmers, Singanayagam, Murray, Hill (bib207) 2008; 121 Ridker, Pradhan, MacFadyen, Libby, Glynn (bib225) 2012; 380 Abramson, Rosenberg, Jewell, Wright (bib298) 2014; 348 Lloyd, Stott, de Craen (bib104) 2013; 8 Hippisley-Cox, Coupland (bib89) 2010; 340 Stampfer, Colditz (bib112) 1991; 20 Gutierrez, Ramirez, Rundek, Sacco (bib195) 2012; 172 Banks, Crouch, Korda (bib305) 2016; 204 O'Neal, Koyama, Koehler (bib211) 2011; 39 Garg, Hackam, Tonelli (bib44) 2008; 3 (bib5) 1997; 15 Sun, Briel, Busse (bib69) 2012; 344 Stroes, Thompson, Corsini (bib75) 2015; 36 Sever, Chang, Gupta, Whitehouse, Poulter (bib105) 2011; 32 (bib1) 2007 Buettner, Rippberger, Smith, Leveille, Davis, Mittleman (bib245) 2012; 125 Nielsen, Nordestgaard (bib308) 2016; 37 Mortensen, Copeland, Pugh (bib208) 2009; 10 (bib163) 2014 bib270 Sano, Bell, Glasko (bib58) 2011; 77 Prieto-Merino, Smeeth, Staa, Roberts (bib38) 2013; 347 Ridker, Danielson, Fonseca (bib48) 2008; 359 (bib288) 2004; 363 Baigent, Peto, Gray, Parish, Collins (bib13) 2010 Holbrook, Wright, Sung, Ribic, Baker (bib217) 2011; 27 Smeeth, Douglas, Hubbard (bib87) 2006; 35 (bib292) 2014; 100 Barron, Zaman, Cole, Wensel, Okonko, Francis (bib142) 2013; 168 Fitchett, Hegele, Verma (bib294) 2015; 131 Godlee (bib244) 2014; 348 Kunz, Vist, Oxman (bib16) 2007 Law, Wald, Thompson (bib174) 1994; 308 Muldoon, Manuck, Matthews (bib176) 1990; 301 Sacks, Pfeffer, Moye (bib50) 1996; 335 (bib32) 2012; 380 bib148 Smeeth, Haines, Ebrahim (bib41) 1999; 318 bib146 Petersen, Christensen, Kragstrup (bib164) 2010; 39 Lang, Buring, Rosner, Cook, Hennekens (bib80) 1991; 10 Mithani, Kuskowski, Slinin (bib277) 2011; 91 Grady, Herrington, Bittner (bib119) 2002; 288 Cooper, O'Flynn (bib82) 2008; 336 van de Garde, Hak, Souverein, Hoes, van den Bosch, Leufkens (bib206) 2006; 61 Zhou, Liao (bib199) 2010; 74 Yusuf, Islam, Chow (bib301) 2011; 378 bib291 Fewell, Davey Smith, Sterne (bib109) 2007; 166 Prentice, Langer, Stefanick (bib128) 2005; 162 Joy, Monjed, Zou, Hegele, McDonald, Mahon (bib251) 2014; 160 Hernan, Alonso, Logan (bib122) 2008; 19 Clarke, Halsey, Lewington (bib133) 2010; 170 Graaf, Beiderbeck, Egberts, Richel, Guchelaar (bib138) 2004; 22 (bib52) 2012; 7 Tsang, Colley, Lynd (bib47) 2009; 62 Soran, Schofield, Durrington (bib186) 2015; 36 Fernandez, Spatz, Jablecki, Phillips (bib24) 2011; 78 Rangarajan S, Yusuf S. Personal communicaction. 2016. Ganga, Slim, Thompson (bib250) 2014; 168 Golomb (bib260) 2006; 114 Gaist, Jeppesen, Andersen, Garcia Rodriguez, Hallas, Sindrup (bib290) 2002; 58 Brass, Alberts, Sparks (bib289) 2006; 97 bib297 Barsky, Saintfort, Rogers, Borus (bib144) 2002; 287 Grimes, Schulz (bib7) 2012; 120 bib295 bib293 Shepherd, Blauw, Murphy (bib51) 2002; 360 (bib62) 2016 Lawlor, Davey Smith, Kundu, Bruckdorfer, Ebrahim (bib134) 2004; 363 Wald, Morris, Wald (bib252) 2012; 7 Bjornsson, Jacobsen, Kalaitzakis (bib285) 2012; 56 (bib31) 2010; 376 (bib156) 2009; 302 Golomb, Kane, Dimsdale (bib282) 2004; 97 Rothwell (bib77) 2005; 365 Davey Smith, Hemani (bib189) 2014; 23 (bib39) 2006; 355 Holdaas, Fellstrom, Cole (bib102) 2005; 5 Phillips, Davey Smith (bib110) 1991; 44 Poynter, Gruber, Higgins (bib139) 2005; 352 Rothman, Gallacher, Hatch (bib66) 2013; 42 Vandenbroucke (bib88) 2008; 5 Malhotra (bib10) 2013; 347 Law, Rudnicka (bib218) 2006; 97 Davey Smith, Pekkanen (bib175) 1992; 304 Goldacre (bib26) Cuzick (bib71) 2005; 365 Vandenbroucke (bib150) 2011; 343 Rossouw, Anderson, Prentice (bib118) 2002; 288 (bib34) 2016 bib281 Schneeweiss, Avorn (bib97) 2005; 58 Vandenbroucke (bib149) 2004; 363 Yusuf, Bosch, Dagenais (bib196) 2016; 374 Egger, Schneider, Davey Smith (bib86) 1998; 316 Taylor, Lorson, White, Thompson (bib255) 2015; 238 MacMahon, Collins (bib4) 2001; 357 Dormuth, Hemmelgarn, Paterson (bib275) 2013; 346 Stone, Robinson, Lichtenstein (bib162) 2014; 129 (bib40) 2009; 373 (bib79) 1995; 75 Kiani, Strand, Fang, Jaranilla, Petri (bib266) 2013; 52 Moriarty, Thompson, Cannon (bib155) 2015; 9 Billings, Hendricks, Schildcrout (bib279) 2016; 315 bib197 Iso, Jacobs, Wentworth, Neaton, Cohen (bib236) 1989; 320 Rosenson, Baker, Jacobson, Kopecky, Parker (bib73) 2014; 8 Cuzick, Edwards, Segnan (bib28) 1997; 16 Mohler, Hiatt, Creager (bib267) 2003; 108 (bib33) 2015; 385 Taylor, Huffman, Macedo (bib161) 2013; 1 Ramsey, Johnson, Caudle (bib220) 2014; 96 McAuley, Laffey, O'Kane (bib213) 2014; 371 Vandenbroucke (bib114) 1991; 337 Janda, Park, FitzGerald, Etminan, Swiston (bib209) 2009; 136 Taylor, Panza, Thompson (bib254) 2016; 209 (bib296) February, 2016 Pocock, Elbourne (bib9) 2000; 342 Carroll, Lacher, Sorlie (bib181) 2005; 294 Diamond, Ravnskov (bib72) 2015; 8 (bib107) 2002; 109 Ye, Song (bib131) 2008; 15 bib185 bib184 Day, Altman (bib17) 2000; 321 Tsai, Thomas, Sudlow (bib237) 2013; 81 (bib222) 2002; 360 Newman, Szarek, Colhoun (bib202) 2008; 5 Glynn, Danielson, Fonseca (bib201) 2009; 360 Assmann, Pocock, Enos, Kasten (bib68) 2000; 355 Barrett-Connor (bib113) 2007; 166 (bib234) 2010; 375 Bruckert, Hayem, Dejager, Yau, Begaud (bib247) 2005; 19 Abramson, Rosenberg, Jewell, Wright (bib11) 2013; 347 Pogue, Devereaux, Thabane, Yusuf (bib35) 2012; 7 Cholesterol Treatment Trialists' (CTT) Collaboration Secretariat. Personal Communication, Mihaylova B, 2016. Pocock (bib14) 1983 Mangin, Sweeney, Heath (bib198) 2007; 335 Grady, Rubin, Petitti (bib111) 1992; 117 Albers (bib36) 2000; 54 Prentice, Manson, Langer (bib124) 2009; 170 Swiger, Manalac, Blumenthal, Blaha, Martin (bib261) 2013; 88 Trompet, van Vliet, de Craen (bib55) 2010; 257 Santanello, Barber, Applegate (bib264) 1997; 45 Williams, Feig, Fisher (bib169) 2008; 5 Black (bib78) 1996; 312 Zhang, Plutzky, Skentzos (bib93) 2013; 158 Mansi, Mortensen (bib23) 2013; 12 Sever, Dahlof, Poulter (bib238) 2003; 361 Feldman, Doody, Kivipelto (bib56) 2010; 74 White, Swerdlow, Preiss (bib233) 2016 Trivedi, Wellsted, Collard, Kirby (bib268) 2014; 14 Grimes, Schulz (bib6) 2002; 359 McGale, Cutter, Darby, Henson, Jagsi, Taylor (bib137) 2016 Gaist, Rodriguez, Huerta, Hallas, Sindrup (bib284) 2001; 56 Madigan, Stang, Berlin (bib95) 2014; 1 Swerdlow, Preiss, Kuchenbaecker (bib231) 2015; 385 Matthews, Herrett, Gasparrini (bib307) 2016; 353 Feinstein, Horwitz (bib76) 1997; 103 Rief, Avorn, Barsky (bib153) 2006; 166 Layton, Kshirsagar, Simpson (bib276) 2013; 111 Pedersen, Berg, Cook (bib61) 1996; 156 Meade, Berra (bib115) 1992; 48 Blamoun, Batty, DeBari, Rashid, Sheikh, Khan (bib210) 2008; 62 Golomb, Dimsdale, Koslik (bib259) 2015; 10 Temple (bib85) 1999; 281 Zadelaar, Kleemann, Verschuren (bib170) 2007; 27 Rawlins (bib2) 2008; 372 Nielsen, Nordestgaard, Bojesen (bib92) 2012; 367 Ford, Murray, McCowan, Packard (bib98) 2016; 133 Buettner, Davis, Leveille, Mittleman, Mukamal (bib151) 2008; 23 Collins, Gray, Godwin, Peto (bib20) 1987; 6 Schatz, Masaki, Yano, Chen, Rodriguez, Curb (bib165) 2001; 358 Houx, Shepherd, Blauw (bib54) 2002; 73 Finegold, Manisty, Goldacre, Barron, Francis (bib239) 2014; 21 Brookhart, Sturmer, Glynn, Rassen, Schneeweiss (bib96) 2010; 48 Deeks, Dinnes, D'Amico (bib108) 2003; 7 Achelrod D, Gray A, Preiss D, Mihaylova B. Personal communication. 2016. Petretta, Costanzo, Perrone-Filardi, Chiariello (bib193) 2010; 138 Guymer, Baird, Varsamidis (bib273) 2013; 8 Sattar, Preiss, Murray (bib49) 2010; 375 Zhang, Patel, Horibe (bib159) 2003; 32 Giordano, Kuo, Duan, Hortobagyi, Freeman, Goodwin (bib135) 2008; 112 Abramson, Redberg (bib190) Nov 13, 2013 (bib29) 200 Malhotra (10.1016/S0140-6736(16)31357-5_bib10) 2013; 347 Gaist (10.1016/S0140-6736(16)31357-5_bib284) 2001; 56 Law (10.1016/S0140-6736(16)31357-5_bib168) 1994; 308 Ueshima (10.1016/S0140-6736(16)31357-5_bib272) 2016; 23 Phillips (10.1016/S0140-6736(16)31357-5_bib110) 1991; 44 (10.1016/S0140-6736(16)31357-5_bib156) 2009; 302 Fewell (10.1016/S0140-6736(16)31357-5_bib109) 2007; 166 Roberts (10.1016/S0140-6736(16)31357-5_bib67) 2014; 384 Golomb (10.1016/S0140-6736(16)31357-5_bib260) 2006; 114 Hague (10.1016/S0140-6736(16)31357-5_bib100) 2016; 133 10.1016/S0140-6736(16)31357-5_bib302 Muldoon (10.1016/S0140-6736(16)31357-5_bib176) 1990; 301 Law (10.1016/S0140-6736(16)31357-5_bib218) 2006; 97 10.1016/S0140-6736(16)31357-5_bib304 Prentice (10.1016/S0140-6736(16)31357-5_bib128) 2005; 162 Bjornsson (10.1016/S0140-6736(16)31357-5_bib285) 2012; 56 (10.1016/S0140-6736(16)31357-5_bib21) 1990 Zhou (10.1016/S0140-6736(16)31357-5_bib199) 2010; 74 Gutierrez (10.1016/S0140-6736(16)31357-5_bib195) 2012; 172 Hippisley-Cox (10.1016/S0140-6736(16)31357-5_bib89) 2010; 340 Schaffer (10.1016/S0140-6736(16)31357-5_bib309) 2015; 202 Preiss (10.1016/S0140-6736(16)31357-5_bib226) 2011; 305 Abramson (10.1016/S0140-6736(16)31357-5_bib191) 2007; 369 (10.1016/S0140-6736(16)31357-5_bib243) 2013 Faasse (10.1016/S0140-6736(16)31357-5_bib141) 2013; 89 Sun (10.1016/S0140-6736(16)31357-5_bib69) 2012; 344 Carroll (10.1016/S0140-6736(16)31357-5_bib179) 2012; 308 Spence (10.1016/S0140-6736(16)31357-5_bib271) 2015; 31 (10.1016/S0140-6736(16)31357-5_bib31) 2010; 376 (10.1016/S0140-6736(16)31357-5_bib5) 1997; 15 Boots Web (10.1016/S0140-6736(16)31357-5_bib147) Brookhart (10.1016/S0140-6736(16)31357-5_bib96) 2010; 48 Chalmers (10.1016/S0140-6736(16)31357-5_bib207) 2008; 121 Vandenbroucke (10.1016/S0140-6736(16)31357-5_bib121) 2009; 373 Maningat (10.1016/S0140-6736(16)31357-5_bib74) 2011; 365 Hernan (10.1016/S0140-6736(16)31357-5_bib122) 2008; 19 Zhang (10.1016/S0140-6736(16)31357-5_bib159) 2003; 32 Garg (10.1016/S0140-6736(16)31357-5_bib44) 2008; 3 Glasziou (10.1016/S0140-6736(16)31357-5_bib84) 2007; 334 Poynter (10.1016/S0140-6736(16)31357-5_bib139) 2005; 352 Madigan (10.1016/S0140-6736(16)31357-5_bib95) 2014; 1 (10.1016/S0140-6736(16)31357-5_bib40) 2009; 373 Sattar (10.1016/S0140-6736(16)31357-5_bib49) 2010; 375 Lang (10.1016/S0140-6736(16)31357-5_bib80) 1991; 10 Banks (10.1016/S0140-6736(16)31357-5_bib305) 2016; 204 Macedo (10.1016/S0140-6736(16)31357-5_bib152) 2014; 12 Petretta (10.1016/S0140-6736(16)31357-5_bib193) 2010; 138 Ramsey (10.1016/S0140-6736(16)31357-5_bib220) 2014; 96 Golomb (10.1016/S0140-6736(16)31357-5_bib259) 2015; 10 Smeeth (10.1016/S0140-6736(16)31357-5_bib41) 1999; 318 Stampfer (10.1016/S0140-6736(16)31357-5_bib112) 1991; 20 Hopewell (10.1016/S0140-6736(16)31357-5_bib183) 2013; 34 Rahimi (10.1016/S0140-6736(16)31357-5_bib203) 2012; 9 Diamond (10.1016/S0140-6736(16)31357-5_bib72) 2015; 8 Chlebowski (10.1016/S0140-6736(16)31357-5_bib126) 2015; 1 Abramson (10.1016/S0140-6736(16)31357-5_bib11) 2013; 347 Ference (10.1016/S0140-6736(16)31357-5_bib173) 2012; 60 Johansen (10.1016/S0140-6736(16)31357-5_bib306) 2014; 12 Moriarty (10.1016/S0140-6736(16)31357-5_bib154) Malhotra (10.1016/S0140-6736(16)31357-5_bib22) 2015; 26 Sever (10.1016/S0140-6736(16)31357-5_bib105) 2011; 32 (10.1016/S0140-6736(16)31357-5_bib29) 2005; 366 Guymer (10.1016/S0140-6736(16)31357-5_bib273) 2013; 8 (10.1016/S0140-6736(16)31357-5_bib300) 2015 (10.1016/S0140-6736(16)31357-5_bib33) 2015; 385 Davey Smith (10.1016/S0140-6736(16)31357-5_bib189) 2014; 23 Layton (10.1016/S0140-6736(16)31357-5_bib276) 2013; 111 Mortensen (10.1016/S0140-6736(16)31357-5_bib208) 2009; 10 Soran (10.1016/S0140-6736(16)31357-5_bib186) 2015; 36 Santanello (10.1016/S0140-6736(16)31357-5_bib264) 1997; 45 (10.1016/S0140-6736(16)31357-5_bib32) 2012; 380 Boushey (10.1016/S0140-6736(16)31357-5_bib130) 1995; 274 Nallamothu (10.1016/S0140-6736(16)31357-5_bib63) 2008; 118 Sacks (10.1016/S0140-6736(16)31357-5_bib50) 1996; 335 Hulley (10.1016/S0140-6736(16)31357-5_bib117) 1998; 280 Ravnskov (10.1016/S0140-6736(16)31357-5_bib177) 1992; 305 Billings (10.1016/S0140-6736(16)31357-5_bib279) 2016; 315 Mansi (10.1016/S0140-6736(16)31357-5_bib23) 2013; 12 Sano (10.1016/S0140-6736(16)31357-5_bib58) 2011; 77 Law (10.1016/S0140-6736(16)31357-5_bib160) 2003; 326 McKenney (10.1016/S0140-6736(16)31357-5_bib216) 2006; 97 Holbrook (10.1016/S0140-6736(16)31357-5_bib217) 2011; 27 Armitage (10.1016/S0140-6736(16)31357-5_bib19) 2014; 384 Waters (10.1016/S0140-6736(16)31357-5_bib227) 2011; 57 Parker (10.1016/S0140-6736(16)31357-5_bib248) 2013; 127 Rosenson (10.1016/S0140-6736(16)31357-5_bib73) 2014; 8 Kunz (10.1016/S0140-6736(16)31357-5_bib16) 2007 Thompson (10.1016/S0140-6736(16)31357-5_bib27) (10.1016/S0140-6736(16)31357-5_bib280) 2014; 25 Janda (10.1016/S0140-6736(16)31357-5_bib209) 2009; 136 Kashani (10.1016/S0140-6736(16)31357-5_bib240) 2006; 114 Trivedi (10.1016/S0140-6736(16)31357-5_bib268) 2014; 14 Desai (10.1016/S0140-6736(16)31357-5_bib53) 2014; 349 Borsch-Supan (10.1016/S0140-6736(16)31357-5_bib303) 2013; 42 Harris (10.1016/S0140-6736(16)31357-5_bib60) 1995; 79 Pocock (10.1016/S0140-6736(16)31357-5_bib14) 1983 Yusuf (10.1016/S0140-6736(16)31357-5_bib301) 2011; 378 Altman (10.1016/S0140-6736(16)31357-5_bib15) 1999; 318 Grady (10.1016/S0140-6736(16)31357-5_bib111) 1992; 117 Law (10.1016/S0140-6736(16)31357-5_bib174) 1994; 308 Kiani (10.1016/S0140-6736(16)31357-5_bib266) 2013; 52 Swiger (10.1016/S0140-6736(16)31357-5_bib261) 2013; 88 Ganga (10.1016/S0140-6736(16)31357-5_bib250) 2014; 168 (10.1016/S0140-6736(16)31357-5_bib39) 2006; 355 Prieto-Merino (10.1016/S0140-6736(16)31357-5_bib38) 2013; 347 Criner (10.1016/S0140-6736(16)31357-5_bib212) 2014; 370 (10.1016/S0140-6736(16)31357-5_bib157) 2007; 370 Banks (10.1016/S0140-6736(16)31357-5_bib123) 2009; 170 Glynn (10.1016/S0140-6736(16)31357-5_bib201) 2009; 360 Davey Smith (10.1016/S0140-6736(16)31357-5_bib175) 1992; 304 Bruckert (10.1016/S0140-6736(16)31357-5_bib247) 2005; 19 (10.1016/S0140-6736(16)31357-5_bib52) 2012; 7 Barron (10.1016/S0140-6736(16)31357-5_bib142) 2013; 168 Williams (10.1016/S0140-6736(16)31357-5_bib169) 2008; 5 Postmus (10.1016/S0140-6736(16)31357-5_bib167) 2015; 44 Clarke (10.1016/S0140-6736(16)31357-5_bib133) 2010; 170 Egger (10.1016/S0140-6736(16)31357-5_bib46) 1997; 315 Anderson (10.1016/S0140-6736(16)31357-5_bib120) 2004; 291 Moriarty (10.1016/S0140-6736(16)31357-5_bib155) 2015; 9 Livingstone (10.1016/S0140-6736(16)31357-5_bib228) 2016; 59 Ebrahim (10.1016/S0140-6736(16)31357-5_bib235) 2006; 333 Glasziou (10.1016/S0140-6736(16)31357-5_bib263) 2002; 177 Golomb (10.1016/S0140-6736(16)31357-5_bib57) 2004; 25 Prentice (10.1016/S0140-6736(16)31357-5_bib129) 2006; 163 (10.1016/S0140-6736(16)31357-5_bib296) 2016 (10.1016/S0140-6736(16)31357-5_bib234) 2010; 375 Dormuth (10.1016/S0140-6736(16)31357-5_bib275) 2013; 346 Cuzick (10.1016/S0140-6736(16)31357-5_bib28) 1997; 16 Meade (10.1016/S0140-6736(16)31357-5_bib115) 1992; 48 Grady (10.1016/S0140-6736(16)31357-5_bib119) 2002; 288 Taylor (10.1016/S0140-6736(16)31357-5_bib254) 2016; 209 Wilkes (10.1016/S0140-6736(16)31357-5_bib116) 1991; 302 Mohler (10.1016/S0140-6736(16)31357-5_bib267) 2003; 108 Lawlor (10.1016/S0140-6736(16)31357-5_bib134) 2004; 363 Khan (10.1016/S0140-6736(16)31357-5_bib205) 2013; 8 Fitchett (10.1016/S0140-6736(16)31357-5_bib294) 2015; 131 Giordano (10.1016/S0140-6736(16)31357-5_bib135) 2008; 112 Stone (10.1016/S0140-6736(16)31357-5_bib162) 2014; 129 Schatz (10.1016/S0140-6736(16)31357-5_bib165) 2001; 358 Buettner (10.1016/S0140-6736(16)31357-5_bib245) 2012; 125 Joy (10.1016/S0140-6736(16)31357-5_bib251) 2014; 160 Yusuf (10.1016/S0140-6736(16)31357-5_bib196) 2016; 374 Barrett-Connor (10.1016/S0140-6736(16)31357-5_bib113) 2007; 166 Lester (10.1016/S0140-6736(16)31357-5_bib283) 2002; 32 (10.1016/S0140-6736(16)31357-5_bib127) 2003; 362 Rawlins (10.1016/S0140-6736(16)31357-5_bib2) 2008; 372 Barsky (10.1016/S0140-6736(16)31357-5_bib144) 2002; 287 Newman (10.1016/S0140-6736(16)31357-5_bib202) 2008; 5 Chen (10.1016/S0140-6736(16)31357-5_bib158) 1991; 303 Rossouw (10.1016/S0140-6736(16)31357-5_bib118) 2002; 288 Fernandez (10.1016/S0140-6736(16)31357-5_bib24) 2011; 78 Godlee (10.1016/S0140-6736(16)31357-5_bib244) 2014; 348 Baigent (10.1016/S0140-6736(16)31357-5_bib13) 2010 (10.1016/S0140-6736(16)31357-5_bib1) 2007 Nissen (10.1016/S0140-6736(16)31357-5_bib253) 2016; 315 (10.1016/S0140-6736(16)31357-5_bib79) 1995; 75 Assmann (10.1016/S0140-6736(16)31357-5_bib68) 2000; 355 Prentice (10.1016/S0140-6736(16)31357-5_bib124) 2009; 170 Garcia-Rodriguez (10.1016/S0140-6736(16)31357-5_bib90) 2008; 17 Nielsen (10.1016/S0140-6736(16)31357-5_bib308) 2016; 37 Feinstein (10.1016/S0140-6736(16)31357-5_bib76) 1997; 103 Walsh (10.1016/S0140-6736(16)31357-5_bib192) 2004; 291 Schulz (10.1016/S0140-6736(16)31357-5_bib18) 2002; 359 Lloyd (10.1016/S0140-6736(16)31357-5_bib104) 2013; 8 (10.1016/S0140-6736(16)31357-5_bib214) 2014; 370 Grimes (10.1016/S0140-6736(16)31357-5_bib143) 2011; 83 Pogue (10.1016/S0140-6736(16)31357-5_bib35) 2012; 7 Vandenbroucke (10.1016/S0140-6736(16)31357-5_bib114) 1991; 337 Roberts (10.1016/S0140-6736(16)31357-5_bib215) 2015; 350 Day (10.1016/S0140-6736(16)31357-5_bib17) 2000; 321 Temple (10.1016/S0140-6736(16)31357-5_bib85) 1999; 281 Zhang (10.1016/S0140-6736(16)31357-5_bib93) 2013; 158 Besseling (10.1016/S0140-6736(16)31357-5_bib232) 2015; 313 McCarey (10.1016/S0140-6736(16)31357-5_bib265) 2004; 363 Rothman (10.1016/S0140-6736(16)31357-5_bib66) 2013; 42 Roberts (10.1016/S0140-6736(16)31357-5_bib37) 2014; 2 Trompet (10.1016/S0140-6736(16)31357-5_bib55) 2010; 257 Margolis (10.1016/S0140-6736(16)31357-5_bib103) 2013; 15 White (10.1016/S0140-6736(16)31357-5_bib233) 2016 Matthews (10.1016/S0140-6736(16)31357-5_bib307) 2016; 353 Egger (10.1016/S0140-6736(16)31357-5_bib86) 1998; 316 Tobert (10.1016/S0140-6736(16)31357-5_bib178) 2003; 2 Culver (10.1016/S0140-6736(16)31357-5_bib229) 2012; 172 Grimes (10.1016/S0140-6736(16)31357-5_bib7) 2012; 120 Schneeweiss (10.1016/S0140-6736(16)31357-5_bib97) 2005; 58 Ioannidis (10.1016/S0140-6736(16)31357-5_bib45) 1999; 25 Nordestgaard (10.1016/S0140-673 27681574 - Nat Rev Cardiol. 2016 Nov;13(11):632-633. doi: 10.1038/nrcardio.2016.164. 28322815 - Lancet. 2017 Mar 18;389(10074):1098. doi: 10.1016/S0140-6736(17)30716-X. 28322814 - Lancet. 2017 Mar 18;389(10074):1098-1099. doi: 10.1016/S0140-6736(17)30718-3. 31554604 - Drug Ther Bull. 2019 Oct;57(10):146. doi: 10.1136/dtb.2019.000066. 28322816 - Lancet. 2017 Mar 18;389(10074):1099-1100. doi: 10.1016/S0140-6736(17)30717-1. 27567278 - Lancet. 2017 Feb 11;389(10069):602. doi: 10.1016/S0140-6736(16)31468-4. 28322813 - Lancet. 2017 Mar 18;389(10074):1097. doi: 10.1016/S0140-6736(17)30713-4. 28322812 - Lancet. 2017 Mar 18;389(10074):1097-1098. doi: 10.1016/S0140-6736(17)30712-2.
References_xml	– volume: 10 start-page: 45 year: 2009 ident: bib208 article-title: Impact of statins and ACE inhibitors on mortality after COPD exacerbations publication-title: Respir Res – volume: 48 start-page: 276 year: 1992 end-page: 308 ident: bib115 article-title: Hormone replacement therapy and cardiovascular disease publication-title: Br Med Bull – volume: 335 start-page: 1001 year: 1996 end-page: 1009 ident: bib50 article-title: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators publication-title: N Engl J Med – volume: 310 start-page: 1353 year: 2013 end-page: 1368 ident: bib125 article-title: Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials publication-title: JAMA – volume: 333 start-page: 22 year: 2006 ident: bib235 article-title: Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study publication-title: BMJ – volume: 97 start-page: 89C year: 2006 end-page: 94C ident: bib216 article-title: Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force publication-title: Am J Cardiol – volume: 318 start-page: 1209 year: 1999 ident: bib15 article-title: Statistics notes. Treatment allocation in controlled trials: why randomise? publication-title: BMJ – volume: 44 start-page: 1223 year: 1991 end-page: 1231 ident: bib110 article-title: How independent are “independent” effects? Relative risk estimation when correlated exposures are measured imprecisely publication-title: J Clin Epidemiol – volume: 133 start-page: 1851 year: 2016 end-page: 1860 ident: bib100 article-title: Long-term effectiveness and safety of pravastatin in patients with coronary heart disease: 16 years of follow-up of the LIPID Study publication-title: Circulation – volume: 14 start-page: 24 year: 2014 ident: bib268 article-title: Simvastatin improves the sexual health-related quality of life in men aged 40 years and over with erectile dysfunction: additional data from the erectile dysfunction and statin trial publication-title: BMC Urol – volume: 27 start-page: 1706 year: 2007 end-page: 1721 ident: bib170 article-title: Mouse models for atherosclerosis and pharmaceutical modifiers publication-title: Arterioscler Thromb Vasc Biol – volume: 32 start-page: 5 year: 2014 end-page: 11 ident: bib140 article-title: Use of statins and the risk of death in patients with prostate cancer publication-title: J Clin Oncol – volume: 365 start-page: 2250 year: 2011 end-page: 2251 ident: bib74 article-title: Needed: pragmatic clinical trials for statin-intolerant patients publication-title: N Engl J Med – volume: 365 start-page: 82 year: 2005 end-page: 93 ident: bib77 article-title: External validity of randomised controlled trials: “to whom do the results of this trial apply?” publication-title: Lancet – volume: 1 start-page: 296 year: 2015 end-page: 305 ident: bib126 article-title: Breast cancer after use of estrogen plus progestin and estrogen alone: analyses of data from 2 Women's Health Initiative randomized clinical trials publication-title: JAMA Oncol – volume: 1 year: 2013 ident: bib161 article-title: Statins for the primary prevention of cardiovascular disease publication-title: Cochrane Database Syst Rev – volume: 35 start-page: 2146 year: 2014 end-page: 2157 ident: bib171 article-title: Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society publication-title: Eur Heart J – volume: 375 start-page: 735 year: 2010 end-page: 742 ident: bib49 article-title: Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials publication-title: Lancet – volume: 359 start-page: 2195 year: 2008 end-page: 2207 ident: bib48 article-title: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein publication-title: N Engl J Med – volume: 36 start-page: 1012 year: 2015 end-page: 1022 ident: bib75 article-title: Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management publication-title: Eur Heart J – volume: 102 start-page: 157 year: 2000 end-page: 165 ident: bib106 article-title: Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators publication-title: Circulation – volume: 274 start-page: 1049 year: 1995 end-page: 1057 ident: bib130 article-title: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes publication-title: JAMA – volume: 42 start-page: 1012 year: 2013 end-page: 1014 ident: bib66 article-title: Why representativeness should be avoided publication-title: Int J Epidemiol – volume: 344 start-page: e1553 year: 2012 ident: bib69 article-title: Credibility of claims of subgroup effects in randomised controlled trials: systematic review publication-title: BMJ – volume: 334 start-page: 349 year: 2007 end-page: 351 ident: bib84 article-title: When are randomised trials unnecessary? Picking signal from noise publication-title: BMJ – volume: 39 start-page: 674 year: 2010 end-page: 680 ident: bib164 article-title: Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds publication-title: Age Ageing – volume: 162 start-page: 404 year: 2005 end-page: 414 ident: bib128 article-title: Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial publication-title: Am J Epidemiol – volume: 42 start-page: 992 year: 2013 end-page: 1001 ident: bib303 article-title: Data Resource Profile: the Survey of Health, Ageing and Retirement in Europe (SHARE) publication-title: Int J Epidemiol – volume: 97 start-page: 77C year: 2006 end-page: 81C ident: bib286 article-title: An assessment of statin safety by hepatologists publication-title: Am J Cardiol – volume: 352 start-page: 2184 year: 2005 end-page: 2192 ident: bib139 article-title: Statins and the risk of colorectal cancer publication-title: N Engl J Med – volume: 78 start-page: 393 year: 2011 end-page: 403 ident: bib24 article-title: Statin myopathy: a common dilemma not reflected in clinical trials publication-title: Cleve Clin J Med – volume: 8 start-page: S72 year: 2014 end-page: S81 ident: bib64 article-title: An assessment by the Statin Intolerance Panel: 2014 update publication-title: J Clin Lipidol – volume: 6 start-page: 239 year: 2009 end-page: 251 ident: bib25 article-title: Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs publication-title: Clin Trials – volume: 269 start-page: 3107 year: 1993 end-page: 3108 ident: bib262 article-title: HMG CoA reductase inhibitors and quality of life publication-title: JAMA – reference: Rangarajan S, Yusuf S. Personal communicaction. 2016. – volume: 168 start-page: 6 year: 2014 end-page: 15 ident: bib250 article-title: A systematic review of statin-induced muscle problems in clinical trials publication-title: Am Heart J – volume: 281 start-page: 841 year: 1999 end-page: 844 ident: bib85 article-title: Meta-analysis and epidemiologic studies in drug development and postmarketing surveillance publication-title: JAMA – volume: 166 start-page: 506 year: 2007 end-page: 510 ident: bib113 article-title: Hormones and heart disease in women: the timing hypothesis publication-title: Am J Epidemiol – volume: 9 start-page: e1001310 year: 2012 ident: bib203 article-title: Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials publication-title: PLoS Med – volume: 25 start-page: 462 year: 1999 end-page: 469 ident: bib45 article-title: Pooling research results: benefits and limitations of meta-analysis publication-title: Jt Comm J Qual Improv – volume: 8 start-page: 201 year: 2015 end-page: 210 ident: bib72 article-title: How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease publication-title: Expert Rev Clin Pharmacol – volume: 385 start-page: 351 year: 2015 end-page: 361 ident: bib231 article-title: HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials publication-title: Lancet – volume: 355 start-page: 549 year: 2006 end-page: 559 ident: bib39 article-title: High-dose atorvastatin after stroke or transient ischemic attack publication-title: N Engl J Med – volume: 37 start-page: 908 year: 2016 end-page: 916 ident: bib308 article-title: Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study publication-title: Eur Heart J – volume: 357 start-page: 455 year: 2001 end-page: 462 ident: bib4 article-title: Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies publication-title: Lancet – volume: 39 start-page: 1343 year: 2011 end-page: 1350 ident: bib211 article-title: Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome publication-title: Crit Care Med – volume: 112 start-page: 2456 year: 2008 end-page: 2466 ident: bib135 article-title: Limits of observational data in determining outcomes from cancer therapy publication-title: Cancer – volume: 129 start-page: S1 year: 2014 end-page: 45 ident: bib162 article-title: 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines publication-title: Circulation – volume: 357 start-page: 373 year: 2001 end-page: 380 ident: bib3 article-title: Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials publication-title: Lancet – volume: 125 start-page: 176 year: 2012 end-page: 182 ident: bib245 article-title: Statin use and musculoskeletal pain among adults with and without arthritis publication-title: Am J Med – volume: 350 start-page: h2463 year: 2015 ident: bib215 article-title: The knowledge system underpinning healthcare is not fit for purpose and must change publication-title: BMJ – volume: 79 start-page: 996 year: 1995 end-page: 1002 ident: bib60 article-title: Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group publication-title: Br J Ophthalmol – volume: 77 start-page: 556 year: 2011 end-page: 563 ident: bib58 article-title: A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease publication-title: Neurology – volume: 23 start-page: 1182 year: 2008 end-page: 1216 ident: bib151 article-title: Prevalence of musculoskeletal pain and statin use publication-title: Int J Cardiol – volume: 19 start-page: 403 year: 2005 end-page: 414 ident: bib247 article-title: Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients—the PRIMO study publication-title: Cardiovasc Drugs Ther – year: February, 2016 ident: bib296 article-title: How Big Pharma greed is killing tens of thousands around the world: Patients are over-medicated and often given profitable drugs with ‘little proven benefits,’ leading doctors warn publication-title: MailOnline – volume: 106 start-page: 969 year: 2010 end-page: 975 ident: bib180 article-title: 30-year trends in serum lipids among United States adults: results from the National Health and Nutrition Examination Surveys II, III, and 1999-2006 publication-title: Am J Cardiol – volume: 347 start-page: f6782 year: 2013 ident: bib38 article-title: Dangers of non-specific composite outcome measures in clinical trials publication-title: BMJ – volume: 17 start-page: 943 year: 2008 end-page: 952 ident: bib90 article-title: The safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary care publication-title: Pharmacoepidemiol Drug Saf – volume: 360 start-page: 1623 year: 2002 end-page: 1630 ident: bib51 article-title: Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial publication-title: Lancet – volume: 370 start-page: 1829 year: 2007 end-page: 1839 ident: bib157 article-title: Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths publication-title: Lancet – volume: 136 start-page: 734 year: 2009 end-page: 743 ident: bib209 article-title: Statins in COPD: a systematic review publication-title: Chest – volume: 62 start-page: 609 year: 2009 end-page: 616 ident: bib47 article-title: Inadequate statistical power to detect clinically significant differences in adverse event rates in randomized controlled trials publication-title: J Clin Epidemiol – volume: 347 start-page: f6123 year: 2013 ident: bib11 article-title: Should people at low risk of cardiovascular disease take a statin? publication-title: BMJ – volume: 44 start-page: 604 year: 2015 end-page: 612 ident: bib167 article-title: LDL cholesterol still a problem in old age? A Mendelian randomization study publication-title: Int J Epidemiol – volume: 15 start-page: 542 year: 2013 end-page: 554 ident: bib103 article-title: Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT) publication-title: J Clin Hypertens – volume: 359 start-page: 248 year: 2002 end-page: 252 ident: bib6 article-title: Bias and causal associations in observational research publication-title: Lancet – volume: 10 start-page: 10 year: 2010 end-page: 17 ident: bib200 article-title: Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering publication-title: Am J Cardiovasc Drugs – volume: 316 start-page: 140 year: 1998 end-page: 144 ident: bib86 article-title: Spurious precision? Meta-analysis of observational studies publication-title: BMJ – volume: 15 start-page: 26 year: 2008 end-page: 34 ident: bib131 article-title: Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies publication-title: Eur J Cardiovasc Prev Rehabil – volume: 21 start-page: 464 year: 2014 end-page: 474 ident: bib239 article-title: What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice publication-title: Eur J Prev Cardiol – volume: 336 start-page: 1246 year: 2008 end-page: 1248 ident: bib82 article-title: Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance publication-title: BMJ – volume: 307 start-page: 1491 year: 2012 end-page: 1492 ident: bib12 article-title: Healthy men should not take statins publication-title: JAMA – volume: 266 start-page: 93 year: 1991 end-page: 98 ident: bib70 article-title: Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials publication-title: JAMA – volume: 360 start-page: 1851 year: 2009 end-page: 1861 ident: bib201 article-title: A randomized trial of rosuvastatin in the prevention of venous thromboembolism publication-title: N Engl J Med – volume: 204 start-page: 320 year: 2016 ident: bib305 article-title: Absolute risk of cardiovascular disease events, and blood pressure- and lipid-lowering therapy in Australia publication-title: Med J Aust – volume: 103 start-page: 529 year: 1997 end-page: 535 ident: bib76 article-title: Problems in the “evidence” of “evidence-based medicine” publication-title: Am J Med – volume: 370 start-page: 2191 year: 2014 end-page: 2200 ident: bib214 article-title: Rosuvastatin for sepsis-associated acute respiratory distress syndrome publication-title: N Engl J Med – volume: 111 start-page: 324 year: 2010 end-page: 330 ident: bib278 article-title: Preoperative statin therapy is not associated with a reduced incidence of postoperative acute kidney injury after cardiac surgery publication-title: Anesth Analg – volume: 170 start-page: 12 year: 2009 end-page: 23 ident: bib124 article-title: Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause publication-title: Am J Epidemiol – volume: 91 start-page: 520 year: 2011 end-page: 526 ident: bib277 article-title: Dose-dependent effect of statins on the incidence of acute kidney injury after cardiac surgery publication-title: Ann Thorac Surg – volume: 120 start-page: 920 year: 2012 end-page: 927 ident: bib7 article-title: False alarms and pseudo-epidemics: the limitations of observational epidemiology publication-title: Obstet Gynecol – volume: 366 start-page: 1267 year: 2005 end-page: 1278 ident: bib29 article-title: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins publication-title: Lancet – volume: 32 start-page: 2525 year: 2011 end-page: 2532 ident: bib105 article-title: The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the UK publication-title: Eur Heart J – volume: 257 start-page: 85 year: 2010 end-page: 90 ident: bib55 article-title: Pravastatin and cognitive function in the elderly. Results of the PROSPER study publication-title: J Neurol – year: Nov 13, 2013 ident: bib190 article-title: Don't Give More Patients Statins publication-title: The New York Times – volume: 287 start-page: 622 year: 2002 end-page: 627 ident: bib144 article-title: Nonspecific medication side effects and the nocebo phenomenon publication-title: JAMA – volume: 312 start-page: 1215 year: 1996 end-page: 1218 ident: bib78 article-title: Why we need observational studies to evaluate the effectiveness of health care publication-title: BMJ – volume: 321 start-page: 504 year: 2000 ident: bib17 article-title: Statistics notes: blinding in clinical trials and other studies publication-title: BMJ – volume: 83 start-page: 5 year: 2011 end-page: 9 ident: bib143 article-title: Nonspecific side effects of oral contraceptives: nocebo or noise? publication-title: Contraception – volume: 348 start-page: g1523 year: 2014 ident: bib298 article-title: Authors' reply to Huffman and colleagues publication-title: BMJ – volume: 349 start-page: g3743 year: 2014 ident: bib53 article-title: Non-cardiovascular effects associated with statins publication-title: BMJ – volume: 74 start-page: 956 year: 2010 end-page: 964 ident: bib56 article-title: Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe publication-title: Neurology – year: 2016 ident: bib62 publication-title: Real world evidence – volume: 7 start-page: e29849 year: 2012 ident: bib52 article-title: Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175 000 people in 27 randomised trials of statin therapy publication-title: PLoS One – volume: 343 start-page: d7020 year: 2011 ident: bib150 article-title: Why do the results of randomised and observational studies differ? publication-title: BMJ – volume: 57 start-page: 1666 year: 2011 end-page: 1675 ident: bib249 article-title: Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) publication-title: J Am Coll Cardiol – volume: 361 start-page: 1149 year: 2003 end-page: 1158 ident: bib238 article-title: Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial publication-title: Lancet – ident: bib184 article-title: Atorvastatin – volume: 67 start-page: 881 year: 2016 end-page: 892 ident: bib274 article-title: Effect of statins on kidney disease outcomes: a systematic review and meta-analysis publication-title: Am J Kidney Dis – volume: 8 start-page: e52929 year: 2013 ident: bib205 article-title: The role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis publication-title: PLoS One – ident: bib281 article-title: Serious adverse events by MedDRA classification – ident: bib185 article-title: Crestor – volume: 59 start-page: 299 year: 2016 end-page: 306 ident: bib228 article-title: Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS) publication-title: Diabetologia – year: 2007 ident: bib1 publication-title: Identifying the environmental causes of disease: how should we decide what to believe and when to take action? – volume: 34 start-page: 982 year: 2013 end-page: 992 ident: bib183 article-title: Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study publication-title: Eur Heart J – volume: 2011 start-page: 1270 year: 2011 end-page: 1279 ident: bib94 article-title: Structured vs. unstructured: factors affecting adverse drug reaction documentation in an EMR repository publication-title: AMIA Annu Symp Proc – volume: 363 start-page: 2015 year: 2004 end-page: 2021 ident: bib265 article-title: Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial publication-title: Lancet – ident: bib197 – volume: 127 start-page: 96 year: 2013 end-page: 103 ident: bib248 article-title: Effect of statins on skeletal muscle function publication-title: Circulation – volume: 81 start-page: 264 year: 2013 end-page: 272 ident: bib237 article-title: Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review publication-title: Neurology – volume: 163 start-page: 589 year: 2006 end-page: 599 ident: bib129 article-title: Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease publication-title: Am J Epidemiol – volume: 5 start-page: 177 year: 2008 end-page: 183 ident: bib202 article-title: The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS) publication-title: Diab Vasc Dis Res – volume: 58 start-page: 323 year: 2005 end-page: 337 ident: bib97 article-title: A review of uses of health care utilization databases for epidemiologic research on therapeutics publication-title: J Clin Epidemiol – volume: 320 start-page: 904 year: 1989 end-page: 910 ident: bib236 article-title: Serum cholesterol levels and six-year mortality from stroke in 350 977 men screened for the multiple risk factor intervention trial publication-title: N Engl J Med – volume: 359 start-page: 696 year: 2002 end-page: 700 ident: bib18 article-title: Blinding in randomised trials: hiding who got what publication-title: Lancet – volume: 109 start-page: 1319 year: 2002 end-page: 1330 ident: bib107 article-title: Patterns of use of hormone replacement therapy in one million women in Britain, 1996–2000 publication-title: BJOG – volume: 131 start-page: e389 year: 2015 end-page: e391 ident: bib294 article-title: Cardiology patient page. Statin intolerance publication-title: Circulation – volume: 371 start-page: 1695 year: 2014 end-page: 1703 ident: bib213 article-title: Simvastatin in the acute respiratory distress syndrome publication-title: N Engl J Med – volume: 118 start-page: 1294 year: 2008 end-page: 1303 ident: bib63 article-title: Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies publication-title: Circulation – volume: 315 start-page: 1371 year: 1997 end-page: 1374 ident: bib46 article-title: Meta-Analysis. Potentials and promise publication-title: BMJ – volume: 54 start-page: 1022 year: 2000 end-page: 1028 ident: bib36 article-title: Choice of endpoints in antiplatelet trials: which outcomes are most relevant to stroke patients? publication-title: Neurology – volume: 23 start-page: R89 year: 2014 end-page: R98 ident: bib189 article-title: Mendelian randomization: genetic anchors for causal inference in epidemiological studies publication-title: Hum Mol Genet – volume: 363 start-page: 1724 year: 2004 end-page: 1727 ident: bib134 article-title: Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? publication-title: Lancet – volume: 56 start-page: 931 year: 2001 end-page: 933 ident: bib284 article-title: Are users of lipid-lowering drugs at increased risk of peripheral neuropathy? publication-title: Eur J Clin Pharmacol – volume: 2 start-page: 56 year: 2014 ident: bib37 article-title: Applying results from clinical trials: tranexamic acid in trauma patients publication-title: J Intensive Care – volume: 302 start-page: 1317 year: 1991 end-page: 1320 ident: bib116 article-title: Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research framework publication-title: BMJ – volume: 372 start-page: 2152 year: 2008 end-page: 2161 ident: bib2 article-title: De testimonio: on the evidence for decisions about the use of therapeutic interventions publication-title: Lancet – volume: 288 start-page: 49 year: 2002 end-page: 57 ident: bib119 article-title: Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II) publication-title: JAMA – volume: 6 start-page: 245 year: 1987 end-page: 254 ident: bib20 article-title: Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews publication-title: Stat Med – volume: 370 start-page: 1781 year: 2007 end-page: 1790 ident: bib145 article-title: The safety of statins in clinical practice publication-title: Lancet – volume: 358 start-page: 351 year: 2001 end-page: 355 ident: bib165 article-title: Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study publication-title: Lancet – reference: Cholesterol Treatment Trialists' (CTT) Collaboration Secretariat. Personal Communication, Mihaylova B, 2016. – volume: 301 start-page: 309 year: 1990 end-page: 314 ident: bib176 article-title: Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials publication-title: BMJ – volume: 313 start-page: 1011 year: 2015 end-page: 1012 ident: bib242 article-title: Statin intolerance: reconciling clinical trials and clinical experience publication-title: JAMA – volume: 67 start-page: 447 year: 1991 end-page: 453 ident: bib59 article-title: Expanded clinical evaluation of lovastatin (EXCEL) study results. II. Assessment of the human lens after 48 weeks of treatment with lovastatin publication-title: Am J Cardiol – volume: 308 start-page: 373 year: 1994 end-page: 379 ident: bib168 article-title: Assessing possible hazards of reducing serum cholesterol publication-title: BMJ – volume: 75 start-page: 1130 year: 1995 end-page: 1134 ident: bib79 article-title: Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens publication-title: Am J Cardiol – volume: 26 start-page: 6 year: 2015 end-page: 7 ident: bib22 article-title: Maximising the benefits and minimising the harms of statins publication-title: Prescriber – volume: 23 start-page: 891 year: 2016 end-page: 896 ident: bib65 article-title: Statin tolerability: In defence of placebo-controlled trials publication-title: Eur J Prev Cardiol – volume: 172 start-page: 909 year: 2012 end-page: 919 ident: bib195 article-title: Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis publication-title: Arch Intern Med – volume: 23 start-page: 976 year: 2016 end-page: 990 ident: bib272 article-title: Rationale and design of the standard versus intensive statin therapy for hypercholesterolemic patients with diabetic retinopathy (EMPATHY) study: a randomized controlled trial publication-title: J Atheroscler Thromb – volume: 378 start-page: 1231 year: 2011 end-page: 1243 ident: bib301 article-title: Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey publication-title: Lancet – volume: 340 start-page: c2197 year: 2010 ident: bib89 article-title: Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database publication-title: BMJ – volume: 97 start-page: 52C year: 2006 end-page: 60C ident: bib218 article-title: Statin safety: a systematic review publication-title: Am J Cardiol – volume: 73 start-page: 385 year: 2002 end-page: 389 ident: bib54 article-title: Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk publication-title: J Neurol Neurosurg Psychiatry – volume: 3 start-page: 253 year: 2008 end-page: 260 ident: bib44 article-title: Systematic review and meta-analysis: when one study is just not enough publication-title: Clin J Am Soc Nephrol – volume: 364 start-page: 771 year: 2004 end-page: 777 ident: bib101 article-title: Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S) publication-title: Lancet – volume: 315 start-page: 877 year: 2016 end-page: 888 ident: bib279 article-title: High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial publication-title: JAMA – volume: 89 start-page: 540 year: 2013 end-page: 546 ident: bib141 article-title: The nocebo effect: patient expectations and medication side effects publication-title: Postgrad Med – year: 2015 ident: bib300 publication-title: Perceptions of statins. Research with patients, GPs and cardiologists – volume: 61 start-page: 957 year: 2006 end-page: 961 ident: bib206 article-title: Statin treatment and reduced risk of pneumonia in patients with diabetes publication-title: Thorax – volume: 384 start-page: 1745 year: 2014 ident: bib67 article-title: Blood pressure lowering and cardiovascular risk publication-title: Lancet – volume: 384 start-page: 1263 year: 2014 end-page: 1264 ident: bib19 article-title: Misrepresentation of statin safety evidence publication-title: Lancet – volume: 5 start-page: 2929 year: 2005 end-page: 2936 ident: bib102 article-title: Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study publication-title: Am J Transplant – volume: 111 start-page: 823 year: 2013 end-page: 828 ident: bib276 article-title: Effect of statin use on acute kidney injury risk following coronary artery bypass grafting publication-title: Am J Cardiol – volume: 27 start-page: 146 year: 2011 end-page: 151 ident: bib217 article-title: Statin-associated rhabdomyolysis: is there a dose-response relationship? publication-title: Can J Cardiol – volume: 58 start-page: 1333 year: 2002 end-page: 1337 ident: bib290 article-title: Statins and risk of polyneuropathy: a case-control study publication-title: Neurology – ident: bib223 article-title: FDA Drug Safety Communication December 2011: New restrictions, contraindications, and dose limitations for Zocor (simvastatin) to reduce the risk of muscle injury – volume: 374 start-page: 2021 year: 2016 end-page: 2031 ident: bib196 article-title: Cholesterol lowering in intermediate-risk persons without cardiovascular disease publication-title: N Engl J Med – year: 2016 ident: bib246 article-title: The nocebo effect in the context of statin intolerance publication-title: J Clin Lipidol – volume: 370 start-page: 2201 year: 2014 end-page: 2210 ident: bib212 article-title: Simvastatin for the prevention of exacerbations in moderate-to-severe COPD publication-title: N Engl J Med – volume: 303 start-page: 276 year: 1991 end-page: 282 ident: bib158 article-title: Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations publication-title: BMJ – volume: 23 start-page: 565 year: 2007 end-page: 574 ident: bib194 article-title: Impact of gender on statin efficacy publication-title: Curr Med Res Opin – volume: 12 start-page: 327 year: 2013 end-page: 337 ident: bib23 article-title: The controversy of a wider statin utilization: why? publication-title: Expert Opin Drug Saf – ident: bib26 article-title: Statins have no side effects? This is what our study really found… – volume: 347 start-page: f6340 year: 2013 ident: bib10 article-title: Saturated fat is not the major issue publication-title: BMJ – volume: 288 start-page: 321 year: 2002 end-page: 333 ident: bib118 article-title: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial publication-title: JAMA – volume: 160 start-page: 301 year: 2014 end-page: 310 ident: bib251 article-title: N-of-1 (single-patient) trials for statin-related myalgia publication-title: Ann Intern Med – volume: 168 start-page: 3572 year: 2013 end-page: 3579 ident: bib142 article-title: Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: recommendations for patient information publication-title: Int J Cardiol – volume: 308 start-page: 804 year: 2012 end-page: 811 ident: bib287 article-title: Lipid-modifying therapies and risk of pancreatitis: a meta-analysis publication-title: JAMA – volume: 363 start-page: 1728 year: 2004 end-page: 1731 ident: bib149 article-title: When are observational studies as credible as randomised trials? publication-title: Lancet – volume: 25 start-page: 178 year: 2004 end-page: 202 ident: bib57 article-title: The UCSD Statin Study: a randomized controlled trial assessing the impact of statins on selected noncardiac outcomes publication-title: Control Clin Trials – volume: 35 start-page: 1310 year: 2006 end-page: 1311 ident: bib87 article-title: Commentary: we still need observational studies of drugs-they just need to be better publication-title: Int J Epidemiol – volume: 172 start-page: 144 year: 2012 end-page: 152 ident: bib229 article-title: Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative publication-title: Arch Intern Med – year: 1990 ident: bib21 publication-title: Treatment of Early Breast Cancer, volume 1. Worldwide Evidence 1985–1990 – volume: 8 start-page: e83759 year: 2013 ident: bib273 article-title: Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration publication-title: PLoS One – volume: 202 start-page: 591 year: 2015 end-page: 594 ident: bib309 article-title: The crux of the matter: did the ABC's publication-title: Med J Aust – volume: 10 start-page: 1585 year: 1991 end-page: 1593 ident: bib80 article-title: Estimating the effect of the run-in on the power of the Physicians' Health Study publication-title: Stat Med – ident: bib146 article-title: Package leaflet: Information for the User, 10/2015. Atorvastatin 10mg, 20mg, 40mg and 80 mg film-coated tablets – volume: 359 start-page: 789 year: 2008 end-page: 799 ident: bib219 article-title: SLCO1B1 variants and statin-induced myopathy—a genomewide study publication-title: N Engl J Med – volume: 7 start-page: 1 year: 2003 end-page: 173 ident: bib108 article-title: Evaluating non-randomised intervention studies publication-title: Health Technol Assess – ident: bib154 article-title: ODYSSEY ALTERNATIVE: Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 monoclonal antibody, alirocumab, versus ezetimibe, in patients with statin intolerance as defined by a placebo run-in and statin rechallenge arm – volume: 9 start-page: 758 year: 2015 end-page: 769 ident: bib155 article-title: Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial publication-title: J Clin Lipidol – volume: 74 start-page: 818 year: 2010 end-page: 826 ident: bib199 article-title: Pleiotropic effects of statins. Basic research and clinical perspectives publication-title: Circ J – volume: 342 start-page: 1907 year: 2000 end-page: 1909 ident: bib9 article-title: Randomized trials or observational tribulations? publication-title: N Engl J Med – volume: 52 start-page: 1651 year: 2013 end-page: 1657 ident: bib266 article-title: Predictors of self-reported health-related quality of life in systemic lupus erythematosus publication-title: Rheumatology (Oxford) – volume: 360 start-page: 7 year: 2002 end-page: 22 ident: bib222 article-title: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial publication-title: Lancet – volume: 304 start-page: 431 year: 1992 end-page: 434 ident: bib175 article-title: Should there be a moratorium on the use of cholesterol lowering drugs? publication-title: BMJ – volume: 20 start-page: 47 year: 1991 end-page: 63 ident: bib112 article-title: Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence publication-title: Prev Med – volume: 176 start-page: 63 year: 2016 end-page: 69 ident: bib187 article-title: Protocol for analyses of adverse event data from randomized controlled trials of statin therapy publication-title: Am Heart J – year: 1998 ident: bib182 publication-title: National Diet and Nutrition Survey: people aged 65 years and over. Volume 1: Report of the diet and nutrition survey – volume: 96 start-page: 423 year: 2014 end-page: 428 ident: bib220 article-title: The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update publication-title: Clin Pharmacol Ther – volume: 88 start-page: 1213 year: 2013 end-page: 1221 ident: bib261 article-title: Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects publication-title: Mayo Clin Proc – reference: Achelrod D, Gray A, Preiss D, Mihaylova B. Personal communication. 2016. – volume: 305 start-page: 15 year: 1992 end-page: 19 ident: bib177 article-title: Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome publication-title: BMJ – year: 2013 ident: bib243 article-title: Statins can weaken muscles and joints: cholesterol drug raises risk of problems by up to 20 per cent publication-title: MailOnline – volume: 56 start-page: 374 year: 2012 end-page: 380 ident: bib285 article-title: Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing publication-title: J Hepatol – volume: 376 start-page: 1670 year: 2010 end-page: 1681 ident: bib31 article-title: Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials publication-title: Lancet – volume: 108 start-page: 1481 year: 2003 end-page: 1486 ident: bib267 article-title: Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease publication-title: Circulation – volume: 280 start-page: 605 year: 1998 end-page: 613 ident: bib117 article-title: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group publication-title: JAMA – volume: 170 start-page: 24 year: 2009 end-page: 28 ident: bib123 article-title: Invited commentary: hormone therapy risks and benefits–The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis publication-title: Am J Epidemiol – year: 1983 ident: bib14 publication-title: Clinical Trials – volume: 156 start-page: 2085 year: 1996 end-page: 2092 ident: bib61 article-title: Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study publication-title: Arch Intern Med – volume: 62 start-page: 1373 year: 2008 end-page: 1378 ident: bib210 article-title: Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study publication-title: Int J Clin Pract – year: 2016 ident: bib34 article-title: Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials publication-title: Lancet Diabetes Endocrinol – volume: 5 start-page: e67 year: 2008 ident: bib88 article-title: Observational research, randomised trials, and two views of medical science publication-title: PLoS Med – volume: 19 start-page: 766 year: 2008 end-page: 779 ident: bib122 article-title: Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease publication-title: Epidemiology – year: 2016 ident: bib137 article-title: Can observational data replace randomized trials? publication-title: J Clin Oncol – volume: 238 start-page: 329 year: 2015 end-page: 335 ident: bib255 article-title: A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy publication-title: Atherosclerosis – volume: 25 start-page: 1825 year: 2014 end-page: 1833 ident: bib280 article-title: Effects of lowering LDL cholesterol on progression of kidney disease publication-title: J Am Soc Nephrol – volume: 305 start-page: 2556 year: 2011 end-page: 2564 ident: bib226 article-title: Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis publication-title: JAMA – volume: 7 start-page: e41297 year: 2012 ident: bib252 article-title: Randomized Polypill crossover trial in people aged 50 and over publication-title: PLoS One – volume: 159 start-page: 688 year: 2013 end-page: 697 ident: bib258 article-title: Statins and cognitive function: a systematic review publication-title: Ann Intern Med – volume: 291 start-page: 1701 year: 2004 end-page: 1712 ident: bib120 article-title: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial publication-title: JAMA – volume: 337 start-page: 833 year: 1991 end-page: 834 ident: bib114 article-title: Postmenopausal oestrogen and cardioprotection publication-title: Lancet – ident: bib256 article-title: Statins: updates to product safety information November 2009. Public Assessment Report – ident: bib295 article-title: Catalyst ABC 2014. Heart of the Matter. The Cholesterol Myth: Dietary Villains and Cholesterol Drug War – volume: 57 start-page: 1535 year: 2011 end-page: 1545 ident: bib227 article-title: Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials publication-title: J Am Coll Cardiol – volume: 371 start-page: 288 year: 2014 end-page: 290 ident: bib43 article-title: Safety profile of extended-release niacin in the AIM-HIGH trial publication-title: N Engl J Med – year: Aug 2001 ident: bib221 article-title: Safety Alerts for Human Medicinal Products. Baycol (cerivastatin sodium tablets) – volume: 133 start-page: 1073 year: 2016 end-page: 1080 ident: bib98 article-title: Long-term safety and efficacy of lowering low-density lipoprotein cholesterol with statin therapy: 20-year follow-up of West of Scotland Coronary Prevention Study publication-title: Circulation – volume: 8 start-page: S58 year: 2014 end-page: S71 ident: bib73 article-title: An assessment by the Statin Muscle Safety Task Force: 2014 update publication-title: J Clin Lipidol – volume: 166 start-page: 155 year: 2006 end-page: 160 ident: bib153 article-title: Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects publication-title: Arch Intern Med – volume: 32 start-page: 563 year: 2003 end-page: 572 ident: bib159 article-title: Cholesterol, coronary heart disease, and stroke in the Asia Pacific region publication-title: Int J Epidemiol – volume: 347 start-page: f6745 year: 2013 ident: bib230 article-title: Role of diuretics, beta blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study publication-title: BMJ – volume: 138 start-page: 25 year: 2010 end-page: 31 ident: bib193 article-title: Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis publication-title: Int J Cardiol – volume: 365 start-page: 1308 year: 2005 ident: bib71 article-title: Forest plots and the interpretation of subgroups publication-title: Lancet – volume: 32 start-page: 333 year: 2002 end-page: 346 ident: bib283 article-title: Serum cholesterol levels and suicide: a meta-analysis publication-title: Suicide Life Threat Behav – year: 2014 ident: bib163 article-title: Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. NICE guideline CG181 – volume: 63 start-page: 64 year: 2010 end-page: 74 ident: bib136 article-title: A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies publication-title: J Clin Epidemiol – volume: 361 start-page: 2017 year: 2003 end-page: 2023 ident: bib132 article-title: Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials publication-title: Lancet – volume: 9 start-page: 6 year: 2009 ident: bib81 article-title: Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20 536 high-risk people publication-title: BMC Clin Pharmacol – volume: 209 start-page: 12 year: 2016 end-page: 13 ident: bib254 article-title: Increased creatine kinase with statin treatment may identify statin-associated muscle symptoms publication-title: Int J Cardiol – volume: 378 start-page: 2013 year: 2011 end-page: 2020 ident: bib99 article-title: Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial publication-title: Lancet – volume: 166 start-page: 646 year: 2007 end-page: 655 ident: bib109 article-title: The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study publication-title: Am J Epidemiol – volume: 10 start-page: e0124451 year: 2015 ident: bib259 article-title: Statin effects on aggression: results from the UCSD Statin Study, a randomized control trial publication-title: PLoS One – volume: 36 start-page: 2975 year: 2015 end-page: 2983 ident: bib186 article-title: Cholesterol, not just cardiovascular risk, is important in deciding who should receive statin treatment publication-title: Eur Heart J – year: 2010 ident: bib13 publication-title: Large-scale randomized evidence: trials and meta-analyses of trials. Oxford Textbook of Medicine – volume: 355 start-page: 1064 year: 2000 end-page: 1069 ident: bib68 article-title: Subgroup analysis and other (mis)uses of baseline data in clinical trials publication-title: Lancet – volume: 362 start-page: 419 year: 2003 end-page: 427 ident: bib127 article-title: Breast cancer and hormone-replacement therapy in the Million Women Study publication-title: Lancet – start-page: MR000012 year: 2007 ident: bib16 article-title: Randomisation to protect against selection bias in healthcare trials publication-title: Cochrane Database Syst Rev – volume: 15 start-page: 105 year: 1997 end-page: 115 ident: bib5 article-title: Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension publication-title: J Hypertens – volume: 308 start-page: 367 year: 1994 end-page: 372 ident: bib174 article-title: By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? publication-title: BMJ – volume: 34 start-page: 3478 year: 2013 end-page: 3490 ident: bib172 article-title: Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society publication-title: Eur Heart J – volume: 173 start-page: 1318 year: 2013 end-page: 1326 ident: bib91 article-title: Statins and musculoskeletal conditions, arthropathies, and injuries publication-title: JAMA Intern Med – volume: 48 start-page: S114 year: 2010 end-page: S120 ident: bib96 article-title: Confounding control in healthcare database research: challenges and potential approaches publication-title: Med Care – volume: 376 start-page: 1658 year: 2010 end-page: 1669 ident: bib83 article-title: Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial publication-title: Lancet – volume: 6 start-page: 390 year: 2013 end-page: 399 ident: bib241 article-title: Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials publication-title: Circ Cardiovasc Qual Outcomes – volume: 34 start-page: 1279 year: 2013 end-page: 1291 ident: bib224 article-title: HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment publication-title: Eur Heart J – ident: bib297 article-title: Why are new treatments needed? – ident: bib147 article-title: Cholesterol management guide. Side effects of statins – volume: 353 start-page: i3283 year: 2016 ident: bib307 article-title: Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data publication-title: BMJ – volume: 367 start-page: 1792 year: 2012 end-page: 1802 ident: bib92 article-title: Statin use and reduced cancer-related mortality publication-title: N Engl J Med – volume: 158 start-page: 526 year: 2013 end-page: 534 ident: bib93 article-title: Discontinuation of statins in routine care settings: a cohort study publication-title: Ann Intern Med – volume: 315 start-page: 1580 year: 2016 end-page: 1590 ident: bib253 article-title: Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: the GAUSS-3 randomized clinical trial publication-title: JAMA – volume: 318 start-page: 1548 year: 1999 end-page: 1551 ident: bib41 article-title: Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading publication-title: BMJ – volume: 375 start-page: 2215 year: 2010 end-page: 2222 ident: bib234 article-title: Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies publication-title: Lancet – volume: 97 start-page: 229 year: 2004 end-page: 235 ident: bib282 article-title: Severe irritability associated with statin cholesterol-lowering drugs publication-title: Q J Med – volume: 8 start-page: e72642 year: 2013 ident: bib104 article-title: Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) publication-title: PLoS One – ident: bib257 article-title: FDA Drug Safety Communication 2012: Important safety label changes to cholesterol-lowering statin drugs – volume: 100 start-page: ii1 year: 2014 end-page: ii67 ident: bib292 article-title: Consensus recommendations for the prevention of cardiovascular disease (JBS3) publication-title: Heart – volume: 373 start-page: 1233 year: 2009 end-page: 1235 ident: bib121 article-title: The HRT controversy: observational studies and RCTs fall in line publication-title: Lancet – volume: 12 start-page: 51 year: 2014 ident: bib152 article-title: Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis publication-title: BMC Med – volume: 97 start-page: 86C year: 2006 end-page: 88C ident: bib289 article-title: An assessment of statin safety by neurologists publication-title: Am J Cardiol – volume: 114 start-page: 2788 year: 2006 end-page: 2797 ident: bib240 article-title: Risks associated with statin therapy: a systematic overview of randomized clinical trials publication-title: Circulation – volume: 16 start-page: 1017 year: 1997 end-page: 1029 ident: bib28 article-title: Adjusting for non-compliance and contamination in randomized clinical trials publication-title: Stat Med – volume: 373 start-page: 1849 year: 2009 end-page: 1860 ident: bib40 article-title: Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials publication-title: Lancet – volume: 374 start-page: 1744 year: 2016 end-page: 1753 ident: bib204 article-title: Perioperative rosuvastatin in cardiac surgery publication-title: N Engl J Med – volume: 326 start-page: 1423 year: 2003 ident: bib160 article-title: Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis publication-title: BMJ – volume: 335 start-page: 285 year: 2007 end-page: 287 ident: bib198 article-title: Preventive health care in elderly people needs rethinking publication-title: BMJ – volume: 114 start-page: II year: 2006 end-page: 289 ident: bib260 article-title: Abstract 1501 do low dose statins affect cognition? Results of the UCSD Statin study publication-title: Circulation – volume: 12 start-page: 215 year: 2014 end-page: 223 ident: bib306 article-title: Cardiovascular risk and statin use in the United States publication-title: Ann Fam Med – volume: 45 start-page: 8 year: 1997 end-page: 14 ident: bib264 article-title: Effect of pharmacologic lipid lowering on health-related quality of life in older persons: results from the Cholesterol Reduction in Seniors Program (CRISP) pilot study publication-title: J Am Geriatr Soc – volume: 6 start-page: e010401 year: 2016 ident: bib166 article-title: Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review publication-title: BMJ Open – volume: 2 start-page: 517 year: 2003 end-page: 526 ident: bib178 article-title: Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors publication-title: Nat Rev Drug Discov – volume: 170 start-page: 1622 year: 2010 end-page: 1631 ident: bib133 article-title: Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals publication-title: Arch Intern Med – year: 2016 ident: bib233 article-title: Association of lipid fractions with risks for coronary artery disease and diabetes publication-title: JAMA Cardiol – volume: 348 start-page: g3306 year: 2014 ident: bib244 article-title: Adverse effects of statins publication-title: BMJ – volume: 308 start-page: 1545 year: 2012 end-page: 1554 ident: bib179 article-title: Trends in lipids and lipoproteins in US adults, 1988–2010 publication-title: JAMA – volume: 380 start-page: 565 year: 2012 end-page: 571 ident: bib225 article-title: Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial publication-title: Lancet – ident: bib293 article-title: Statins and reporting bias – volume: 369 start-page: 168 year: 2007 end-page: 169 ident: bib191 article-title: Are lipid-lowering guidelines evidence-based? publication-title: Lancet – volume: 1 start-page: 11 year: 2014 end-page: 39 ident: bib95 article-title: A systematic statistical approach to evaluating evidence from observational studies publication-title: Ann Rev Stat Appl – volume: 31 start-page: 691 year: 2015 ident: bib271 article-title: Statins and cataracts: reverse causality? publication-title: Can J Cardiol – volume: 121 start-page: 1002 year: 2008 end-page: 1007 ident: bib207 article-title: Prior statin use is associated with improved outcomes in community-acquired pneumonia publication-title: Am J Med – volume: 313 start-page: 1029 year: 2015 end-page: 1036 ident: bib232 article-title: Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus publication-title: JAMA – volume: 117 start-page: 1016 year: 1992 end-page: 1037 ident: bib111 article-title: Hormone therapy to prevent disease and prolong life in postmenopausal women publication-title: Ann Intern Med – volume: 22 start-page: 2388 year: 2004 end-page: 2394 ident: bib138 article-title: The risk of cancer in users of statins publication-title: J Clin Oncol – ident: bib291 article-title: Serious adverse events by MedDRA classification – volume: 302 start-page: 1993 year: 2009 end-page: 2000 ident: bib156 article-title: Major lipids, apolipoproteins, and risk of vascular disease publication-title: JAMA – volume: 10 start-page: 663 year: 1991 end-page: 666 ident: bib8 article-title: Problems with using observational databases to compare treatments publication-title: Stat Med – ident: bib148 article-title: Statins - Side Effects – volume: 294 start-page: 1773 year: 2005 end-page: 1781 ident: bib181 article-title: Trends in serum lipids and lipoproteins of adults, 1960–2002 publication-title: JAMA – volume: 346 start-page: f880 year: 2013 ident: bib275 article-title: Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases publication-title: BMJ – ident: bib27 article-title: Concerns about the latest NICE draft guidance on statins – ident: bib270 article-title: QIntervention website – volume: 385 start-page: 1397 year: 2015 end-page: 1405 ident: bib33 article-title: Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials publication-title: Lancet – volume: 60 start-page: 2631 year: 2012 end-page: 2639 ident: bib173 article-title: Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis publication-title: J Am Coll Cardiol – volume: 363 start-page: 757 year: 2004 end-page: 767 ident: bib288 article-title: Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions publication-title: Lancet – volume: 371 start-page: 117 year: 2008 end-page: 125 ident: bib30 article-title: Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis publication-title: Lancet – volume: 291 start-page: 2243 year: 2004 end-page: 2252 ident: bib192 article-title: Drug treatment of hyperlipidemia in women publication-title: JAMA – volume: 10 start-page: 154 year: 2012 ident: bib269 article-title: The impact of statins on psychological wellbeing: a systematic review and meta-analysis publication-title: BMC Med – volume: 380 start-page: 581 year: 2012 end-page: 590 ident: bib32 article-title: The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials publication-title: Lancet – volume: 177 start-page: 428 year: 2002 end-page: 434 ident: bib263 article-title: Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective? publication-title: Med J Aust – volume: 5 start-page: 91 year: 2008 end-page: 102 ident: bib169 article-title: Rapid regression of atherosclerosis: insights from the clinical and experimental literature publication-title: Nat Clin Pract Cardiovasc Med – volume: 8 start-page: 189 year: 2015 end-page: 199 ident: bib299 article-title: Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms publication-title: Expert Rev Clin Pharmacol – volume: 7 start-page: e34785 year: 2012 ident: bib35 article-title: Designing and analyzing clinical trials with composite outcomes: consideration of possible treatment differences between the individual outcomes publication-title: PLoS One – volume: 371 start-page: 203 year: 2014 end-page: 212 ident: bib42 article-title: Effects of extended-release niacin with laropiprant in high-risk patients publication-title: N Engl J Med – volume: 302 start-page: 1993 year: 2009 ident: 10.1016/S0140-6736(16)31357-5_bib156 article-title: Major lipids, apolipoproteins, and risk of vascular disease publication-title: JAMA doi: 10.1001/jama.2009.1619 – volume: 125 start-page: 176 year: 2012 ident: 10.1016/S0140-6736(16)31357-5_bib245 article-title: Statin use and musculoskeletal pain among adults with and without arthritis publication-title: Am J Med doi: 10.1016/j.amjmed.2011.08.007 – volume: 10 start-page: 154 year: 2012 ident: 10.1016/S0140-6736(16)31357-5_bib269 article-title: The impact of statins on psychological wellbeing: a systematic review and meta-analysis publication-title: BMC Med doi: 10.1186/1741-7015-10-154 – volume: 204 start-page: 320 year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib305 article-title: Absolute risk of cardiovascular disease events, and blood pressure- and lipid-lowering therapy in Australia publication-title: Med J Aust doi: 10.5694/mja15.01004 – volume: 7 start-page: 1 year: 2003 ident: 10.1016/S0140-6736(16)31357-5_bib108 article-title: Evaluating non-randomised intervention studies publication-title: Health Technol Assess doi: 10.3310/hta7270 – volume: 60 start-page: 2631 year: 2012 ident: 10.1016/S0140-6736(16)31357-5_bib173 article-title: Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2012.09.017 – volume: 172 start-page: 144 year: 2012 ident: 10.1016/S0140-6736(16)31357-5_bib229 article-title: Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative publication-title: Arch Intern Med doi: 10.1001/archinternmed.2011.625 – volume: 288 start-page: 49 year: 2002 ident: 10.1016/S0140-6736(16)31357-5_bib119 article-title: Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II) publication-title: JAMA doi: 10.1001/jama.288.1.49 – volume: 370 start-page: 1781 year: 2007 ident: 10.1016/S0140-6736(16)31357-5_bib145 article-title: The safety of statins in clinical practice publication-title: Lancet doi: 10.1016/S0140-6736(07)60716-8 – volume: 333 start-page: 22 year: 2006 ident: 10.1016/S0140-6736(16)31357-5_bib235 article-title: Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study publication-title: BMJ doi: 10.1136/bmj.38855.610324.80 – volume: 347 start-page: f6782 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib38 article-title: Dangers of non-specific composite outcome measures in clinical trials publication-title: BMJ doi: 10.1136/bmj.f6782 – volume: 42 start-page: 1012 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib66 article-title: Why representativeness should be avoided publication-title: Int J Epidemiol doi: 10.1093/ije/dys223 – volume: 312 start-page: 1215 year: 1996 ident: 10.1016/S0140-6736(16)31357-5_bib78 article-title: Why we need observational studies to evaluate the effectiveness of health care publication-title: BMJ doi: 10.1136/bmj.312.7040.1215 – volume: 17 start-page: 943 year: 2008 ident: 10.1016/S0140-6736(16)31357-5_bib90 article-title: The safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary care publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.1603 – volume: 23 start-page: 976 year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib272 article-title: Rationale and design of the standard versus intensive statin therapy for hypercholesterolemic patients with diabetic retinopathy (EMPATHY) study: a randomized controlled trial publication-title: J Atheroscler Thromb doi: 10.5551/jat.33563 – volume: 2011 start-page: 1270 year: 2011 ident: 10.1016/S0140-6736(16)31357-5_bib94 article-title: Structured vs. unstructured: factors affecting adverse drug reaction documentation in an EMR repository publication-title: AMIA Annu Symp Proc – volume: 166 start-page: 506 year: 2007 ident: 10.1016/S0140-6736(16)31357-5_bib113 article-title: Hormones and heart disease in women: the timing hypothesis publication-title: Am J Epidemiol doi: 10.1093/aje/kwm214 – volume: 34 start-page: 982 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib183 article-title: Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study publication-title: Eur Heart J doi: 10.1093/eurheartj/ehs344 – volume: 114 start-page: II year: 2006 ident: 10.1016/S0140-6736(16)31357-5_bib260 article-title: Abstract 1501 do low dose statins affect cognition? Results of the UCSD Statin study publication-title: Circulation – volume: 67 start-page: 881 year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib274 article-title: Effect of statins on kidney disease outcomes: a systematic review and meta-analysis publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2016.01.016 – volume: 347 start-page: f6123 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib11 article-title: Should people at low risk of cardiovascular disease take a statin? publication-title: BMJ doi: 10.1136/bmj.f6123 – volume: 365 start-page: 1308 year: 2005 ident: 10.1016/S0140-6736(16)31357-5_bib71 article-title: Forest plots and the interpretation of subgroups publication-title: Lancet doi: 10.1016/S0140-6736(05)61026-4 – volume: 45 start-page: 8 year: 1997 ident: 10.1016/S0140-6736(16)31357-5_bib264 article-title: Effect of pharmacologic lipid lowering on health-related quality of life in older persons: results from the Cholesterol Reduction in Seniors Program (CRISP) pilot study publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.1997.tb00971.x – volume: 369 start-page: 168 year: 2007 ident: 10.1016/S0140-6736(16)31357-5_bib191 article-title: Are lipid-lowering guidelines evidence-based? publication-title: Lancet doi: 10.1016/S0140-6736(07)60084-1 – volume: 74 start-page: 956 year: 2010 ident: 10.1016/S0140-6736(16)31357-5_bib56 article-title: Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe publication-title: Neurology doi: 10.1212/WNL.0b013e3181d6476a – volume: 375 start-page: 735 year: 2010 ident: 10.1016/S0140-6736(16)31357-5_bib49 article-title: Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials publication-title: Lancet doi: 10.1016/S0140-6736(09)61965-6 – volume: 352 start-page: 2184 year: 2005 ident: 10.1016/S0140-6736(16)31357-5_bib139 article-title: Statins and the risk of colorectal cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa043792 – volume: 75 start-page: 1130 year: 1995 ident: 10.1016/S0140-6736(16)31357-5_bib79 article-title: Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens publication-title: Am J Cardiol doi: 10.1016/S0002-9149(99)80744-9 – volume: 8 start-page: S72 issue: 3 suppl year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib64 article-title: An assessment by the Statin Intolerance Panel: 2014 update publication-title: J Clin Lipidol doi: 10.1016/j.jacl.2014.03.002 – volume: 78 start-page: 393 year: 2011 ident: 10.1016/S0140-6736(16)31357-5_bib24 article-title: Statin myopathy: a common dilemma not reflected in clinical trials publication-title: Cleve Clin J Med doi: 10.3949/ccjm.78a.10073 – volume: 358 start-page: 351 year: 2001 ident: 10.1016/S0140-6736(16)31357-5_bib165 article-title: Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study publication-title: Lancet doi: 10.1016/S0140-6736(01)05553-2 – volume: 363 start-page: 1728 year: 2004 ident: 10.1016/S0140-6736(16)31357-5_bib149 article-title: When are observational studies as credible as randomised trials? publication-title: Lancet doi: 10.1016/S0140-6736(04)16261-2 – volume: 97 start-page: 89C year: 2006 ident: 10.1016/S0140-6736(16)31357-5_bib216 article-title: Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2006.02.030 – volume: 360 start-page: 1851 year: 2009 ident: 10.1016/S0140-6736(16)31357-5_bib201 article-title: A randomized trial of rosuvastatin in the prevention of venous thromboembolism publication-title: N Engl J Med doi: 10.1056/NEJMoa0900241 – volume: 8 start-page: e52929 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib205 article-title: The role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis publication-title: PLoS One doi: 10.1371/journal.pone.0052929 – ident: 10.1016/S0140-6736(16)31357-5_bib27 – volume: 26 start-page: 6 year: 2015 ident: 10.1016/S0140-6736(16)31357-5_bib22 article-title: Maximising the benefits and minimising the harms of statins publication-title: Prescriber doi: 10.1002/psb.1293 – volume: 109 start-page: 1319 year: 2002 ident: 10.1016/S0140-6736(16)31357-5_bib107 article-title: Patterns of use of hormone replacement therapy in one million women in Britain, 1996–2000 publication-title: BJOG doi: 10.1046/j.1471-0528.2002.02214.x – volume: 1 start-page: 296 year: 2015 ident: 10.1016/S0140-6736(16)31357-5_bib126 article-title: Breast cancer after use of estrogen plus progestin and estrogen alone: analyses of data from 2 Women's Health Initiative randomized clinical trials publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2015.0494 – volume: 370 start-page: 2201 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib212 article-title: Simvastatin for the prevention of exacerbations in moderate-to-severe COPD publication-title: N Engl J Med doi: 10.1056/NEJMoa1403086 – volume: 127 start-page: 96 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib248 article-title: Effect of statins on skeletal muscle function publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.136101 – volume: 168 start-page: 3572 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib142 article-title: Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: recommendations for patient information publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2013.05.068 – year: 1990 ident: 10.1016/S0140-6736(16)31357-5_bib21 – volume: 77 start-page: 556 year: 2011 ident: 10.1016/S0140-6736(16)31357-5_bib58 article-title: A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease publication-title: Neurology doi: 10.1212/WNL.0b013e318228bf11 – year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib34 article-title: Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials publication-title: Lancet Diabetes Endocrinol – volume: 304 start-page: 431 year: 1992 ident: 10.1016/S0140-6736(16)31357-5_bib175 article-title: Should there be a moratorium on the use of cholesterol lowering drugs? publication-title: BMJ doi: 10.1136/bmj.304.6824.431 – volume: 159 start-page: 688 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib258 article-title: Statins and cognitive function: a systematic review publication-title: Ann Intern Med doi: 10.7326/0003-4819-159-10-201311190-00007 – volume: 25 start-page: 462 year: 1999 ident: 10.1016/S0140-6736(16)31357-5_bib45 article-title: Pooling research results: benefits and limitations of meta-analysis publication-title: Jt Comm J Qual Improv doi: 10.1016/S1070-3241(16)30460-6 – volume: 9 start-page: 6 year: 2009 ident: 10.1016/S0140-6736(16)31357-5_bib81 article-title: Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20 536 high-risk people publication-title: BMC Clin Pharmacol doi: 10.1186/1472-6904-9-6 – volume: 59 start-page: 299 year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib228 article-title: Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS) publication-title: Diabetologia doi: 10.1007/s00125-015-3802-6 – volume: 52 start-page: 1651 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib266 article-title: Predictors of self-reported health-related quality of life in systemic lupus erythematosus publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/ket171 – volume: 118 start-page: 1294 year: 2008 ident: 10.1016/S0140-6736(16)31357-5_bib63 article-title: Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.703579 – volume: 8 start-page: e72642 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib104 article-title: Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) publication-title: PLoS One doi: 10.1371/journal.pone.0072642 – volume: 6 start-page: 390 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib241 article-title: Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials publication-title: Circ Cardiovasc Qual Outcomes doi: 10.1161/CIRCOUTCOMES.111.000071 – volume: 209 start-page: 12 year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib254 article-title: Increased creatine kinase with statin treatment may identify statin-associated muscle symptoms publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2016.02.028 – volume: 2 start-page: 517 year: 2003 ident: 10.1016/S0140-6736(16)31357-5_bib178 article-title: Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors publication-title: Nat Rev Drug Discov doi: 10.1038/nrd1112 – volume: 371 start-page: 288 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib43 article-title: Safety profile of extended-release niacin in the AIM-HIGH trial publication-title: N Engl J Med doi: 10.1056/NEJMc1311039 – volume: 373 start-page: 1233 year: 2009 ident: 10.1016/S0140-6736(16)31357-5_bib121 article-title: The HRT controversy: observational studies and RCTs fall in line publication-title: Lancet doi: 10.1016/S0140-6736(09)60708-X – year: 2007 ident: 10.1016/S0140-6736(16)31357-5_bib1 – volume: 5 start-page: 2929 year: 2005 ident: 10.1016/S0140-6736(16)31357-5_bib102 article-title: Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2005.01105.x – volume: 160 start-page: 301 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib251 article-title: N-of-1 (single-patient) trials for statin-related myalgia publication-title: Ann Intern Med doi: 10.7326/M13-1921 – volume: 23 start-page: R89 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib189 article-title: Mendelian randomization: genetic anchors for causal inference in epidemiological studies publication-title: Hum Mol Genet doi: 10.1093/hmg/ddu328 – volume: 62 start-page: 1373 year: 2008 ident: 10.1016/S0140-6736(16)31357-5_bib210 article-title: Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study publication-title: Int J Clin Pract doi: 10.1111/j.1742-1241.2008.01731.x – volume: 303 start-page: 276 year: 1991 ident: 10.1016/S0140-6736(16)31357-5_bib158 article-title: Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations publication-title: BMJ doi: 10.1136/bmj.303.6797.276 – volume: 269 start-page: 3107 year: 1993 ident: 10.1016/S0140-6736(16)31357-5_bib262 article-title: HMG CoA reductase inhibitors and quality of life publication-title: JAMA doi: 10.1001/jama.269.24.3107 – volume: 97 start-page: 52C year: 2006 ident: 10.1016/S0140-6736(16)31357-5_bib218 article-title: Statin safety: a systematic review publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2005.12.010 – volume: 96 start-page: 423 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib220 article-title: The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2014.125 – volume: 14 start-page: 24 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib268 article-title: Simvastatin improves the sexual health-related quality of life in men aged 40 years and over with erectile dysfunction: additional data from the erectile dysfunction and statin trial publication-title: BMC Urol doi: 10.1186/1471-2490-14-24 – volume: 335 start-page: 1001 year: 1996 ident: 10.1016/S0140-6736(16)31357-5_bib50 article-title: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators publication-title: N Engl J Med doi: 10.1056/NEJM199610033351401 – volume: 380 start-page: 581 year: 2012 ident: 10.1016/S0140-6736(16)31357-5_bib32 article-title: The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials publication-title: Lancet doi: 10.1016/S0140-6736(12)60367-5 – ident: 10.1016/S0140-6736(16)31357-5_bib304 – volume: 343 start-page: d7020 year: 2011 ident: 10.1016/S0140-6736(16)31357-5_bib150 article-title: Why do the results of randomised and observational studies differ? publication-title: BMJ doi: 10.1136/bmj.d7020 – volume: 35 start-page: 2146 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib171 article-title: Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society publication-title: Eur Heart J doi: 10.1093/eurheartj/ehu274 – volume: 371 start-page: 203 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib42 article-title: Effects of extended-release niacin with laropiprant in high-risk patients publication-title: N Engl J Med doi: 10.1056/NEJMoa1300955 – volume: 347 start-page: f6745 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib230 article-title: Role of diuretics, beta blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study publication-title: BMJ doi: 10.1136/bmj.f6745 – volume: 88 start-page: 1213 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib261 article-title: Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects publication-title: Mayo Clin Proc doi: 10.1016/j.mayocp.2013.07.013 – volume: 384 start-page: 1263 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib19 article-title: Misrepresentation of statin safety evidence publication-title: Lancet doi: 10.1016/S0140-6736(14)61765-7 – volume: 385 start-page: 351 year: 2015 ident: 10.1016/S0140-6736(16)31357-5_bib231 article-title: HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials publication-title: Lancet doi: 10.1016/S0140-6736(14)61183-1 – volume: 42 start-page: 992 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib303 article-title: Data Resource Profile: the Survey of Health, Ageing and Retirement in Europe (SHARE) publication-title: Int J Epidemiol doi: 10.1093/ije/dyt088 – volume: 20 start-page: 47 year: 1991 ident: 10.1016/S0140-6736(16)31357-5_bib112 article-title: Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence publication-title: Prev Med doi: 10.1016/0091-7435(91)90006-P – volume: 287 start-page: 622 year: 2002 ident: 10.1016/S0140-6736(16)31357-5_bib144 article-title: Nonspecific medication side effects and the nocebo phenomenon publication-title: JAMA doi: 10.1001/jama.287.5.622 – volume: 56 start-page: 931 year: 2001 ident: 10.1016/S0140-6736(16)31357-5_bib284 article-title: Are users of lipid-lowering drugs at increased risk of peripheral neuropathy? publication-title: Eur J Clin Pharmacol doi: 10.1007/s002280000248 – volume: 25 start-page: 1825 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib280 article-title: Effects of lowering LDL cholesterol on progression of kidney disease publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2013090965 – volume: 346 start-page: f880 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib275 article-title: Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases publication-title: BMJ doi: 10.1136/bmj.f880 – volume: 353 start-page: i3283 year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib307 article-title: Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data publication-title: BMJ doi: 10.1136/bmj.i3283 – volume: 22 start-page: 2388 year: 2004 ident: 10.1016/S0140-6736(16)31357-5_bib138 article-title: The risk of cancer in users of statins publication-title: J Clin Oncol doi: 10.1200/JCO.2004.02.027 – volume: 349 start-page: g3743 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib53 article-title: Non-cardiovascular effects associated with statins publication-title: BMJ doi: 10.1136/bmj.g3743 – volume: 177 start-page: 428 year: 2002 ident: 10.1016/S0140-6736(16)31357-5_bib263 article-title: Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective? publication-title: Med J Aust doi: 10.5694/j.1326-5377.2002.tb04883.x – volume: 156 start-page: 2085 year: 1996 ident: 10.1016/S0140-6736(16)31357-5_bib61 article-title: Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study publication-title: Arch Intern Med doi: 10.1001/archinte.1996.00440170097011 – volume: 308 start-page: 1545 year: 2012 ident: 10.1016/S0140-6736(16)31357-5_bib179 article-title: Trends in lipids and lipoproteins in US adults, 1988–2010 publication-title: JAMA doi: 10.1001/jama.2012.13260 – volume: 10 start-page: 10 issue: suppl 1 year: 2010 ident: 10.1016/S0140-6736(16)31357-5_bib200 article-title: Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering publication-title: Am J Cardiovasc Drugs doi: 10.2165/1158822-S0-000000000-00000 – volume: 363 start-page: 757 year: 2004 ident: 10.1016/S0140-6736(16)31357-5_bib288 article-title: Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions publication-title: Lancet doi: 10.1016/S0140-6736(04)15690-0 – volume: 173 start-page: 1318 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib91 article-title: Statins and musculoskeletal conditions, arthropathies, and injuries publication-title: JAMA Intern Med doi: 10.1001/jamainternmed.2013.6184 – volume: 58 start-page: 323 year: 2005 ident: 10.1016/S0140-6736(16)31357-5_bib97 article-title: A review of uses of health care utilization databases for epidemiologic research on therapeutics publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2004.10.012 – volume: 257 start-page: 85 year: 2010 ident: 10.1016/S0140-6736(16)31357-5_bib55 article-title: Pravastatin and cognitive function in the elderly. Results of the PROSPER study publication-title: J Neurol doi: 10.1007/s00415-009-5271-7 – volume: 281 start-page: 841 year: 1999 ident: 10.1016/S0140-6736(16)31357-5_bib85 article-title: Meta-analysis and epidemiologic studies in drug development and postmarketing surveillance publication-title: JAMA doi: 10.1001/jama.281.9.841 – volume: 385 start-page: 1397 year: 2015 ident: 10.1016/S0140-6736(16)31357-5_bib33 article-title: Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials publication-title: Lancet doi: 10.1016/S0140-6736(14)61368-4 – volume: 359 start-page: 248 year: 2002 ident: 10.1016/S0140-6736(16)31357-5_bib6 article-title: Bias and causal associations in observational research publication-title: Lancet doi: 10.1016/S0140-6736(02)07451-2 – volume: 32 start-page: 333 year: 2002 ident: 10.1016/S0140-6736(16)31357-5_bib283 article-title: Serum cholesterol levels and suicide: a meta-analysis publication-title: Suicide Life Threat Behav doi: 10.1521/suli.32.3.333.22177 – volume: 340 start-page: c2197 year: 2010 ident: 10.1016/S0140-6736(16)31357-5_bib89 article-title: Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database publication-title: BMJ doi: 10.1136/bmj.c2197 – volume: 19 start-page: 403 year: 2005 ident: 10.1016/S0140-6736(16)31357-5_bib247 article-title: Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients—the PRIMO study publication-title: Cardiovasc Drugs Ther doi: 10.1007/s10557-005-5686-z – volume: 44 start-page: 604 year: 2015 ident: 10.1016/S0140-6736(16)31357-5_bib167 article-title: LDL cholesterol still a problem in old age? A Mendelian randomization study publication-title: Int J Epidemiol doi: 10.1093/ije/dyv031 – volume: 313 start-page: 1011 year: 2015 ident: 10.1016/S0140-6736(16)31357-5_bib242 article-title: Statin intolerance: reconciling clinical trials and clinical experience publication-title: JAMA doi: 10.1001/jama.2015.1335 – year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib190 article-title: Don't Give More Patients Statins publication-title: The New York Times – volume: 8 start-page: e83759 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib273 article-title: Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration publication-title: PLoS One doi: 10.1371/journal.pone.0083759 – volume: 176 start-page: 63 year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib187 article-title: Protocol for analyses of adverse event data from randomized controlled trials of statin therapy publication-title: Am Heart J doi: 10.1016/j.ahj.2016.01.016 – volume: 136 start-page: 734 year: 2009 ident: 10.1016/S0140-6736(16)31357-5_bib209 article-title: Statins in COPD: a systematic review publication-title: Chest doi: 10.1378/chest.09-0194 – volume: 355 start-page: 1064 year: 2000 ident: 10.1016/S0140-6736(16)31357-5_bib68 article-title: Subgroup analysis and other (mis)uses of baseline data in clinical trials publication-title: Lancet doi: 10.1016/S0140-6736(00)02039-0 – volume: 334 start-page: 349 year: 2007 ident: 10.1016/S0140-6736(16)31357-5_bib84 article-title: When are randomised trials unnecessary? Picking signal from noise publication-title: BMJ doi: 10.1136/bmj.39070.527986.68 – volume: 367 start-page: 1792 year: 2012 ident: 10.1016/S0140-6736(16)31357-5_bib92 article-title: Statin use and reduced cancer-related mortality publication-title: N Engl J Med doi: 10.1056/NEJMoa1201735 – volume: 58 start-page: 1333 year: 2002 ident: 10.1016/S0140-6736(16)31357-5_bib290 article-title: Statins and risk of polyneuropathy: a case-control study publication-title: Neurology doi: 10.1212/WNL.58.9.1333 – volume: 2 start-page: 56 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib37 article-title: Applying results from clinical trials: tranexamic acid in trauma patients publication-title: J Intensive Care doi: 10.1186/s40560-014-0056-1 – volume: 44 start-page: 1223 year: 1991 ident: 10.1016/S0140-6736(16)31357-5_bib110 article-title: How independent are “independent” effects? Relative risk estimation when correlated exposures are measured imprecisely publication-title: J Clin Epidemiol doi: 10.1016/0895-4356(91)90155-3 – volume: 23 start-page: 891 year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib65 article-title: Statin tolerability: In defence of placebo-controlled trials publication-title: Eur J Prev Cardiol doi: 10.1177/2047487315602861 – volume: 365 start-page: 2250 year: 2011 ident: 10.1016/S0140-6736(16)31357-5_bib74 article-title: Needed: pragmatic clinical trials for statin-intolerant patients publication-title: N Engl J Med doi: 10.1056/NEJMp1112023 – ident: 10.1016/S0140-6736(16)31357-5_bib26 – volume: 6 start-page: 245 year: 1987 ident: 10.1016/S0140-6736(16)31357-5_bib20 article-title: Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews publication-title: Stat Med doi: 10.1002/sim.4780060308 – volume: 63 start-page: 64 year: 2010 ident: 10.1016/S0140-6736(16)31357-5_bib136 article-title: A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2009.03.001 – volume: 111 start-page: 324 year: 2010 ident: 10.1016/S0140-6736(16)31357-5_bib278 article-title: Preoperative statin therapy is not associated with a reduced incidence of postoperative acute kidney injury after cardiac surgery publication-title: Anesth Analg doi: 10.1213/ANE.0b013e3181d8a078 – volume: 73 start-page: 385 year: 2002 ident: 10.1016/S0140-6736(16)31357-5_bib54 article-title: Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.73.4.385 – volume: 10 start-page: 1585 year: 1991 ident: 10.1016/S0140-6736(16)31357-5_bib80 article-title: Estimating the effect of the run-in on the power of the Physicians' Health Study publication-title: Stat Med doi: 10.1002/sim.4780101010 – volume: 6 start-page: e010401 year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib166 article-title: Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review publication-title: BMJ Open doi: 10.1136/bmjopen-2015-010401 – volume: 117 start-page: 1016 year: 1992 ident: 10.1016/S0140-6736(16)31357-5_bib111 article-title: Hormone therapy to prevent disease and prolong life in postmenopausal women publication-title: Ann Intern Med doi: 10.7326/0003-4819-117-12-1016 – volume: 302 start-page: 1317 year: 1991 ident: 10.1016/S0140-6736(16)31357-5_bib116 article-title: Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research framework publication-title: BMJ doi: 10.1136/bmj.302.6788.1317 – volume: 83 start-page: 5 year: 2011 ident: 10.1016/S0140-6736(16)31357-5_bib143 article-title: Nonspecific side effects of oral contraceptives: nocebo or noise? publication-title: Contraception doi: 10.1016/j.contraception.2010.06.010 – volume: 316 start-page: 140 year: 1998 ident: 10.1016/S0140-6736(16)31357-5_bib86 article-title: Spurious precision? Meta-analysis of observational studies publication-title: BMJ doi: 10.1136/bmj.316.7125.140 – volume: 370 start-page: 1829 year: 2007 ident: 10.1016/S0140-6736(16)31357-5_bib157 article-title: Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths publication-title: Lancet doi: 10.1016/S0140-6736(07)61778-4 – volume: 31 start-page: 691 year: 2015 ident: 10.1016/S0140-6736(16)31357-5_bib271 article-title: Statins and cataracts: reverse causality? publication-title: Can J Cardiol doi: 10.1016/j.cjca.2014.12.018 – volume: 129 start-page: S1 issue: suppl 2 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib162 article-title: 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines publication-title: Circulation doi: 10.1161/01.cir.0000437738.63853.7a – volume: 39 start-page: 674 year: 2010 ident: 10.1016/S0140-6736(16)31357-5_bib164 article-title: Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds publication-title: Age Ageing doi: 10.1093/ageing/afq129 – volume: 7 start-page: e41297 year: 2012 ident: 10.1016/S0140-6736(16)31357-5_bib252 article-title: Randomized Polypill crossover trial in people aged 50 and over publication-title: PLoS One doi: 10.1371/journal.pone.0041297 – volume: 27 start-page: 1706 year: 2007 ident: 10.1016/S0140-6736(16)31357-5_bib170 article-title: Mouse models for atherosclerosis and pharmaceutical modifiers publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.107.142570 – volume: 57 start-page: 1666 year: 2011 ident: 10.1016/S0140-6736(16)31357-5_bib249 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.09.082 – volume: 12 start-page: 215 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib306 article-title: Cardiovascular risk and statin use in the United States publication-title: Ann Fam Med doi: 10.1370/afm.1641 – volume: 37 start-page: 908 year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib308 article-title: Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv641 – volume: 89 start-page: 540 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib141 article-title: The nocebo effect: patient expectations and medication side effects publication-title: Postgrad Med doi: 10.1136/postgradmedj-2012-131730 – volume: 10 start-page: 45 year: 2009 ident: 10.1016/S0140-6736(16)31357-5_bib208 article-title: Impact of statins and ACE inhibitors on mortality after COPD exacerbations publication-title: Respir Res doi: 10.1186/1465-9921-10-45 – volume: 25 start-page: 178 year: 2004 ident: 10.1016/S0140-6736(16)31357-5_bib57 article-title: The UCSD Statin Study: a randomized controlled trial assessing the impact of statins on selected noncardiac outcomes publication-title: Control Clin Trials doi: 10.1016/j.cct.2003.08.014 – volume: 308 start-page: 373 year: 1994 ident: 10.1016/S0140-6736(16)31357-5_bib168 article-title: Assessing possible hazards of reducing serum cholesterol publication-title: BMJ doi: 10.1136/bmj.308.6925.373 – volume: 32 start-page: 2525 year: 2011 ident: 10.1016/S0140-6736(16)31357-5_bib105 article-title: The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the UK publication-title: Eur Heart J doi: 10.1093/eurheartj/ehr333 – volume: 9 start-page: 758 year: 2015 ident: 10.1016/S0140-6736(16)31357-5_bib155 article-title: Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial publication-title: J Clin Lipidol doi: 10.1016/j.jacl.2015.08.006 – volume: 12 start-page: 51 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib152 article-title: Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis publication-title: BMC Med doi: 10.1186/1741-7015-12-51 – ident: 10.1016/S0140-6736(16)31357-5_bib154 – volume: 62 start-page: 609 year: 2009 ident: 10.1016/S0140-6736(16)31357-5_bib47 article-title: Inadequate statistical power to detect clinically significant differences in adverse event rates in randomized controlled trials publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2008.08.005 – volume: 288 start-page: 321 year: 2002 ident: 10.1016/S0140-6736(16)31357-5_bib118 article-title: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial publication-title: JAMA doi: 10.1001/jama.288.3.321 – year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib137 article-title: Can observational data replace randomized trials? publication-title: J Clin Oncol doi: 10.1200/JCO.2016.68.8879 – year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib233 article-title: Association of lipid fractions with risks for coronary artery disease and diabetes publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2016.1884 – volume: 27 start-page: 146 year: 2011 ident: 10.1016/S0140-6736(16)31357-5_bib217 article-title: Statin-associated rhabdomyolysis: is there a dose-response relationship? publication-title: Can J Cardiol doi: 10.1016/j.cjca.2010.12.024 – volume: 170 start-page: 12 year: 2009 ident: 10.1016/S0140-6736(16)31357-5_bib124 article-title: Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause publication-title: Am J Epidemiol doi: 10.1093/aje/kwp115 – volume: 337 start-page: 833 year: 1991 ident: 10.1016/S0140-6736(16)31357-5_bib114 article-title: Postmenopausal oestrogen and cardioprotection publication-title: Lancet doi: 10.1016/0140-6736(91)92526-8 – volume: 81 start-page: 264 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib237 article-title: Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review publication-title: Neurology doi: 10.1212/WNL.0b013e31829bfde3 – volume: 372 start-page: 2152 year: 2008 ident: 10.1016/S0140-6736(16)31357-5_bib2 article-title: De testimonio: on the evidence for decisions about the use of therapeutic interventions publication-title: Lancet doi: 10.1016/S0140-6736(08)61930-3 – volume: 359 start-page: 789 year: 2008 ident: 10.1016/S0140-6736(16)31357-5_bib219 article-title: SLCO1B1 variants and statin-induced myopathy—a genomewide study publication-title: N Engl J Med doi: 10.1056/NEJMoa0801936 – volume: 359 start-page: 696 year: 2002 ident: 10.1016/S0140-6736(16)31357-5_bib18 article-title: Blinding in randomised trials: hiding who got what publication-title: Lancet doi: 10.1016/S0140-6736(02)07816-9 – volume: 342 start-page: 1907 year: 2000 ident: 10.1016/S0140-6736(16)31357-5_bib9 article-title: Randomized trials or observational tribulations? publication-title: N Engl J Med doi: 10.1056/NEJM200006223422511 – volume: 359 start-page: 2195 year: 2008 ident: 10.1016/S0140-6736(16)31357-5_bib48 article-title: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein publication-title: N Engl J Med doi: 10.1056/NEJMoa0807646 – volume: 61 start-page: 957 year: 2006 ident: 10.1016/S0140-6736(16)31357-5_bib206 article-title: Statin treatment and reduced risk of pneumonia in patients with diabetes publication-title: Thorax doi: 10.1136/thx.2006.062885 – volume: 347 start-page: f6340 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib10 article-title: Saturated fat is not the major issue publication-title: BMJ doi: 10.1136/bmj.f6340 – volume: 103 start-page: 529 year: 1997 ident: 10.1016/S0140-6736(16)31357-5_bib76 article-title: Problems in the “evidence” of “evidence-based medicine” publication-title: Am J Med doi: 10.1016/S0002-9343(97)00244-1 – volume: 112 start-page: 2456 year: 2008 ident: 10.1016/S0140-6736(16)31357-5_bib135 article-title: Limits of observational data in determining outcomes from cancer therapy publication-title: Cancer doi: 10.1002/cncr.23452 – year: 1998 ident: 10.1016/S0140-6736(16)31357-5_bib182 – volume: 280 start-page: 605 year: 1998 ident: 10.1016/S0140-6736(16)31357-5_bib117 article-title: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group publication-title: JAMA doi: 10.1001/jama.280.7.605 – volume: 371 start-page: 117 year: 2008 ident: 10.1016/S0140-6736(16)31357-5_bib30 article-title: Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis publication-title: Lancet doi: 10.1016/S0140-6736(08)60104-X – volume: 3 start-page: 253 year: 2008 ident: 10.1016/S0140-6736(16)31357-5_bib44 article-title: Systematic review and meta-analysis: when one study is just not enough publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.01430307 – volume: 67 start-page: 447 year: 1991 ident: 10.1016/S0140-6736(16)31357-5_bib59 article-title: Expanded clinical evaluation of lovastatin (EXCEL) study results. II. Assessment of the human lens after 48 weeks of treatment with lovastatin publication-title: Am J Cardiol doi: 10.1016/0002-9149(91)90002-3 – volume: 376 start-page: 1658 year: 2010 ident: 10.1016/S0140-6736(16)31357-5_bib83 article-title: Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial publication-title: Lancet doi: 10.1016/S0140-6736(10)60310-8 – volume: 301 start-page: 309 year: 1990 ident: 10.1016/S0140-6736(16)31357-5_bib176 article-title: Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials publication-title: BMJ doi: 10.1136/bmj.301.6747.309 – volume: 344 start-page: e1553 year: 2012 ident: 10.1016/S0140-6736(16)31357-5_bib69 article-title: Credibility of claims of subgroup effects in randomised controlled trials: systematic review publication-title: BMJ doi: 10.1136/bmj.e1553 – volume: 361 start-page: 2017 year: 2003 ident: 10.1016/S0140-6736(16)31357-5_bib132 article-title: Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials publication-title: Lancet doi: 10.1016/S0140-6736(03)13637-9 – volume: 357 start-page: 373 year: 2001 ident: 10.1016/S0140-6736(16)31357-5_bib3 article-title: Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials publication-title: Lancet doi: 10.1016/S0140-6736(00)03651-5 – volume: 12 start-page: 327 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib23 article-title: The controversy of a wider statin utilization: why? publication-title: Expert Opin Drug Saf doi: 10.1517/14740338.2013.779667 – volume: 294 start-page: 1773 year: 2005 ident: 10.1016/S0140-6736(16)31357-5_bib181 article-title: Trends in serum lipids and lipoproteins of adults, 1960–2002 publication-title: JAMA doi: 10.1001/jama.294.14.1773 – volume: 326 start-page: 1423 year: 2003 ident: 10.1016/S0140-6736(16)31357-5_bib160 article-title: Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis publication-title: BMJ doi: 10.1136/bmj.326.7404.1423 – start-page: MR000012 year: 2007 ident: 10.1016/S0140-6736(16)31357-5_bib16 article-title: Randomisation to protect against selection bias in healthcare trials publication-title: Cochrane Database Syst Rev – ident: 10.1016/S0140-6736(16)31357-5_bib188 – volume: 7 start-page: e34785 year: 2012 ident: 10.1016/S0140-6736(16)31357-5_bib35 article-title: Designing and analyzing clinical trials with composite outcomes: consideration of possible treatment differences between the individual outcomes publication-title: PLoS One doi: 10.1371/journal.pone.0034785 – volume: 10 start-page: 663 year: 1991 ident: 10.1016/S0140-6736(16)31357-5_bib8 article-title: Problems with using observational databases to compare treatments publication-title: Stat Med doi: 10.1002/sim.4780100417 – volume: 35 start-page: 1310 year: 2006 ident: 10.1016/S0140-6736(16)31357-5_bib87 article-title: Commentary: we still need observational studies of drugs-they just need to be better publication-title: Int J Epidemiol doi: 10.1093/ije/dyl134 – volume: 133 start-page: 1851 year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib100 article-title: Long-term effectiveness and safety of pravastatin in patients with coronary heart disease: 16 years of follow-up of the LIPID Study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.115.018580 – volume: 348 start-page: g1523 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib298 article-title: Authors' reply to Huffman and colleagues publication-title: BMJ doi: 10.1136/bmj.g1523 – ident: 10.1016/S0140-6736(16)31357-5_bib302 – volume: 318 start-page: 1209 year: 1999 ident: 10.1016/S0140-6736(16)31357-5_bib15 article-title: Statistics notes. Treatment allocation in controlled trials: why randomise? publication-title: BMJ doi: 10.1136/bmj.318.7192.1209 – volume: 202 start-page: 591 year: 2015 ident: 10.1016/S0140-6736(16)31357-5_bib309 article-title: The crux of the matter: did the ABC's Catalyst program change statin use in Australia? publication-title: Med J Aust doi: 10.5694/mja15.00103 – volume: 365 start-page: 82 year: 2005 ident: 10.1016/S0140-6736(16)31357-5_bib77 article-title: External validity of randomised controlled trials: “to whom do the results of this trial apply?” publication-title: Lancet doi: 10.1016/S0140-6736(04)17670-8 – volume: 321 start-page: 504 year: 2000 ident: 10.1016/S0140-6736(16)31357-5_bib17 article-title: Statistics notes: blinding in clinical trials and other studies publication-title: BMJ doi: 10.1136/bmj.321.7259.504 – volume: 363 start-page: 2015 year: 2004 ident: 10.1016/S0140-6736(16)31357-5_bib265 article-title: Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(04)16449-0 – volume: 21 start-page: 464 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib239 article-title: What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice publication-title: Eur J Prev Cardiol doi: 10.1177/2047487314525531 – year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib246 article-title: The nocebo effect in the context of statin intolerance publication-title: J Clin Lipidol doi: 10.1016/j.jacl.2016.05.002 – volume: 34 start-page: 1279 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib224 article-title: HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment publication-title: Eur Heart J doi: 10.1093/eurheartj/eht055 – volume: 384 start-page: 1745 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib67 article-title: Blood pressure lowering and cardiovascular risk publication-title: Lancet doi: 10.1016/S0140-6736(14)62067-5 – volume: 366 start-page: 1267 year: 2005 ident: 10.1016/S0140-6736(16)31357-5_bib29 article-title: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins publication-title: Lancet doi: 10.1016/S0140-6736(05)67394-1 – volume: 360 start-page: 7 year: 2002 ident: 10.1016/S0140-6736(16)31357-5_bib222 article-title: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(02)09327-3 – volume: 36 start-page: 1012 year: 2015 ident: 10.1016/S0140-6736(16)31357-5_bib75 article-title: Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv043 – volume: 102 start-page: 157 year: 2000 ident: 10.1016/S0140-6736(16)31357-5_bib106 article-title: Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators publication-title: Circulation doi: 10.1161/01.CIR.102.2.157 – volume: 363 start-page: 1724 year: 2004 ident: 10.1016/S0140-6736(16)31357-5_bib134 article-title: Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? publication-title: Lancet doi: 10.1016/S0140-6736(04)16260-0 – volume: 8 start-page: 189 year: 2015 ident: 10.1016/S0140-6736(16)31357-5_bib299 article-title: Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms publication-title: Expert Rev Clin Pharmacol doi: 10.1586/17512433.2015.1011125 – volume: 158 start-page: 526 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib93 article-title: Discontinuation of statins in routine care settings: a cohort study publication-title: Ann Intern Med doi: 10.7326/0003-4819-158-7-201304020-00004 – volume: 9 start-page: e1001310 year: 2012 ident: 10.1016/S0140-6736(16)31357-5_bib203 article-title: Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials publication-title: PLoS Med doi: 10.1371/journal.pmed.1001310 – volume: 291 start-page: 1701 year: 2004 ident: 10.1016/S0140-6736(16)31357-5_bib120 article-title: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial publication-title: JAMA doi: 10.1001/jama.291.14.1701 – volume: 19 start-page: 766 year: 2008 ident: 10.1016/S0140-6736(16)31357-5_bib122 article-title: Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease publication-title: Epidemiology doi: 10.1097/EDE.0b013e3181875e61 – volume: 376 start-page: 1670 year: 2010 ident: 10.1016/S0140-6736(16)31357-5_bib31 article-title: Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials publication-title: Lancet doi: 10.1016/S0140-6736(10)61350-5 – volume: 310 start-page: 1353 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib125 article-title: Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials publication-title: JAMA doi: 10.1001/jama.2013.278040 – volume: 335 start-page: 285 year: 2007 ident: 10.1016/S0140-6736(16)31357-5_bib198 article-title: Preventive health care in elderly people needs rethinking publication-title: BMJ doi: 10.1136/bmj.39241.630741.BE1 – volume: 315 start-page: 1580 year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib253 article-title: Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: the GAUSS-3 randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2016.3608 – volume: 374 start-page: 1744 year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib204 article-title: Perioperative rosuvastatin in cardiac surgery publication-title: N Engl J Med doi: 10.1056/NEJMoa1507750 – volume: 166 start-page: 155 year: 2006 ident: 10.1016/S0140-6736(16)31357-5_bib153 article-title: Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects publication-title: Arch Intern Med doi: 10.1001/archinte.166.2.155 – volume: 15 start-page: 26 year: 2008 ident: 10.1016/S0140-6736(16)31357-5_bib131 article-title: Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies publication-title: Eur J Cardiovasc Prev Rehabil doi: 10.1097/HJR.0b013e3282f11f95 – volume: 54 start-page: 1022 year: 2000 ident: 10.1016/S0140-6736(16)31357-5_bib36 article-title: Choice of endpoints in antiplatelet trials: which outcomes are most relevant to stroke patients? publication-title: Neurology doi: 10.1212/WNL.54.5.1022 – volume: 163 start-page: 589 year: 2006 ident: 10.1016/S0140-6736(16)31357-5_bib129 article-title: Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease publication-title: Am J Epidemiol doi: 10.1093/aje/kwj079 – volume: 8 start-page: S58 issue: 3 suppl year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib73 article-title: An assessment by the Statin Muscle Safety Task Force: 2014 update publication-title: J Clin Lipidol doi: 10.1016/j.jacl.2014.03.004 – volume: 360 start-page: 1623 year: 2002 ident: 10.1016/S0140-6736(16)31357-5_bib51 article-title: Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(02)11600-X – volume: 170 start-page: 1622 year: 2010 ident: 10.1016/S0140-6736(16)31357-5_bib133 article-title: Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals publication-title: Arch Intern Med doi: 10.1001/archinternmed.2010.348 – volume: 364 start-page: 771 year: 2004 ident: 10.1016/S0140-6736(16)31357-5_bib101 article-title: Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S) publication-title: Lancet doi: 10.1016/S0140-6736(04)16936-5 – volume: 15 start-page: 542 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib103 article-title: Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT) publication-title: J Clin Hypertens doi: 10.1111/jch.12139 – year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib62 – volume: 371 start-page: 1695 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib213 article-title: Simvastatin in the acute respiratory distress syndrome publication-title: N Engl J Med doi: 10.1056/NEJMoa1403285 – volume: 361 start-page: 1149 year: 2003 ident: 10.1016/S0140-6736(16)31357-5_bib238 publication-title: Lancet doi: 10.1016/S0140-6736(03)12948-0 – volume: 56 start-page: 374 year: 2012 ident: 10.1016/S0140-6736(16)31357-5_bib285 article-title: Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing publication-title: J Hepatol doi: 10.1016/j.jhep.2011.07.023 – year: 2010 ident: 10.1016/S0140-6736(16)31357-5_bib13 – volume: 305 start-page: 15 year: 1992 ident: 10.1016/S0140-6736(16)31357-5_bib177 article-title: Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome publication-title: BMJ doi: 10.1136/bmj.305.6844.15 – volume: 170 start-page: 24 year: 2009 ident: 10.1016/S0140-6736(16)31357-5_bib123 article-title: Invited commentary: hormone therapy risks and benefits–The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis publication-title: Am J Epidemiol doi: 10.1093/aje/kwp113 – volume: 336 start-page: 1246 year: 2008 ident: 10.1016/S0140-6736(16)31357-5_bib82 article-title: Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance publication-title: BMJ doi: 10.1136/bmj.39554.624086.AD – volume: 23 start-page: 1182 year: 2008 ident: 10.1016/S0140-6736(16)31357-5_bib151 article-title: Prevalence of musculoskeletal pain and statin use publication-title: Int J Cardiol – volume: 97 start-page: 86C issue: suppl year: 2006 ident: 10.1016/S0140-6736(16)31357-5_bib289 article-title: An assessment of statin safety by neurologists publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2005.12.017 – volume: 32 start-page: 5 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib140 article-title: Use of statins and the risk of death in patients with prostate cancer publication-title: J Clin Oncol doi: 10.1200/JCO.2013.49.4757 – volume: 315 start-page: 1371 year: 1997 ident: 10.1016/S0140-6736(16)31357-5_bib46 article-title: Meta-Analysis. Potentials and promise publication-title: BMJ doi: 10.1136/bmj.315.7119.1371 – volume: 1 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib161 article-title: Statins for the primary prevention of cardiovascular disease publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD009217.pub2 – volume: 106 start-page: 969 year: 2010 ident: 10.1016/S0140-6736(16)31357-5_bib180 article-title: 30-year trends in serum lipids among United States adults: results from the National Health and Nutrition Examination Surveys II, III, and 1999-2006 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2010.05.030 – volume: 7 start-page: e29849 year: 2012 ident: 10.1016/S0140-6736(16)31357-5_bib52 article-title: Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175 000 people in 27 randomised trials of statin therapy publication-title: PLoS One doi: 10.1371/journal.pone.0029849 – volume: 166 start-page: 646 year: 2007 ident: 10.1016/S0140-6736(16)31357-5_bib109 article-title: The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study publication-title: Am J Epidemiol doi: 10.1093/aje/kwm165 – volume: 8 start-page: 201 year: 2015 ident: 10.1016/S0140-6736(16)31357-5_bib72 article-title: How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease publication-title: Expert Rev Clin Pharmacol doi: 10.1586/17512433.2015.1012494 – volume: 97 start-page: 77C year: 2006 ident: 10.1016/S0140-6736(16)31357-5_bib286 article-title: An assessment of statin safety by hepatologists publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2005.12.014 – volume: 39 start-page: 1343 year: 2011 ident: 10.1016/S0140-6736(16)31357-5_bib211 article-title: Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome publication-title: Crit Care Med doi: 10.1097/CCM.0b013e3182120992 – volume: 172 start-page: 909 year: 2012 ident: 10.1016/S0140-6736(16)31357-5_bib195 article-title: Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis publication-title: Arch Intern Med doi: 10.1001/archinternmed.2012.2145 – volume: 5 start-page: 91 year: 2008 ident: 10.1016/S0140-6736(16)31357-5_bib169 article-title: Rapid regression of atherosclerosis: insights from the clinical and experimental literature publication-title: Nat Clin Pract Cardiovasc Med doi: 10.1038/ncpcardio1086 – volume: 108 start-page: 1481 year: 2003 ident: 10.1016/S0140-6736(16)31357-5_bib267 article-title: Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease publication-title: Circulation doi: 10.1161/01.CIR.0000090686.57897.F5 – volume: 378 start-page: 2013 year: 2011 ident: 10.1016/S0140-6736(16)31357-5_bib99 article-title: Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(11)61125-2 – volume: 32 start-page: 563 year: 2003 ident: 10.1016/S0140-6736(16)31357-5_bib159 article-title: Cholesterol, coronary heart disease, and stroke in the Asia Pacific region publication-title: Int J Epidemiol doi: 10.1093/ije/dyg106 – volume: 373 start-page: 1849 year: 2009 ident: 10.1016/S0140-6736(16)31357-5_bib40 article-title: Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials publication-title: Lancet doi: 10.1016/S0140-6736(09)60503-1 – volume: 15 start-page: 105 year: 1997 ident: 10.1016/S0140-6736(16)31357-5_bib5 article-title: Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension publication-title: J Hypertens – volume: 5 start-page: 177 year: 2008 ident: 10.1016/S0140-6736(16)31357-5_bib202 article-title: The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS) publication-title: Diab Vasc Dis Res doi: 10.3132/dvdr.2008.029 – volume: 114 start-page: 2788 year: 2006 ident: 10.1016/S0140-6736(16)31357-5_bib240 article-title: Risks associated with statin therapy: a systematic overview of randomized clinical trials publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.624890 – volume: 121 start-page: 1002 year: 2008 ident: 10.1016/S0140-6736(16)31357-5_bib207 article-title: Prior statin use is associated with improved outcomes in community-acquired pneumonia publication-title: Am J Med doi: 10.1016/j.amjmed.2008.06.030 – volume: 131 start-page: e389 year: 2015 ident: 10.1016/S0140-6736(16)31357-5_bib294 article-title: Cardiology patient page. Statin intolerance publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.114.013189 – volume: 318 start-page: 1548 year: 1999 ident: 10.1016/S0140-6736(16)31357-5_bib41 article-title: Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading publication-title: BMJ doi: 10.1136/bmj.318.7197.1548 – volume: 97 start-page: 229 year: 2004 ident: 10.1016/S0140-6736(16)31357-5_bib282 article-title: Severe irritability associated with statin cholesterol-lowering drugs publication-title: Q J Med doi: 10.1093/qjmed/hch035 – volume: 5 start-page: e67 year: 2008 ident: 10.1016/S0140-6736(16)31357-5_bib88 article-title: Observational research, randomised trials, and two views of medical science publication-title: PLoS Med doi: 10.1371/journal.pmed.0050067 – volume: 357 start-page: 455 year: 2001 ident: 10.1016/S0140-6736(16)31357-5_bib4 article-title: Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies publication-title: Lancet doi: 10.1016/S0140-6736(00)04017-4 – volume: 266 start-page: 93 year: 1991 ident: 10.1016/S0140-6736(16)31357-5_bib70 article-title: Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials publication-title: JAMA doi: 10.1001/jama.1991.03470010097038 – volume: 120 start-page: 920 year: 2012 ident: 10.1016/S0140-6736(16)31357-5_bib7 article-title: False alarms and pseudo-epidemics: the limitations of observational epidemiology publication-title: Obstet Gynecol doi: 10.1097/AOG.0b013e31826af61a – volume: 100 start-page: ii1 issue: suppl 2 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib292 article-title: Consensus recommendations for the prevention of cardiovascular disease (JBS3) publication-title: Heart doi: 10.1136/heartjnl-2014-305693 – volume: 238 start-page: 329 year: 2015 ident: 10.1016/S0140-6736(16)31357-5_bib255 article-title: A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2014.12.016 – volume: 274 start-page: 1049 year: 1995 ident: 10.1016/S0140-6736(16)31357-5_bib130 article-title: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes publication-title: JAMA doi: 10.1001/jama.1995.03530130055028 – year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib243 article-title: Statins can weaken muscles and joints: cholesterol drug raises risk of problems by up to 20 per cent publication-title: MailOnline – volume: 348 start-page: g3306 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib244 article-title: Adverse effects of statins publication-title: BMJ doi: 10.1136/bmj.g3306 – volume: 162 start-page: 404 year: 2005 ident: 10.1016/S0140-6736(16)31357-5_bib128 article-title: Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial publication-title: Am J Epidemiol doi: 10.1093/aje/kwi223 – volume: 48 start-page: S114 issue: 6 suppl year: 2010 ident: 10.1016/S0140-6736(16)31357-5_bib96 article-title: Confounding control in healthcare database research: challenges and potential approaches publication-title: Med Care doi: 10.1097/MLR.0b013e3181dbebe3 – volume: 291 start-page: 2243 year: 2004 ident: 10.1016/S0140-6736(16)31357-5_bib192 article-title: Drug treatment of hyperlipidemia in women publication-title: JAMA doi: 10.1001/jama.291.18.2243 – year: 1983 ident: 10.1016/S0140-6736(16)31357-5_bib14 – year: 2015 ident: 10.1016/S0140-6736(16)31357-5_bib300 – volume: 91 start-page: 520 year: 2011 ident: 10.1016/S0140-6736(16)31357-5_bib277 article-title: Dose-dependent effect of statins on the incidence of acute kidney injury after cardiac surgery publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2010.10.061 – volume: 34 start-page: 3478 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib172 article-title: Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society publication-title: Eur Heart J doi: 10.1093/eurheartj/eht273 – volume: 313 start-page: 1029 year: 2015 ident: 10.1016/S0140-6736(16)31357-5_bib232 article-title: Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus publication-title: JAMA doi: 10.1001/jama.2015.1206 – volume: 320 start-page: 904 year: 1989 ident: 10.1016/S0140-6736(16)31357-5_bib236 article-title: Serum cholesterol levels and six-year mortality from stroke in 350 977 men screened for the multiple risk factor intervention trial publication-title: N Engl J Med doi: 10.1056/NEJM198904063201405 – volume: 57 start-page: 1535 year: 2011 ident: 10.1016/S0140-6736(16)31357-5_bib227 article-title: Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.10.047 – volume: 168 start-page: 6 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib250 article-title: A systematic review of statin-induced muscle problems in clinical trials publication-title: Am Heart J doi: 10.1016/j.ahj.2014.03.019 – volume: 48 start-page: 276 year: 1992 ident: 10.1016/S0140-6736(16)31357-5_bib115 article-title: Hormone replacement therapy and cardiovascular disease publication-title: Br Med Bull doi: 10.1093/oxfordjournals.bmb.a072548 – volume: 378 start-page: 1231 year: 2011 ident: 10.1016/S0140-6736(16)31357-5_bib301 article-title: Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey publication-title: Lancet doi: 10.1016/S0140-6736(11)61215-4 – volume: 375 start-page: 2215 year: 2010 ident: 10.1016/S0140-6736(16)31357-5_bib234 article-title: Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies publication-title: Lancet doi: 10.1016/S0140-6736(10)60484-9 – volume: 315 start-page: 877 year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib279 article-title: High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2016.0548 – volume: 370 start-page: 2191 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib214 article-title: Rosuvastatin for sepsis-associated acute respiratory distress syndrome publication-title: N Engl J Med doi: 10.1056/NEJMoa1401520 – volume: 1 start-page: 11 year: 2014 ident: 10.1016/S0140-6736(16)31357-5_bib95 article-title: A systematic statistical approach to evaluating evidence from observational studies publication-title: Ann Rev Stat Appl doi: 10.1146/annurev-statistics-022513-115645 – volume: 133 start-page: 1073 year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib98 article-title: Long-term safety and efficacy of lowering low-density lipoprotein cholesterol with statin therapy: 20-year follow-up of West of Scotland Coronary Prevention Study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.115.019014 – volume: 36 start-page: 2975 year: 2015 ident: 10.1016/S0140-6736(16)31357-5_bib186 article-title: Cholesterol, not just cardiovascular risk, is important in deciding who should receive statin treatment publication-title: Eur Heart J – volume: 6 start-page: 239 year: 2009 ident: 10.1016/S0140-6736(16)31357-5_bib25 article-title: Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs publication-title: Clin Trials doi: 10.1177/1740774509105223 – volume: 307 start-page: 1491 year: 2012 ident: 10.1016/S0140-6736(16)31357-5_bib12 article-title: Healthy men should not take statins publication-title: JAMA doi: 10.1001/jama.2012.423 – volume: 305 start-page: 2556 year: 2011 ident: 10.1016/S0140-6736(16)31357-5_bib226 article-title: Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis publication-title: JAMA doi: 10.1001/jama.2011.860 – volume: 380 start-page: 565 year: 2012 ident: 10.1016/S0140-6736(16)31357-5_bib225 article-title: Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial publication-title: Lancet doi: 10.1016/S0140-6736(12)61190-8 – volume: 355 start-page: 549 year: 2006 ident: 10.1016/S0140-6736(16)31357-5_bib39 article-title: High-dose atorvastatin after stroke or transient ischemic attack publication-title: N Engl J Med doi: 10.1056/NEJMoa061894 – volume: 362 start-page: 419 year: 2003 ident: 10.1016/S0140-6736(16)31357-5_bib127 article-title: Breast cancer and hormone-replacement therapy in the Million Women Study publication-title: Lancet doi: 10.1016/S0140-6736(03)14065-2 – volume: 79 start-page: 996 year: 1995 ident: 10.1016/S0140-6736(16)31357-5_bib60 article-title: Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group publication-title: Br J Ophthalmol doi: 10.1136/bjo.79.11.996 – volume: 374 start-page: 2021 year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib196 article-title: Cholesterol lowering in intermediate-risk persons without cardiovascular disease publication-title: N Engl J Med doi: 10.1056/NEJMoa1600176 – volume: 308 start-page: 804 year: 2012 ident: 10.1016/S0140-6736(16)31357-5_bib287 article-title: Lipid-modifying therapies and risk of pancreatitis: a meta-analysis publication-title: JAMA doi: 10.1001/jama.2012.8439 – volume: 74 start-page: 818 year: 2010 ident: 10.1016/S0140-6736(16)31357-5_bib199 article-title: Pleiotropic effects of statins. Basic research and clinical perspectives publication-title: Circ J doi: 10.1253/circj.CJ-10-0110 – volume: 350 start-page: h2463 year: 2015 ident: 10.1016/S0140-6736(16)31357-5_bib215 article-title: The knowledge system underpinning healthcare is not fit for purpose and must change publication-title: BMJ doi: 10.1136/bmj.h2463 – volume: 138 start-page: 25 year: 2010 ident: 10.1016/S0140-6736(16)31357-5_bib193 article-title: Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2008.08.001 – volume: 308 start-page: 367 year: 1994 ident: 10.1016/S0140-6736(16)31357-5_bib174 article-title: By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? publication-title: BMJ doi: 10.1136/bmj.308.6925.367 – volume: 10 start-page: e0124451 year: 2015 ident: 10.1016/S0140-6736(16)31357-5_bib259 article-title: Statin effects on aggression: results from the UCSD Statin Study, a randomized control trial publication-title: PLoS One doi: 10.1371/journal.pone.0124451 – volume: 111 start-page: 823 year: 2013 ident: 10.1016/S0140-6736(16)31357-5_bib276 article-title: Effect of statin use on acute kidney injury risk following coronary artery bypass grafting publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2012.11.047 – year: 2016 ident: 10.1016/S0140-6736(16)31357-5_bib296 article-title: How Big Pharma greed is killing tens of thousands around the world: Patients are over-medicated and often given profitable drugs with ‘little proven benefits,’ leading doctors warn publication-title: MailOnline – ident: 10.1016/S0140-6736(16)31357-5_bib147 – volume: 23 start-page: 565 year: 2007 ident: 10.1016/S0140-6736(16)31357-5_bib194 article-title: Impact of gender on statin efficacy publication-title: Curr Med Res Opin doi: 10.1185/030079906X167516 – volume: 16 start-page: 1017 year: 1997 ident: 10.1016/S0140-6736(16)31357-5_bib28 article-title: Adjusting for non-compliance and contamination in randomized clinical trials publication-title: Stat Med doi: 10.1002/(SICI)1097-0258(19970515)16:9<1017::AID-SIM508>3.0.CO;2-V – reference: 28322814 - Lancet. 2017 Mar 18;389(10074):1098-1099. doi: 10.1016/S0140-6736(17)30718-3. – reference: 28322812 - Lancet. 2017 Mar 18;389(10074):1097-1098. doi: 10.1016/S0140-6736(17)30712-2. – reference: 28322815 - Lancet. 2017 Mar 18;389(10074):1098. doi: 10.1016/S0140-6736(17)30716-X. – reference: 27567278 - Lancet. 2017 Feb 11;389(10069):602. doi: 10.1016/S0140-6736(16)31468-4. – reference: 28322816 - Lancet. 2017 Mar 18;389(10074):1099-1100. doi: 10.1016/S0140-6736(17)30717-1. – reference: 27681574 - Nat Rev Cardiol. 2016 Nov;13(11):632-633. doi: 10.1038/nrcardio.2016.164. – reference: 28322813 - Lancet. 2017 Mar 18;389(10074):1097. doi: 10.1016/S0140-6736(17)30713-4. – reference: 31554604 - Drug Ther Bull. 2019 Oct;57(10):146. doi: 10.1136/dtb.2019.000066.
SSID	ssj0004605
Score	2.6951222
SecondaryResourceType	review_article
Snippet	This Review is intended to help clinicians, patients, and the public make informed decisions about statin therapy for the prevention of heart attacks and... Summary This Review is intended to help clinicians, patients, and the public make informed decisions about statin therapy for the prevention of heart attacks...
SourceID	proquest pubmed crossref elsevier
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	2532
SubjectTerms	Anticholesteremic Agents - therapeutic use Cardiovascular disease Cholesterol Cholesterol, LDL - blood Clinical outcomes Clinical Trials as Topic Coronary Disease - drug therapy Coronary Disease - prevention & control Drug therapy Drug-Related Side Effects and Adverse Reactions Health risks Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Internal Medicine Myocardial Infarction - drug therapy Myocardial Infarction - prevention & control Pain Patient safety Patients Prevention Risk Assessment Safety Side effects Simvastatin - therapeutic use Statins Stroke - drug therapy Stroke - prevention & control Studies Vascular diseases
Title	Interpretation of the evidence for the efficacy and safety of statin therapy
URI	https://www.clinicalkey.com/#!/content/1-s2.0-S0140673616313575 https://www.clinicalkey.es/playcontent/1-s2.0-S0140673616313575 https://dx.doi.org/10.1016/S0140-6736(16)31357-5 https://www.ncbi.nlm.nih.gov/pubmed/27616593 https://www.proquest.com/docview/1846832134 https://www.proquest.com/docview/1842598143
Volume	388
WOSCitedRecordID	wos000388166300031&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M7P dateStart: 19920104 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 7X7 dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Healthcare Administration Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M0T dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/healthmanagement providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Source (ProQuest) customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 7RV dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: BENPR dateStart: 19920104 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Consumer Health Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M0R dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/familyhealth providerName: ProQuest – providerCode: PRVPQU databaseName: Psychology Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2M dateStart: 19920104 isFulltext: true titleUrlDefault: https://www.proquest.com/psychology providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 8C1 dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2O dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2P dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RFiEuvEsXyipIHOAQGq8T2zkhqFpxYJdVKWhvluM4UiWULc220v57ZmwnFdKWInEZ5fUlUTz2fI7nAfDGoFJQUpeUmTxLcydsaoRocAs7lpWlsiIUm5CzmVosynn84dZFt8p-TPQDdb209I_8AGcigqrq8PzD-a-UqkbR6mosobEFO5QlgXvXvfmmuEjv4n4dwXPwbTj4lol3nPFCpsVNtukm7ult0PHD_337R_Agss_kY1CXx3DHtU_g3jSurz-FL3_6ICbLJkGCmLhYejRBhhsOUOIJY9eJaeukM41brelaik46a5MQ07V-Bt-Pj04PP6ex3kKKDVKsUptnDqd7VWG5Y45VmbJo4GokFBPstWVtHLLBitVSWFOp0kreCGFznjeitiJzfBe222Xr9iCpkWa4phKU3T13CmfskleKKlobZdFojiDvv7S2MRk51cT4qTd4neGebyBdjOD9ADsP2ThuA4i-GXUfaoqDo0Z7cRtQbgK6LnbxTjPdTXQW0ARGYktQRKoBGVlMYCf_8tD9Xnv09XMG1RnB6-E0DgK0smNat7z01-A0ViH3HcHzoKHD95lIfLWi5C_-fvOXcB-5oKAwS1buw_bq4tK9grv2anXWXYxhS578ILmQXiqU6pCNYefT0Wx-gnvTLMhTkpOpl1-9nI99r_wNd2srXg
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgigX3o-FAkYCCQ6hSZw4zgEhBFSturtCYpF6cx1nIlWqsqXZgvZP8RuZiZNUSFvKpQdueX1xYs-MPyfzAHhpSSg4qUsQ2SQMElQusEpVtEWK5bJcO-WLTWTTqd7fz7-swa8-FobdKnub2Brqcu74G_kWrUQUV9WRyfvj7wFXjeK_q30JDS8We7j8SUu25t3uJxrfV3G8_Xn2cSfoqgoE1Gy6CFwSIi1qitRJjDAqQu3IjJc0bcYkm3lpkThPEZWZcrbQuctkpZRLZFKp0qkQJd33ClzlvHrsQjgJZ6viMFuX-rOIoa2vw8HXkXojI5lmQXreXHge123nvO1b_1tv3YabHbsWH7w63IE1rO_C9UnnP3APxn_6WIp5JYgAC-xKqwpi8P4AJ9awbilsXYrGVrhY8rUcfXVYCx-ztrwP3y7lXR7Aej2v8RGIkmgUVoXi7PUJaixkJgvNFbutdkQKRpD0I2tcl2yda34cmRVedbTXCoRJR_B2gB37bCMXAVQvNqYPpSXjb2g-vAiYrQJi05mwxkSmiU3o0Qwm4s5QQuoB2bE0z77-pdHNXlrNWTuDqI7gxXCajBz_ubI1zk_ba2iZronbj-Ch14ihf-KMHi3N5eO_3_w5bOzMJmMz3p3uPYEbxHsVh5RG-SasL05O8Slccz8Wh83Js1anBRxctlr8Bma-fgM
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1ba9RAFD7UKsUX6921VUdQ0Ie4mUwyM3koIq2LpXUpqNC36WRyAgXJ1mar7F_z1_VMJkkRttaXPviW25fJ5Vy-Sc4F4JUlofBFXSJu0zhKUbrISlnREimWU7l2MjSbUNOpPjzMD1bgd58L48Mqe5vYGupy5vw38jHNRKTvqiPScdWFRRzsTN6f_Ih8Byn_p7VvpxFEZA8Xv2j61mzt7tC7fp0kk49ftz9FXYeBiC4hm0cujZEmOEXmBHLkRawdmfSSXGhCcpqXFon_FLxU0tlC506JSkqXirSSpZMxCjrvDbipBEmxz1Lf5styMtvw-ovsofGXYeMbLt8KLjIVZZf5xct4b-v_Juv_85O7C3c61s0-BDW5BytY34e1z11cwQPY_zP2ks0qRsSYYddylRGzDxt8wQ3rFszWJWtshfOFP9ZnZR3XLOSyLR7Ct2u5l0ewWs9qfAKsJHqFVSF9VfsUNRZCiUL7Tt5WOyILI0j7t2xcV4Td9wL5bpZE29FaKxwmG8G7AXYSqpBcBZC9CJk-xZacgiE_eRVQLQNi05m2xnDTJCYOaA8mQu-hhNQDsmNvgZX9y6CbveSai3EGsR3By2E3GT__R8vWODtrj6HpuybOP4LHQTuG55MourQsF0__fvIXsEbaYPZ3p3sbcJvosPSZpjzfhNX56Rk-g1vu5_y4OX3eqjeDo-vWinNGwIaB
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interpretation+of+the+evidence+for+the+efficacy+and+safety+of+statin+therapy&rft.jtitle=The+Lancet+%28British+edition%29&rft.au=Collins%2C+Rory&rft.au=Reith%2C+Christina&rft.au=Emberson%2C+Jonathan&rft.au=Armitage%2C+Jane&rft.date=2016-11-19&rft.eissn=1474-547X&rft.volume=388&rft.issue=10059&rft.spage=2532&rft_id=info:doi/10.1016%2FS0140-6736%2816%2931357-5&rft_id=info%3Apmid%2F27616593&rft.externalDocID=27616593
thumbnail_m	http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01406736%2FS0140673616X00499%2Fcov150h.gif